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ABSTRACT 
This PhD thesis represents development in the understanding of the 
epidemiology of the commonest skin cancer, basal cell carcinoma. 
 
Basal cell carcinoma (BCC) is a skin cancer of particular importance to the 
Australian community.  Its rate of occurrence is highest in Queensland, 
where 1% to 2% of people are newly affected annually.  This is an order of 
magnitude higher than corresponding incidence estimates in European and 
North American populations.  Individuals with a sun-sensitive complexion are 
particularly susceptible because sun exposure is the single most important 
causative agent, as shown by the anatomic distribution of BCC which is in 
general consistent with the levels of sun exposure across body sites.  A 
distinguishing feature of BCC is the occurrence of multiple primary tumours 
within individuals, synchronously or over time, and their diagnosis and 
treatment costs contribute substantially to the major public health burden 
caused by BCC.  A primary knowledge gap about BCC pathogenesis 
however was an understanding of the true frequency of multiple BCC 
occurrences and their body distribution, and why a proportion of people do 
develop more than one BCC in their life. 
 
This research project sought to address this gap under an overarching 
research aim to better understand the detailed epidemiology of BCC with the 
ultimate goal of reducing the burden of this skin cancer through prevention.  
The particular aim was to document prospectively the rate of BCC 
occurrence and its associations with constitutional and environmental (solar) 
factors, all the while paying special attention to persons affected by more 
than one BCC.  The study built on previous findings and recent 
developments in the field but set out to confirm and extend these and 
propose more adequate theories about the complex epidemiology of this 
cancer. 
 
Addressing these goals required a new approach to researching basal cell 
carcinoma, due to the need to account for the phenomenon of multiple 
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incident BCCs per person.  This was enabled by a 20 year community-based 
study of skin cancer in Australians that provided the methodological 
foundation for this thesis.  Study participants were originally randomly 
selected in 1986 from the electoral register of all adult residents of the 
subtropical township of Nambour in Queensland, Australia.  On various 
occasions during the study, participants were fully examined by 
dermatologists who documented cumulative photodamage as well as skin 
cancers.  Participants completed standard questionnaires about skin cancer-
related factors, and consented to have any diagnosed skin cancers notified to 
the investigators by regional pathology laboratories in Queensland.  These 
methods allowed 100% ascertainment of histologically confirmed BCCs in 
this study population.  1339 participants had complete follow-up to the end of 
2007.  Statistical analyses in this thesis were carried out using SAS and 
SUDAAN statistical software packages. Modelling methods, including 
multivariate logistic regressions, allowed for repeated measures in terms of 
multiple BCCs per person.  This innovative approach gave new findings on 
two levels, presented in five chapters as scientific papers: 
 
1. Incidence of basal cell carcinoma multiplicity and detailed anatomic 
distribution: longitudinal study of an Australian population  
The incidence of people affected multiple times by BCC was 705 
per 100,000 person years compared to an incidence rate of people 
singly affected of 935 per 100,000 person years.  Among multiply 
and singly affected persons alike, site-specific BCC incidence 
rates were far highest on facial subsites, followed by upper limbs, 
trunk, and then lower limbs 
2. Melanocytic nevi and basal cell carcinoma: is there an association? 
BCC risk was significantly increased in those with forearm nevi 
(Odds Ratios (OR) 1.43, 95% Confidence Intervals (CI) 1.09-1.89) 
compared to people without forearm nevi, especially among those 
who spent their time mainly outdoors (OR 1.6, 95%CI 1.1-2.3) 
compared to those who spent their time mainly indoors.  Nevi on 
the back were not associated with BCC.       
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3. Clinical signs of photodamage are associated with basal cell                   
carcinoma multiplicity and site: a 16-year longitudinal study 
Over a 16-year follow-up period, 58% of people affected by BCC 
developed more than one BCC.  Among these people 60% 
developed BCCs across different anatomic sites.  Participants with 
high numbers of solar keratoses, compared to people without solar 
keratoses, were most likely to experience the highest BCC counts 
overall (OR 3.3, 95%CI 1.4-13.5).  Occurrences of BCC on the 
trunk (OR 3.3, 95%CI 1.4-7.6) and on the limbs (OR 3.7, 95%CI 
2.0-7.0) were strongly associated with high numbers of solar 
keratoses on these sites. 
4. Occurrence and determinants of basal cell carcinoma by histological 
subtype in an Australian community 
Among 1202 BCCs, 77% had a single growth pattern and 23% 
were of mixed histological composition.  Among all BCCs the 
nodular followed by the superficial growth patterns were 
commonest.  Risk of nodular and superficial BCCs on the head 
was raised if 5 or more solar keratoses were present on the face 
(OR 1.8, 95%CI 1.2-2.7 and OR 4.5, 95%CI 2.1-9.7 respectively) 
and similarly on the trunk in the presence of multiple solar 
keratoses on the trunk (OR 4.2, 95%CI 1.5-11.9 and OR 2.2, 
95%CI 1.1-4.4 respectively). 
5. Basal cell carcinoma and measures of cumulative sun exposure: an 
Australian longitudinal community-based study 
Dermal elastosis was more likely to be seen adjacent to head and 
neck BCCs than trunk BCCs (p=0.01).  Severity of dermal 
elastosis increased on each site with increasing clinical signs of 
cutaneous sun damage on that site.  BCCs that occurred without 
perilesional elastosis per se, were always found in an anatomic 
region with signs of photodamage. 
 
This thesis thus has identified the magnitude of the burden of multiple BCCs.  
It does not support the view that people affected by more than one BCC 
represent a distinct group of people who are prone to BCCs on certain body 
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sites.  The results also demonstrate that BCCs regardless of site, histology or 
order of occurrence are strongly associated with cumulative sun exposure 
causing photodamage to the skin, and hence challenge the view that BCCs 
occurring on body sites with typically low opportunities for sun exposure or of 
the superficial growth pattern are different in their association with the sun 
from those on typically sun-exposed sites, or nodular BCCs, respectively.  
Through dissemination in the scientific and medical literature, and to the 
community at large, these findings can ultimately assist in the primary and 
secondary prevention of BCC, perhaps especially in high-risk populations.  
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CHAPTER 1 
Review of literature and research questions 
  
  2 
1.1 Introduction 
Basal cell carcinoma (BCC) is the most common human malignancy and 
among Caucasian populations it is the predominant cancer of the skin 
(Zedan et al.) (All references from Chapter 1 can be found in the final List of 
References).  The highest reported incidence rates are recorded for 
Queensland, Australia where 1 to 2 people per 100 are affected annually 
(Raasch and Buettner, 2002).  This is an order of magnitude higher than 
corresponding estimates in European and North American populations.  Sun 
exposure is the single most important causative agent, and the anatomic 
distribution of BCC is in general consistent with the levels of sun exposure 
across body sites (Diffey et al., 1979).  A distinguishing feature of BCC is the 
common occurrence of multiple primary tumors within individuals, 
synchronously or over time, and it is their treatment costs that underscore the 
major public health relevance of BCC (Joseph et al., 2001; Mathers et al., 
1999). 
 
This literature review has a dual purpose.  First, it will provide an overview of 
pertinent areas of research in order to position this study within its field.  
There is an extensive focus on the frequency of this disease and the causal 
and susceptibility factors of this skin cancer.  Thus this body of work centres 
on the epidemiology of BCC.  Secondly, this literature review is a collection of 
evidence that supports the identification of gaps in the field and thus 
establishes its potential significance and its innovative contribution to 
knowledge.  The literature search that forms the basis of this literature review 
was performed largely in Entrez Pubmed 
(http://www.ncbi.nlm.nih.gov/sites/entrez), which was accessed regularly 
throughout the duration of the research.  In order to place BCC within the 
context of human body anatomy, exposures, and other pathological skin 
conditions a vast array of literature was read and integrated into the literature 
review.  However, its scope was limited to concentrate on prominent 
research and the latest publications within each area.  Papers were selected 
to offer a balanced representation of both Australian and international 
research. 
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Basal cell carcinomas are not routinely recorded at cancer registries, thus 
incidence estimates in northern and southern hemisphere populations have 
largely come from ad hoc studies (these studies are further discussed in 
1.4.1 Rate of Occurrence below).  This is also true for many studies that have 
sought to identify risk factors for BCC (these studies are further discussed 
below in 1.4.3 Risk Factors).  Cellular- and molecular-based investigations 
often rely on ex vivo and animal model experiments to advance the 
understanding of BCC pathogenesis in relation to phenotype and 
environmental exposures but rarely translate the results adequately into 
human in-vivo knowledge.  This research project seeks to in-part address 
these gaps, based on a unique resource, namely the Nambour Skin Cancer 
Study. 
1.2 Skin structure and function 
In its normal capacity, human skin is the natural boundary between the 
person and their external environment.  Skin belongs to the integumentary 
system and in terms of body weight, is the largest human organ (Goldsmith, 
1990).  Skin originates from the juxtaposition of the embryological ectoderm 
and underlying mesoderm, which give rise to the epidermis and the dermis 
respectively.  It is highly differentiated and dynamic; responsible for a range 
of precise functions.  The two main types of skin are non-hairy, found on the 
soles and palms, and hair-bearing skin.  Functions include homeostatic 
support through regulation of body temperature, protection from pathogens 
and mechanical and chemical insults, sensory reception and pigmentation.  
Whilst the skin layers appear independent of one another, they do cooperate 
to perform these skin-specific functions.  As the body’s outermost layer skin 
is susceptible to damage from external influences. 
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1.2.1 Epidermis 
The stratified, multi-cellular epidermis is a continually renewing epithelium.  It 
has four levels of differentiation based on keratinocyte morphology (see 
Keratinocytes section below and Figure 1.1) (Freinkel and Woodley, 2001; 
Rook, 2004).  As the most superficial layer, the stratum corneum is the 
barrier to water loss (containing 15-30 sheets of flattened terminally 
differentiated keratinocytes called corneocytes).  The concentrated keratin 
within these cells is also the primary obstruction between ultraviolet radiation 
(UVR) and epidermal DNA.  The next, inner, layer is composed of 3-5 sheets 
of non-dividing keratinocytes that produce cytoplasmic basophilic 
keratohyalin granules (Holbrook, 1989).  Immediately below are 8-10 sheets 
of keratinocytes with limited ability for cell division that produce spinous-
shaped  
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Figure 1 Human skin: its structure and appendages (source: 
http://en.wikipedia.org/wiki/Skin). 
 
keratinocytes.  The innermost layer, the basal layer, contains columnar-
shaped, mitotically active keratinocytes and keratinocytes with stem cell-like  
properties.  It is here, that immigrant cells such as melanocytes, Langerhans 
and Merkel cells can enter the epidermis.  Blood vessels do not infiltrate the 
epidermis; it receives nourishment by diffusion from the dermis.  Cells within 
the basal layer are anchored to a non-cellular basement membrane that is 
the division between the epidermis and dermis.  
 
Keratinocytes 
 
Keratinocytes are the major cell type of the epidermis.  They originate in the 
basal layer from the mitotic division of keratinocyte stem cells and their 
transient amplifying daughter cells.  A proportion of the dividing basal 
keratinocytes are stem cells (Watt, 2001), and they reside in clusters in the 
interfollicular basal epidermis and in the bulge region of hair follicle.  As these 
cells differentiate and travel through the epidermal layers they accumulate 
quantities of the protein keratin, which acts as a structural matrix, until they 
apoptose and are completely keratinised.  At the end of this process, which 
takes about a month, they are shed and replaced.  Each layer is composed 
of a different amount of keratin, ranging from approximately 30% in the basal 
layer up to 80% in the stratum corneum (Tobin, 2006). 
 
Melanocytes 
 
Embryologically, melanocytes arise from the neural crest and reside in the 
basal layer of the adult epidermis (Erickson, 1993; Weston, 1970).  The 
number of these pigment synthesising cells is constant across individuals 
(Szabo, 1959).  However, the level of melanin-production and distribution 
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varies; yielding skin colour variation.  The melanin protein is produced in the 
melanosome, a specialised and melanocyte-specific organelle (Freinkel and 
Woodley, 2001).  This biochemical process is continuous and is termed 
melanogenesis (Slominski et al., 2004).  Production is regulated and heavily 
influenced by UVR exposure.  Melanosomes are transferred to the 
keratinocytes where they sit atop the nucleus, lessening the amount of UVR 
reaching the cells’ DNA.  Two types of cutaneous melanin have been 
described: eumelanin and pheomelanin (Rook, 2004).  The former produces 
brown-black colours; the latter provides yellow-red colours and is more 
prominent in fair-skinned individuals (Rook, 2004). 
1.2.2 Dermis 
The epidermis and dermis are detached from one another by the dermal-
epidermal junction, to which they are both anchored.  The major constituent 
of this is the basement membrane serving as the interface and filter (Freinkel 
and Woodley, 2001).  Of mesodermal origin, the dermis acts as a structural 
support and nutrient-provider for the cells of the epidermis.  Regional 
variation based on the size of collagen fibrils and cell density, splits the 
dermis into two layers.  The upper papillary dermis interweaves with the 
epidermis, is cell-rich and here the collagen fibrils are smaller in diameter 
compared to those of the deeper reticular dermis which blends with 
subcutaneous fat tissue.  The principal cellular elements are fibroblasts, 
responsible for the manufacture of dermal connective tissue elements or their 
precursors, and mast cells, which have a significant role in the event of an 
allergic reaction.  The dermis contains blood vessels and lymphatic 
capillaries that provide nourishment to the basal layer of the epidermis.  It is 
also filled with sensory and motor nerve endings and is abundantly supported 
with secretory and excretory glands, namely eccrine, apocrine, apoeccrine 
and sebaceous glands, and hair follicles (Freinkel and Woodley, 2001). 
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Hair 
 
Hair is characteristic to the mammalian class and the human body is almost 
entirely covered by millions of highly structured hair follicles (Dawber, 1997; 
Paus and Peker, 2003).  In humans, hair has little purpose except for the 
protective capabilities of eyebrows, eyelashes, nose and ear hair, and 
physical differentiation within society.  In the adult two hair types are 
recognised: vellus and terminal.  Vellus hairs found on most body sites are 
short (< 1 cm), light coloured and thin.  Terminal hair is the thicker and darker 
hair of the scalp, and is more widespread on males (Rook, 2004). 
 
Hair follicle structure 
 
Hair follicles are the structures that produce hair, and similar to cutaneous 
keratinocytes they are constantly renewed, undergoing continual cycles of 
growth and regression.  Embedded within the dermis, hair follicles are 
distributed in a periodic pattern.  It is believed that few, if any hair follicles are 
formed after birth and that their density reduces with advancing age 
(Giacometti, 1965).  Between races, the vellus and terminal hair follicle 
density (number of hair follicles per unit area) varies but the chemical 
composition of hair protein is uniform (Lee et al., 2002; Loussouarn, 2001; 
Mangelsdorf et al., 2006; Sperling, 1999; Whiting, 1993).  However, within 
any one ethnic group, these measures are similar among individuals, with 
density varying dramatically according to body site, and the highest being 
consistently recorded on the facial region (Blume et al., 1991; Otberg et al., 
2004). 
 
Structurally, hair follicles lie at an angle to the skin surface.  Two distinct 
layers line the length of the hair follicle: the keratin rich outer and the inner 
root sheaths.  The former extends the follicle’s entire length whilst the latter 
stops in line with the sebaceous gland and has some contact with the hair 
shaft.  Giving rise to these inner and outer layers of the hair fibre are 
germinative cells.  They have a high division rate and surround the papilla 
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located at the base of the hair follicle.  On one side of the follicle, within the 
outer root sheath is the bulge region.  Anatomically, this appears as a 
thickened region and functionally, it harbours stems cells (Akiyama et al., 
1995; Lyle et al., 1998).  The continual regeneration of the hair follicles relies 
upon these stem cells.  Attached to the bulge are the erector pili, a bundle of 
smooth muscles, which enable the hair to stand vertically when contracted. 
Further up the hair follicle, is the sebaceous gland whose gland size, density 
and activity vary depending upon the local milieu of the body site (hormones) 
(Randall et al., 2000).  Only on mucosal membranes are sebaceous glands 
found in absence of hair follicles (for example, the lips).  They are found in 
high density on the scalp and face, at up to 200 sebaceous glands cm-2, and 
not at all on the palms, soles and dorsum of the feet (Tobin, 2006).  The 
primary function of sebaceous glands is the production of sebum, a yellowish 
viscous fluid that mainly contains lipids (Tobin, 2006).  These glands are also 
involved in steroidogenesis and possibly the production of anti- and pro-
inflammatory compounds (Zouboulis, 2004).  A hair follicle together with its 
sebaceous gland is traditionally termed ‘the pilosebaceous unit’. 
 
1.3 Clinical and pathological diagnosis 
1.3.1 Clinical diagnosis 
With regard to sun-induced lesions, the appearance of BCC is generally 
distinct clinically  (Rook, 2004).  Basal cell carcinoma may develop anywhere 
on the skin surface and whilst the majority of these cancers are slow growing 
in nature and confined to the anatomic sub-site of origin they can be very 
destructive to the local anatomy (Rigel, 2005).  Patients may acquire new 
primary BCCs more than once (synchronously and metachronously).  
Recurrent BCCs, on the other hand, present at the sites of previously treated 
BCCs. 
 
The appearance of BCC may vary for several fundamental reasons including 
stage at diagnosis and histological type.  Early tumours appear small, 
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translucent, raised and rounded and dilated superficial blood vessels may 
infiltrate (Rook, 2004).  With disease progression the lesions tend to maintain 
their original growth pattern extending peripherally in a slow and locally 
invasive manner (Telfer et al., 1999).  A common type is the Nodular BCC; 
typically raised, shiny and pearly with defined margins (Rigel, 2005).  The 
degree of vascularity varies and ulceration occurs late in development.  
Superficial types tend to be bright pink and shiny in appearance, but are less 
well-defined erythematous macular lesions (Rigel, 2005);  vascularity and 
pigmentation may be present.  The Morphoeic BCC looks like a pale scar 
and patients can be unaware of them.  They have a disposition to be deeply 
invasive, due to a sclerosing growth pattern with fibrosis causing greater 
tissue destruction (Rook, 2004).  Mixed types occur also, making diagnosis 
difficult. 
 
The clinical diagnosis of BCC is not without difficulty but accurate diagnosis 
is important, especially in high risk populations.  In the primary care setting 
the initial diagnosis is normally made by a general practitioner or 
dermatologist and a suspected clinical diagnosis is often verified 
histologically (Streeton et al., 2006).  A recent Australian-based study 
compared the clinical and histological diagnosis of excised skin lesions in 
8694 patients; they reported that clinical diagnostic accuracy was highest for 
BCC (positive predictive value (PPV) 72%) when compared with squamous 
cell carcinoma and melanoma (PPV 49% and 33% respectively) (Heal et al., 
2008).  Similarly, Youl et al. compared the diagnostic accuracy of skin lesions 
among general practitioners and doctors within primary care “skin cancer 
clinics”.  They reported that the overall clinical accuracy for diagnosing skin 
cancer was similar between general practitioners and skin cancer clinic 
doctors, and the latter group had greater sensitivity when diagnosing BCC 
and melanoma (Youl et al., 2007). 
          
  10 
1.3.2 Histology 
In 1827 the first description of BCC was recorded by Sir Arthur Jacob (1790-
1874) (Jacob, 1827).  Jacob’s account encompassed the well-defined 
margins of BCCs, their lack of potential to metastasise and the limited 
morbidity of those affected (Jacob, 1827).  Edumund Krompecher later 
differentiated BCC from other epithelial tumors and suggested they are 
derived from the pluripotent, undifferentiated cells of the basal layer of the 
epidermis or the cutaneous appendages (Krompecher, 1903). 
 
On this basis it is not surprising that at least twenty histological subtypes 
have been described subsequently (Slater, 2002), among them several 
common growth patterns ((NHMRC), 2002).  Histological classification is 
traditionally based on the extent and type of differentiation with 
acknowledgment of the growth pattern.  Typically, tumour cells resemble 
those of the basal layer of the epidermis and the matrix cells of the 
appendages.  They are noted for their compact nuclei, small cytoplasm and 
interaction with the adjacent dermis which produces their well organised 
stroma (Freinkel and Woodley, 2001).  The interaction with the dermis, a 
principal function of the normal basal cell, produces the characteristic 
marginal palisade of tumour cells.  Some lesions may have a degree of 
differentiation toward epithelial adnexa but in most cases this is not true to 
the derivation of any individual epithelial structure.  Histological differentiation 
may occur because, during development, tumour cells may sever their 
connection to epithelial appendages or establish a secondary connection to 
structures to which it becomes close.  Of the common types, the superficial 
and morphoeic variants each have a representative histopathologic image 
that differs slightly from lesion to lesion.  The most common subtype Nodular, 
which accounts for up to 80% (Boi et al., 2003) can show many different 
histopathological variants. 
 
To provide examples of typical histological pictures of the common variants: 
superficial BCCs show horizontally arranged lobules of atypical basal cells in 
the papillary dermis that maintain epidermal contact yet there is minimal 
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extension into the lower epidermis.  The morphoeic type has fine radiating 
extensions that complicate margin identification and show no residual 
association with the epidermis and epithelial structures.  Nodular BCCs are 
characteristically dome-shaped, composed of irregularly sized and shaped 
islands of basaloid cells with a circumscribed growth pattern. 
 
1.3.3 Cell of origin theories 
When compared histologically to other cutaneous lesions, BCCs show little 
cellular organisation.  Research has propagated many theories about the cell 
of origin of this common cancer.  Among them are the basal cells of the 
epidermis, the infundibular and the outer root sheath of the hair follicle, 
dormant primordial epithelial germ cells, cells of the pilosebaceous unit and 
cells of appendageal structures other than the hair follicle (Lang and Maize 
Sr, 2005).  Pioneering studies using light microscopy to detect the earliest 
signs of proliferation in human tumours and experimental tumours of the rat 
pointed to the outer root sheath of the hair follicle and the interfollicular 
epidermis as the site of origin (Miller, 1991; Zackheim, 1962, 1963).  At this 
cellular position, it is possible for the tumour to grow with the epidermis, 
however, recent investigations point to the epidermal stem cell populations 
that reside in the hair follicle bulge and in a non-random distribution within the 
basal cells of the interfollicular epidermis (also termed keratinocyte stem 
cells).  At the present pluripotent germinative cells of the epidermis and bulge 
region of the hair follicle are considered a likely cell of origin allowing the 
BCC to develop into any of the epithelial structures (Barthel and Aberdam, 
2005; Tilli et al., 2005). 
1.4 Epidemiology 
1.4.1 Rates of occurrence 
Validity of reported estimates 
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In most countries it is not a legal requirement of the treating doctor to notify 
population-based cancer registries of keratinocyte cancer.  In some 
countries, notification is optional, leading to incomplete data.  This is for 
various reasons, depending on the country: the ubiquity of the lesions and 
resulting logistical difficulties in sustaining correct records (high incidence) or 
the lack of severity (low incidence) (Green and Maclennan, 1989).  
Furthermore, a portion of BCCs are treated without surgical measures and 
not histologically confirmed (Albert and Weinstock, 2003; Streeton et al., 
2006).  Consequently incidence estimates in northern and southern 
hemisphere populations have largely come from ad hoc studies (these 
studies are further discussed in 1.4.1 Rate of Occurrence below).  It is 
therefore likely that the BCC estimates that are available are in fact 
underestimates of the true rate of occurrence, hence accurate and 
representative epidemiological findings of BCC are sparse.  
 
1.4.1.1 Incidence 
BCC is the commonest cancer in Caucasian populations worldwide (Telfer et 
al., 1999) (Bower et al., 2000; Diepgen and Mahler, 2002). 
 
Australia 
 
A survey in 2002 of over 57,000 Australians estimated an age-standardised 
incidence rate of 884 BCCs per 100,000 persons (Staples et al., 2006).  
Findings from the same investigation showed that incidence increased with 
age and was generally higher in men than women in each age group.  
Incidence peaked at ages 70 years or older at 5308 BCCs per 100,000 
persons: 7051 and 3880 BCCs per 100,000 men and women respectively.  
Incidence (Staples et al., 2006).  The same National survey data indicated 
the incidence of BCC had increased by 35% in 18-years leading up to 2002 
(Staples et al., 2006).  Despite the high incidence rates of BCC, the case 
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fatality rate is low at 2.0 per 100 000 for males and 0.6 per 100 000 for 
females (AIHW, 2004). 
 
Repeated occurrences 
 
Basal cell carcinoma has a predilection to occur more than once, either 
synchronously or over time, in a proportion of people affected.  Since no 
previous estimates however have accounted for this occurrence of multiple 
BCCs per person, these previous studies would have underestimated the 
true BCC tumour incidence. 
 
Australian national survey data for the year of 2002 revealed that 27% of 
people affected by BCC (where 81% were histologically confirmed) 
experienced more than one BCC.  This proportion was similar for males and 
females (Staples et al., 2006).  In a tropical Australian community, over a 3-
year period, 26% of people affected by BCC were treated for more than one 
BCC (Raasch and Buettner, 2002).  It was not made clear in either of these 
studies whether peoples’ BCCs were diagnosed at the same or different 
times.  When describing the occurrence of multiple BCCs within the Nambour 
Skin Cancer Trial, Pandeya et al found that 47% of people who had 
developed a BCC experienced a second primary BCC, and of these 50% 
went on to develop a third primary BCC, all within a 4.5-year period (Pandeya 
et al., 2005).  In the Australian population the incidence of people affected by 
multiple BCCs has not been estimated previously. 
 
International 
 
Selected incidence estimates for countries other than Australia are presented 
in order of decreasing latitude (of the major city in the respective region).  
They are presented separately because incidence estimates for different 
geographical regions have been age standardised to different populations 
and are therefore not directly comparable.     
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The Netherlands  (Latitude 52°N) 
Using cancer registry data it is estimated that 93 males and 82 females were 
affected by BCC per 100 000 person-years at risk (pyar) in the Netherlands 
from 1973 to 2000 (European age standardised) (de Vries et al., 2004).  
Incidence rates increased with advancing age in both sexes, but in particular 
among young women.  In the same population, for the period 1973 to 2000 
the estimated annual percentage increase in BCC incidence for males and 
females was 2.4% and 3.9% respectively (de Vries et al., 2004). 
 
United Kingdom  (Latitude 51°N) 
Recent estimates from the United Kingdom indicate BCC affected 60 persons 
per 100 000 pyar in 1996 to 2003 (world age standardised) (Bath-Hextall et 
al., 2007a).  The incidence of BCC was slightly higher among men than 
women: 69 and 53 persons per 100 000 pyar, respectively.  During the 
period, 1996 to 2003, there was a 3% increase year by year and this trend 
was strongest for those aged 30 to 39 years (Bath-Hextall et al., 2007a).   
 
North America  (Latitude 30-47°N) 
A cross-sectional study in 1993-1994 of the state of New Hampshire (latitude 
43°N),  indicated BCC occurs at a rate of 310 and 166 per 100 000 persons 
for males and females, respectively and increased with age (these estimates 
are general and inclusive of all ethnic groups, and age standardised to North 
America) (Karagas et al., 1999).  When the latter estimates are compared to 
the corresponding estimates for 14 years earlier there was an annual 4% 
increase for both men and women (Karagas et al., 1999).  In the southeast of 
Arizona (latitude 33°N) the incidence of BCC in 1996 was 936 and 497 per 
100 000 persons for male and females respectively (these estimates are 
general and inclusive of all ethnic groups) (Harris et al., 2001).  Over the 
period 1985 to 1996 there was an increase in the incidence of BCC, 
however, this was not a steady increase with some years showing a reduced 
incidence compared to the previous year. 
 
Singapore (Latitude 1°N) 
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The most recently reported incidence rate of BCC in Singapore was 5.5 per 
100 000 pyar during 1993 to 1997 (Koh et al., 2003).  The incidence among 
males and females was similar.  According to ethnic groups, the Chinese 
people had the highest BCC rates (6.4 per 100 000 pyar among males), 
followed by the Malays (3 per 100 000 pyar among females) and then Indians 
(1.4 per 100 000 pyar among females).   
 
The overall incidence of BCC increased significantly during 1968 to 1997 with 
an annual increase of 3%. 
 
Repeated occurrences 
 
In northern hemisphere populations in temperate climates, where the 
incidence of single BCC does not reach 1% (Bath-Hextall et al., 2007a; 
Karagas et al., 1999), multiplicity of this skin cancer is still observed (Lear et 
al., 1997; Levi et al., 2006).  A study using Swiss cancer registry data 
revealed the risk for second BCC was higher among people who were 
diagnosed with their first BCC at a young age (Levi et al., 2006).  
Furthermore, the cumulative incidence of a second BCC increased with time 
since diagnosis of the first BCC: 11% at 5-years, 21% at 10-years and 40% 
at 20-years.  This finding was further supported by a meta-analysis of seven 
separate studies previously conducted on American populations: following a 
first BCC the incidence of subsequent BCC increased by a factor of 10, 
compared to those not affected by BCC and with no known genetic 
susceptibility (Marcil and Stern, 2000).   
 
Incidence and repeated occurrences overall 
 
In general as above, international estimates for the incidence of BCC are less 
than the corresponding estimates from Australian populations.  This is 
because the Australian population are predominantly Caucasian and live in 
closer proximity to the equator than those living in the northern hemisphere.  
Regardless of geographic region, BCC incidence estimates increase with 
advancing age and are almost always higher for men than women.  
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Furthermore the incidence of this skin cancer appears to be increasing with 
time and it is likely there is a combination of reasons behind this, including, 
increased outdoor activities, change in clothing habits, increased longevity, 
ozone depletion all of which reflect a greater opportunity for sun-exposure, 
and as a result of skin cancer awareness and prevention campaigns more 
people present for treatment (Diepgen and Mahler, 2002; Gloster and 
Brodland, 1996) 
 
1.4.2 Anatomic distribution 
Like other sun-induced cutaneous cancers, BCC occurs frequently on 
anatomical sites exposed to solar UVR. 
 
Australia 
 
The anatomic distribution of BCC is generally well described for the 
Australian population.  Information is needed however, on the specific 
anatomic subsites affected by BCC.  The results of the 2002 keratinocytic 
skin cancer survey of 57,215 people (Staples et al., 2006), of whom 817 had 
a BCC in the previous 12 months, revealed that the head and neck region 
followed by the trunk had the greatest relative tumour density (calculated as 
the ratio of the proportion of tumours at a particular site to the proportion of 
total skin surface area of that site).  In a prospective population-based survey 
in tropical north Queensland, including 2,327 patients with 3,538 BCCs, by 
far the most BCCs were excised from the face (males: 43%, females: 51%) 
followed by the posterior trunk (males: 15%, females: 9%) (Buettner and 
Raasch, 1998).  The same study also reported site-specific incidence rates of 
BCC that were extreme on the ear, nose and cheek for men (56,402 per 
100,000 body units) and women (29,879 per 100,000 body units) (Buettner 
and Raasch, 1998).  In men, the neck, posterior trunk and shoulders and in 
women the neck, shoulders and arms also showed extreme incidence rates 
of BCC.  These findings reflect the results of an earlier skin cancer survey of 
  17 
tropical north Queensland (Raasch et al., 1998).  Among each of these 
studies, the hands and feet were rarely affected by BCC.  
 
 Histological subtypes 
 
One Queensland-based study to report the anatomic distribution of BCC by 
histological subtype revealed that the nodular, infiltrative and micronodular 
BCC were most common on the face for both sexes, while superficial BCCs 
were most frequent on the posterior trunk among males and the upper limbs 
among females (Raasch et al., 2006).  A Victorian study of 3885 BCC 
patients reported that the nodular growth pattern was the most common 
overall (64%) and at each subsite, especially the head and neck where it 
accounted for 65% of specimens taken from this site (McCormack et al., 
1997).  Superficial BCCs accounted for 15% of BCCs overall and they were 
roughly equally distributed between the trunk, lower limbs and upper limbs 
(29%, 27% and 23% respectively) (McCormack et al., 1997).   
 
 Repeated occurrences 
 
The anatomic distribution of BCCs among people affected by more than one 
BCC has not previously been described within the Australian population.  It is 
not known if overall site distribution varies between people with a single BCC 
and those with multiple BCC occurrences or between males and females. 
 
International 
 
Retrospective studies originating in the northern hemisphere report that 
BCCs of the head and neck region account for at least 69% of lesions 
(Bastiaens et al., 1998; Diepgen and Mahler, 2002; Scrivener et al., 2002).  
The next most common site is the trunk (posterior and anterior trunk are 
grouped together), hosting 12% to 21% of tumours (Bastiaens et al., 1998; 
Scrivener et al., 2002).  These findings were supported by an Italian case-
control study (Pelucchi et al., 2007) and further corroborated by two reports 
  18 
from population-based cancer registries in Switzerland and the USA 
(Franceschi et al., 1996; Harris et al., 2001).  Using the Swiss population-
based cancer registry data, Franchesci et al reported that that highest rate of 
BCC (per unit surface area) were seen for both males and females on the 
face, followed by the neck, ears and scalp and the trunk (Franceschi et al., 
1996). 
 
Few studies have considered anatomic subsite distribution of BCC: Pearl and 
Scott, using combined data from five datasets, reported an excess of BCC on 
the nose (Pearl and Scott, 1986).  BCCs were more common on the ears 
among males than females but the reverse was true for the lower leg (Pearl 
and Scott, 1986).  Lovatt et al found truncal BCC to be significantly more 
common in males (Lovatt et al., 2004). 
  
Histological subtypes 
 
In a large retrospective study of BCC in France with some 10 245 people 
affected by BCC, both the nodular and morpheic BCCs were predominant on 
the head (90% and 95% respectively), whereas superficial BCCs most 
commonly occurred on the trunk (46%) (Scrivener et al., 2002).  The 
predominance of the nodular type for the head and neck, and the superficial 
subtype for the trunk was also observed in a retrospective collection of 1711 
Dutch people and their BCCs and an Italian case-control study (Bastiaens et 
al., 1998; Pelucchi et al., 2007).  No studies have assessed the proportion of 
BCC histological subtypes according to anatomic subsite. 
 
Repeated occurrences 
 
One study described, in broad terms that people with multiple BCCs tend to 
develop their BCCs on a single site (Ramachandran et al., 2001), however, 
there was no explicit evidence provided about the proportion of people who 
developed BCC on a single anatomic site or on more than one anatomic site.  
In contrast, a hospital-based study in the Netherlands with a median follow-
up time of 3.1-years revealed that 33% of people affected by multiple BCCs 
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were affected across different sites (van Iersel et al., 2005).  Furthermore in 
an American study 45% of people affected by multiple BCCs developed 
BCCs on different anatomic sites during 7-years of follow-up (Marghoob et 
al., 1993). 
 
1.4.3 Risk Factors 
 
BCC pathogenesis occurs as a result of a complex of factors both 
endogenous and exogenous to the human body.  These include: solar 
ultraviolet radiation, constitutional factors, arsenic, ionising radiation and 
immunosuppressive treatments.  The following paragraphs acknowledge 
those risk factors for which the majority of BCCs are likely attributable to 
(solar ultraviolet radiation and constitutional factors).  
 
1.4.3.1 Solar ultraviolet radiation 
 
Ultraviolet radiation (UVR) is the component of the sun’s rays that cannot be 
seen or felt but has the preeminent role in skin cancer causation.  There are 
three main components to UVR, namely UVA(320-400nm), UVB(280-320nm) and 
UVC(200-280nm) (Green and Whiteman, 2006).  The latter is entirely blocked by 
the ozone layer leaving only UVA and UVB to reach the Earth’s surface.  The 
quality and quantity of UVR is determined by many factors.  The time of day 
and season have a direct role in the amount of UVR that reaches the Earth’s 
surface such that up to 30% of the total UVR is received between 11am and 
1pm especially during Summer months (Matts, 2006).  On a global scale 
factors that increase the UVR at the Earth’s surface include decreasing 
latitude, increasing altitude and cloud cover (Matts, 2006).  All UVR that 
reaches the skin’s surface has potential carcinogenic effects and the principal 
mechanism of action is via DNA damage where UVB acts directly and UVA 
indirectly.  UVB produces dimers, which interrupt the functionality of the DNA.  
They usually take on the form of C to T or CC to TT mutations at 
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dypyrimidine sites and are typically called ‘UV signatures’.  UVA causes the 
production of reactive oxygen species within cells (Halliday, 2005).  Whilst 
skin cells have mechanisms in place that lessen these photo-biological 
products through the repair of DNA and mopping up of reactive oxygen 
species (Ravanat et al., 2001) this does not always happen efficiently and 
carcinogenesis is a major consequence. 
 
Solar ultraviolet radiation and basal cell carcinoma 
 
Sun exposure is considered the major environmental factor that causes BCC 
pathogenesis (Rubin et al., 2005).  Its association with BCC development is 
traditionally supported by a strong inverse latitudinal gradient (Muir et al., 
1987) and distribution that is consistent with general levels of sun exposure 
across body sites (International Agency for Research on Cancer, 1992). 
 
Although evidence is available for an association between general BCC 
occurrence and cutaneous sun damage, it is not known how acute and 
chronic sun damage interrelate in BCC pathogenesis.  In previous analytical 
epidemiological studies, BCC’s association with sun exposure has been 
supported by various degrees of evidence.  In order of increasing objectivity 
measures of solar exposure that have been used include self-recalled sun 
exposure, clinical, and histological evidence of photodamage.   
 
The effects of the UV bands in epidemiological studies are difficult to 
separate, and UVR exposure usually refers to the effects of both UVA and 
UVB.  Within the cause and effect model (UVR and BCC) the carcinogenic 
effect of UVR is not fully understood, but the various cutaneous effects of sun 
exposure as known are discussed below in relation to BCC. 
 
Self-recalled sunburns 
 
Sunburns are a consequence of acute overexposure to UVR for the skin type 
concerned and they are associated with BCC.  With regard to self-reported 
acute sun exposure six independent studies have shown that self-reported 
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histories of sunburns are strongly associated with BCC risk (Green et al., 
1996; Kricker et al., 1991; Naldi et al., 2000; van Dam et al., 1999; Walther et 
al., 2004; Zanetti et al., 1996).  Previous findings from the Australia 
community-based Nambour study found the odds for BCC to be almost 2-fold 
higher among people with a history of six or more sunburns compared to 
people with no sunburn history (Green et al., 1996).  In the Health 
Professionals Follow-up Study a history of any number of sunburns 
increased the risk for BCC significantly (van Dam et al., 1999).  In an Italian 
case-control study, two or more sunburns under the age of 15 years was 
associated with a 4-fold increase in the odds for BCC compared to people 
with no sunburns before age 15 (Naldi et al., 2000).  A study that recorded 
information about sunburns at specific anatomic sites found a significant 
association with painful sunburns at the site of BCC occurrence (Kricker et 
al., 1991).   
 
Although numerous epidemiological studies support a significant association 
between sunburn history and BCC development, sunburn history is a 
particularly subjective measure of sun damage.  There is mixed literature 
surrounding the reliability of sunburn recall among adults (Berwick and Chen, 
1995; Shoveller and Lovato, 2001; van der Mei et al., 2006) and naturally no 
study has been able to truly document the accuracy of sunburn recall during 
individuals’ lifetimes.  Consequently it is difficult to assess the true 
association between acute intense patterns of sun exposure and BCC. 
 
Self-recalled recreational and occupational activities 
 
Studies that have investigated BCC’s association with cumulative sun 
exposure, by recall of outdoor occupational and recreational histories, 
consistently have reported weak or even negative associations (Gallagher et 
al., 1995; Green et al., 1996; Rosso et al., 1996).  In a small Canadian case-
control study those with self-reported high occupational sun exposure did not 
have increased odds for BCC (OR=1.4, 95%CI 0.8-2.4) compared to people 
with the lowest mean occupational exposure (Gallagher et al., 1995).  In the 
same study, people with the highest value of mean recreational sun exposure 
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per year during their lifetime had negative odds for BCC (OR=0.4, 95%CI 
0.2-1.0) when compared to people in the lowest category of exposure.  
However, with regard to recreational sun exposure under the age of 20 
years, those with the highest mean value per year did have increased odds 
for developing BCC (OR=2.6, 95%CI 1.1-6.5).  A larger European case-
control study also found that people with a high lifetime number of outdoor 
work hours did not have increased odds for BCC (OR=1.0, 95%CI 0.8-1.3) 
compared to those in the lowest category of lifetime outdoor work hours 
(Rosso et al., 1996); they did however, find that people with a high number of 
hours spent at the beach during holidays were significantly more likely to be 
affected by BCC (OR=1.5, 95%CI 1.2-1.8).  Furthermore, an Italian case-
control study that found no association between summer holidays at the 
beach after age 20 and BCC development, did find that the longer a person 
spent at the beach during summer holidays under the age of 20 increased 
their odds for BCC significantly (Corona et al., 2001).  In the Australian 
Nambour study neither people with mainly outdoor occupations or 
recreational activities had increased odds for developing BCC (OR=1.4, 
95%CI 0.8-2.3 and OR=1.3, 95%CI 0.7-2.5 respectively) compared to people 
who spent their time mainly indoors (Green et al., 1996).  These findings may 
be explained in part by the self-selection of people with fair or medium 
complexions and a tendency to burn to not have outdoor long-term 
occupations in Queensland even though they represented over 80% of the 
community study sample (Green et al., 1996).  
 
All in all, there is some variation in the reported associations between 
occupational and recreational exposure and BCC development.  Some 
findings suggest that irregular rather than chronic sun exposure is more 
strongly associated with BCC development.  The findings do suggest, 
however that sun exposure early in life, in particular through recreational 
activities, is more important than regular sun exposure later in life. 
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Clinical markers of photodamage 
 
Chronic photodamage occurs as a response to long-term overexposure to 
UVR (Evridiki et al., 2006).  It is increasingly common with increasing age on 
exposed body sites among white skinned populations.  Typical clinical 
markers of photodamage include telangiectasia (small dilated blood vessels 
near the surface of the skin), clinical elastosis (yellow discolouration and 
thickened and lined skin surface), solar lentigines (flat, pigmented and 
irregularly shaped benign lesions) and solar keratoses (thickened scaly 
growth of mature keratinocytes) (Yaar and Gilchrest, 2007).  It should be 
noted that evidence for the association between overexposure to UVR and 
photodamage usually does not elucidate the exact pattern and dose of UVR, 
an inherent problem to the study of UVR.  Photodamage is usually measured 
clinically and is therefore a more objective measure of past long-term sun 
exposure than recalled sun exposure.       
 
Focussing on solar keratoses, several independent studies (one cohort, four 
case-control) have quantified the significant value of these as a risk factor for 
BCC (Corona et al., 2001; Green et al., 1996; Kricker et al., 1991; Naldi et al., 
2000; Walther et al., 2004).  Two Italian case-control studies reported the 
presence of solar keratoses increased a person’s odds for BCC about 3-fold 
(Corona et al., 2001; Naldi et al., 2000), whereas a German case-control 
study found the presence of solar keratoses increased the odds for BCC 
development over 7-fold (Walther et al., 2004).  One Australian case-control 
study found an increasing number of solar keratoses was associated with 
increasing odds for BCC, such that 40 or more solar keratoses increased a 
person’s odds for BCC development over 10-fold when compared to people 
without these skin changes (Kricker et al., 1991).  The only cohort study to 
assess the predictive value of solar keratoses to date has been the Nambour 
community-based study that found the risk for BCC was 2.5 times higher 
among people with up to 10 solar keratoses and 4 times higher among 
people with 11 or more solar keratoses when compared to people without 
solar keratoses (Green et al., 1996). 
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Photodamage is a robust determinant of BCC development, however 
previous studies have assessed the total body solar keratosis counts and 
thus it is not known if there is a specific association between solar keratoses 
and BCC site of occurrence.  Photodamage has not been investigated in 
relation to multiple BCCs. 
 
 Histological markers of photodamage 
 
At the objective tissue level, two previous studies have measured the degree 
of solar elastosis histologically in and around BCC tumour tissue (Zaynoun et 
al., 1985) or in adjacent normal skin (Kaur et al., 2006; Moon and Oh, 2001).  
The first (Zaynoun et al., 1985) was a Lebanese hospital-based study of 262 
BCCs (95% from the head and neck), which reported that 93% of BCCs were 
associated with some degree of solar elastosis.  This study also observed 
that the facial subsites with the greatest proportion of BCCs with 
moderate/marked solar elastosis were the nose, cheeks and forehead.  They 
also reported that 33% of BCCs had no or at the most, mild solar elastosis, 
and about half of these BCCs were also from the head and neck.  A study of 
175 BCCs (58% from the head and neck) diagnosed at assorted primary care 
and specialist clinics in the northern USA observed only 25% of BCCs to be 
associated with solar elastosis (Kaur et al., 2006). 
 
1.4.3.2 Constitutional factors 
Genetic predisposition 
 
Several genetic disorders characterised, in part, by the development of 
multiple BCCs have been described.  The study of patients with the 
autosomal dominant Nevoid Basal Cell Carcinoma syndrome (NBCCS or 
Gorlin’s syndrome) has shaped the current knowledge about BCC 
pathogenesis. Typically, NBCCS is distinguished by the childhood onset of 
multiple BCCs, as well as multisystemic internal tumours, pitting of the palms 
and soles and dental and brain malformations (Gorlin, 2004).  Exposure to 
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solar UVR likely modifies the risk as 40% of black-skinned NBCCS syndrome 
patients develop BCC compared to 90% of white-skinned patients (Goldstein 
et al., 1994).  NBCCS patients inherit defective copies of the tumour 
suppressor patched-1 gene and tumours arise following inactivation of the 
remaining allele (Wicking and McGlinn, 2001).  Similarly, patients with the X-
linked dominant Bazex syndrome also develop multiple BCCs among other 
phenotypic abnormalities including, congenital hypotrichosis and follicular 
atrophoderma of selected body sites (Bazex et al., 1966).  Rombo syndrome, 
of autosomal dominant inheritance, results in a similar phenotype but BCCs 
develop later in life (Michaelsson et al., 1981).  Xeroderma pigmentosum 
(XP) is a rare autosomal recessive nucleotide excision repair disorder.  
Clinically, XP patients’ have extreme photosensitivity to UVR as a result of a 
defect in any one of the seven genes that regulate excisional repair of UVR-
damaged DNA.  Skin tumours in XP patients show high levels of ras 
oncogene activation, Ink4a-Arf and TP53 tumour suppressor gene 
modifications and aberrations of the sonic hedgehog pathway (Daya-
Grosjean and Sarasin, 2005).  UV-specific mutations of the smoothened 
gene are three times higher in XP patients than in those with sporadic BCCs, 
confirming the high rate of UV-induced mutations in these DNA-repair 
deficient persons (Couve-Privat et al., 2002).  Although mutations in the sonic 
hedgehog gene are rare in sporadic BCCs, they are found in 15% of BCCs 
from XP patients (Couve-Privat et al., 2004).  The glutathione-S-peroxidase 
enzyme family is part of the skin’s defence mechanism against UV-induced 
oxidative stress and polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 
in particular appear to be associated with increased occurrence of BCC (Lear 
et al., 1996; Ramachandran et al., 2000).  
 
Pigmentation phenotype 
 
Personal physical characteristics can inherently increase a person’s  
susceptibility to the effects of sun exposure and hence predispose them to 
BCC.  Independent determinants of raised BCC risk include characteristics 
such as pale complexion, a tendency to sunburn and lack of propensity to tan 
(see Appendix 3).  Two case-control (Gallagher et al., 1995; Walther et al., 
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2004) and one cohort study (Green et al., 1996) have found that people with 
fair skin are at increased risk for BCC compared to those with darker skin.  A 
larger number of independent studies (including one cohort study (van Dam 
et al., 1999) and seven case-control studies (Kricker et al., 1991; Naldi et al., 
2000; Rosso et al., 1996; Rosso et al., 1998; Vlajinac et al., 2000; Walther et 
al., 2004; Zanetti et al., 2006)) have assessed the predictive value of the 
skin’s response to sun exposure:  people with skin that burns readily but 
does not tan are consistently reported to be at increased risk for BCC when 
compared to people with skin that tans readily.  With regard to eye and hair 
colour case-control and cohort studies alike consistently report that people 
with red hair and often those with blonde hair, or those with blue or green 
coloured eyes have an increased risk for BCC (see Appendix 3).  Just one 
case-control study failed to find a significant association between hair and 
eye colour and increased risk for BCC (Gallagher et al., 1995).         
 
Melanocytic nevi 
 
Nevi can be defined as pigmented macules or papules of any size and 
distinguishable from other pigmented lesions on the skin.  While it is known 
that the prevalence of melanocytic nevi is strongly predictive of melanoma 
occurrence (Chang et al., 2009), the association with BCC is uncertain based 
on the mixed evidence to date.  Two recent Italian case-control studies have 
reported respectively no association (Zanetti et al., 2006) and a significantly 
increased risk for BCC on the trunk (Pelucchi et al., 2007), among people 
with nevi on the upper limbs.  A case-control study in Western Australia 
found that overall risk of BCC rose with increasing nevus counts on the back 
(Kricker et al., 1991), while the Health Professionals Follow-up Study in the 
USA showed that nevi on the forearms were modest but significant predictors 
of risk for BCC (van Dam et al., 1999).  Limited prospective data from the 
Nambour Skin Cancer Study suggested that persons with nevi on the back 
were at a moderately increased risk of first BCC on the head and neck but 
not the trunk (Neale et al., 2007). 
 
Repeated occurrences 
  27 
 
Predictive factors for subsequent BCCs may be important for follow-up 
regimes but valid prognostic studies are sparse.  van Iersel et al (van Iersel 
et al., 2005) followed 237 patients and found older age at diagnosis, 
infiltrative type and BCC with a diameter greater than 1 cm to be risk factors.  
They found no associations with sex, anatomical site, depth or layer of 
invasion.  These findings are supported by other studies (Ramachandran et 
al., 2002; Ramachandran et al., 2003).  In contrast, a retrospective study of 
BCC patients found that truncal BCC is associated with significantly more 
BCCs at this site (Ramachandran et al., 2001).  The same group have 
suggested that different mechanisms determine the development of truncal 
and nontruncal BCC; they reported that the rate of increase of nontruncal 
BCCs per year was similar in patients with and without initial truncal lesions 
(Ramachandran et al., 2001).  A study based on Swiss cancer registries 
indicates that the relative risk of second BCC is greater at younger age, 
declining with increasing age (Levi et al., 2006).  The presentation of multiple 
BCCs synchronously appears to be a significant predictor of subsequent 
lesions, and most likely associated with genetic susceptibility 
(Ramachandran et al., 1999).  It is important to note that investigations into 
factors distinguishing the number of subsequent BCC (single or multiple) are 
yet to be conducted.  To date, however, Marcil and Stern (Marcil and Stern, 
2000) have shown that the average proportion of patients developing a 
subsequent BCC within three years of diagnosis was 44% and that this was 
strongly associated with the number of previously diagnosed lesions.   
 
1.5 Treatment and economic impact 
There are a number of treatment modalities available for BCC.  The common 
purpose of each is to remove the tumour whilst maintaining the cosmetic and 
functional capacity of nearby skin.  Surgery is normally the first line of 
defence.  It is performed with either pre-determined margins of normal tissue, 
by frozen section or the removal of the tumour in layers (Moh’s micrographic 
surgery).  Non-surgical treatments include curettage, cryotherapy, 
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radiotherapy, phototherapy and topical treatments.  The effectiveness of 
these treatments was addressed in a recent Cochrane review (Bath-Hextall 
et al., 2007b):  surgery and radiotherapy were the most effective treatments 
for BCC and Moh’s micrographic surgery was the most effective for BCC on 
facial sub-sites.  Cosmetically photodynamic therapy yields better results 
than surgery or radiotherapy, however, long term follow-up of all 
photodynamic therapy recipients is needed due to the comparatively high 
recurrence rate.  While cryotherapy is easier to administer it is not as 
effective as surgery or radiotherapy.  The short-term therapeutic efficacy of 
the topical treatment Imiquimod appears to be effective for superficial BCCs; 
two ongoing studies will assess the long-term effectiveness of Imiquimod 
(Gollnick et al., 2005; Quirk et al., 2006).  
 
Skin cancer exerts a considerable national and global disease burden.  While 
BCC accounts for 80% of all skin cancers the associated morbidity and 
mortality is comparatively minimal, thus its disease burden is what underlies 
the substantial economic burden of BCC treatment on Western health 
systems (Joseph et al., 2001).  In the United States, some USD 13 billion is 
spent annually to treat keratinocyte cancers, ranking them among the most 
costly cancers (Chen et al., 2001).  Similarly in England, skin cancers cost 
GBP 71 million to the National Health Service annually (Morris et al., 2005).  
In Australia, a recent assessment of treatment for BCC revealed that 22% of 
patients are referred to a specialist for BCC, while the typical number of 
doctor visits ranged from 3 to 7, with a range of total cost per patient of AUD 
$147 to $496, depending on complexity and the need for referral (Streeton et 
al., 2006).  The Australian Federal Government outlays in excess of AUD 180 
million per year for BCC treatment alone: in conjunction with squamous cell 
carcinoma of the skin, these are by far the most expensive cancers treated in 
Australia (AIHW, 2005).  These estimates do not include the health resource 
consumption associated with benign skin tumours suspected of malignancy 
or the costs of skin cancer prevention campaigns. 
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1.6 Comparisons with other skin cancers 
Nomenclature 
Due to the cellular complexity of the skin, it can give rise to a wide spectrum 
of epithelial tumours.  Based on the causal role of solar ultraviolet radiation, 
they can be grouped as “sun-induced” and “non-sun-induced” malignancies.  
The former include basal and squamous cell carcinomas, melanomas, and 
premalignant lesions such as actinic keratoses and nevi.  For many years the 
term “non-melanoma skin cancer” was used to collectively refer to cutaneous 
BCC and squamous cell carcinoma (SCC), to reflect their distinction from 
melanomas.  In recent years, however, they have more appropriately been 
termed “keratinocyte cancers” to reflect their cells of origin. 
 
There is a larger range of non sun-induced tumours yet they are much less 
frequent.  They include adnexal tumours of the four skin appendages, namely 
the hair follicle, eccrine, apocrine and sebaceous glands; Paget’s disease; 
Merkel cell carcinoma; and vascular neoplasms (Rigel, 2005).  (It has been 
suggested that Merkel cell carcinoma may be associated with sun exposure 
(Kampshoff and Cogbill, 2009)).  It is not uncommon for these tumours to be 
misdiagnosed as the more common keratinocyte cancers, however, 
differentiation is important as they each have different capabilities for local 
recurrence, invasion and metastasis.  These non sun induced skin conditions 
generally present sporadically, however, familial cases may occur and some 
individuals may have a genetic predisposition. 
 
1.6.1 Melanoma 
Melanoma is the most serious form of skin cancer and Australia has the 
highest incidence in the world (Parkin and Muir, 1992), especially in 
Queensland, with an incidence rate of invasive melanomas of 82 per 100 000 
persons for males and 55 per 100 000 persons for females (Coory et al., 
2006).  Although melanoma ranks as the third most common form of skin 
cancer, behind basal and squamous cell carcinomas, it has a higher mortality 
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rate because it readily metastasises (Rook, 2004).  In recent decades, both 
incidence and mortality of this highly aggressive cancer have increased 
(Jemal et al., 2001).  Melanomas originate from melanocytes: pigment 
synthesising cells of neural-crest lineage, which may become malignant as a 
result of combined genetic, epigenetic and environmental insults.  Many 
factors are known to be independent determinants of melanoma risk, 
including: physical characteristics such as pale complexion, a tendency to 
sunburn, lack of propensity to tan and high number of cutaneous naevi 
(Elwood et al., 1990; Green et al., 1986; Holman et al., 1986).  A family or 
personal history of melanoma, and more commonly, exposure to solar 
ultraviolet radiation also strongly feature in the development of this cancer.  
The presence of melanomas on habitually sun-exposed body sites and on 
skin usually covered by clothing (Elwood and Gallagher, 1983; Green et al., 
1993; Whiteman et al., 2007) is explained by the divergent pathway model 
(Whiteman et al., 2003).  This model proposes that for melanomas arising on 
sun-exposed body sites such as the face and neck, chronic sun exposure 
drives proliferation of transformed epidermal melanocytes.  In contrast, 
melanomas arising on body sites with unstable melanocyte populations such 
as the trunk require that exposure to sunlight is early in life and thereafter, 
host factors drive melanoma development. 
 
1.6.2 Squamous cell carcinoma 
The second most common skin cancer, squamous cell carcinoma, arises 
from committed keratinocytes in the epidermal skin layer.  They may arise de 
novo or from actinic keratoses (Frost et al., 2000; Marks et al., 1988).  In 
Australia SCC occurs at a rate of 387 per 100 000 persons and incidence 
has increased since 1985 when SCC affected an estimated 166 people per 
100 000 (Staples et al., 2006).  The incidence increases more sharply with 
age than for BCC (Staples et al., 2006) reflecting the causal role of 
cumulative sunlight.  The phenotypic risk factors for SCC are shared among 
all three sun-induced skin cancers and they include: fair hair, eye and skin 
complexion, propensity to burn and inability to tan (English et al., 1998).  
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Given that some SCCs arise from actinic keratoses, as expected a personal 
history of these lesions is strongly associated with this skin cancer (English et 
al., 1998).  Actinic keratoses themselves are associated with chronic sun 
exposure, and their especially strong association with SCC risk is not 
mirrored to such an extent in either BCC or melanoma.  SCC most frequently 
develops on sun-exposed anatomic sites such as the head and neck and 
exposed parts of the limbs (Franceschi et al., 1996; Raasch et al., 1998) and 
there is an inverse relationship between latitude and SCC incidence (Parkin 
and Muir, 1992; Scotto et al., 1983).  A history of sunburns and cutaneous 
markers of chronic sun exposure (for example, elastosis of skin on the neck) 
are strong predictors for SCC risk (Green et al., 1996).  Other occupational 
and genetic factors can predispose to SCC. 
 
1.7 Research questions, hypotheses and projected 
Outcomes 
1.7.1 Rationale 
As above, the highest reported incidence rates of basal cell carcinoma (BCC) 
are recorded for Queensland, Australia where 1 to 2 people per 100 are 
affected annually (Raasch and Buettner, 2002).  This skin cancer has a 
predilection to occur multiply in individuals, either synchronously or over time, 
and this is observed in populations where BCC incidence is an order of 
magnitude lower (Bath-Hextall et al., 2007a) (Karagas et al., 1999).   
 
While much is known about the complex constitutional and environmental 
risk factors for general BCC occurrence (English et al., 1998; Green et al., 
1996; Naldi et al., 2000; Zanetti et al., 2006), little is known about their 
relative importance in multiple BCC occurrences in individuals.  Further, there 
is no agreement on whether there is any relationship between this 
keratinocyte cancer and the propensity to develop melanocytic naevi, the 
strongest phenotypic predictor for melanoma (Wachsmuth et al., 2001; Zhu 
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et al., 1999) (Swerdlow and Green(1987)BJDerm).  The association between 
BCC and its principal environmental risk factor solar UVR ((IARC), 2000) is 
unclear regarding self-reported recreational UVR and history of high 
occupational and cumulative UVR exposure (Bastiaens et al., 1998; 
Gallagher et al., 1995; Green et al., 1996; Marehbian et al., 2007; Zanetti et 
al., 2006) (English et al., 1998; Kricker et al., 1995).  On the other hand, 
clinical markers of cutaneous sun damage (solar keratoses, telangiectasia 
and elastosis) are risk factors for general BCC occurrence (Green et al., 
1996; Kricker et al., 1991; Marcil and Stern, 2000; Revenga et al., 2004).  It 
has not previously been investigated whether signs of sun damage to the 
skin are predictors of multiple primary BCCs. 
 
This information arising from and the preceding literature review gives rise to 
a set of research questions (Table 1) that centre on the epidemiology of 
BCC.  They seek to address these important knowledge gaps within the 
realm of the Nambour Skin Cancer Study, a longitudinal study of the 
occurrence and causes of sun-induced skin cancers among a population-
based sample of Nambour residents from Queensland, Australia. 
 
 
Research questions and hypotheses 
 
 
Chapter 
 
Projected outcomes 
R1 What are the age-standardised 
incidence rates of primary single and 
multiple BCCs according to age, sex 
and anatomic subsite of occurrence 
during 1997 to 2006? 
2  
Up to date report of the 
overall incidence of BCC 
and its anatomic 
distribution among the 
population of 
Queensland, Australia. 
Foundational document 
for the incidence of 
people singly and 
multiply affected by 
BCC. 
 
H1 
 
That the incidence of single and 
multiple BCC will increase with 
advancing age and the male sex.  
The BCC distribution across 
anatomic subsites will reflect the 
associated levels of sun exposure. 
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R2 
 
What is the association between the 
propensity for melanocytic nevi on 
the arms and on the back, and the 
occurrence of single and multiple 
BCCs, and their anatomic site of 
occurrence among people affected 
more than once? 
 
3 
 
A detailed document that 
describes the 
association between an 
individual’s propensity 
for melanocytic nevi and 
the acquisition of BCC. 
 
  
H2 
 
There is no association between the 
presence of melanocytic nevi on the 
arms or back and the occurrence of 
single or multiple BCCs.  Melanocytic 
nevi on the arms or back will not 
influence the anatomic site of BCC 
development. 
 
R3 
 
Is the association between risk 
factors for BCC (age, sex, 
pigmentary traits, sun exposure, sun 
dose) different among people who 
are affected by 2-3 or ≥4 BCCs 
compared to people singly affected? 
 
4 
 
Foundation document 
that describes the 
association between 
putative risk factors (age, 
sex, pigmentary traits, 
sun exposure, sun dose) 
and the acquisition of 
multiple BCC and the 
anatomic site of BCC 
occurrence.  
 
H3 
 
People who develop multiple BCCs will 
have a fairer skin complexion and 
more evidence of cutaneous sun 
damage compared to people with a 
single BCC. 
 
R4 
 
Are anatomic sites with cutaneous 
sun damage more likely to develop 
BCCs than sites without cutaneous 
sun damage? 
 
H4 
 
Basal cell carcinomas are more likely 
to develop on sites with cutaneous 
sun damage than sites without 
evidence of cutaneous sun damage. 
 
R5 
 
What are the common histological 
growth patterns of basal cell 
carcinoma in a high risk Australian 
population? 
 
5 
 
Foundation document 
detailing the association 
between BCC risk 
factors and nodular and 
superficial BCCs.  
H5 
 
The nodular growth pattern will be 
the most common growth pattern 
followed by superficial in this series 
of BCCs. 
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R6 
 
Do nodular and superficial BCCs 
have the same associations with risk 
factors (age, sex, pigmentary traits, 
sun exposure, sun dose) when 
compared to people unaffected by 
BCC? 
 
H6 
 
Nodular and superficial BCCs have 
similar associations with regard to 
risk factors when compared to people 
unaffected by BCC.  
 
R7 
 
To what extent do BCCs develop on 
people who have histological 
evidence of chronic cutaneous sun 
damage or other clinical signs of 
actinic skin damage? 
 
6 
 
Foundation document 
detailing a synthesis of 
perilesional solar 
elastosis associated with 
BCCs and chronic 
markers of photodamage.  
H7 
 
BCCs are associated with a 
moderate to severe degree of 
perilesional solar elastosis and  
persons with these BCCs have some 
evidence of chronic cutaneous sun 
damage. 
Table 1: Research questions, their corresponding hypotheses and 
projected outcomes.  
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CHAPTER 2  
INCIDENCE OF BASAL CELL CARCINOMA 
MULTIPLICITY AND DETAILED ANATOMIC 
DISTRIBUTION: LONGITUDINAL STUDY OF AN 
AUSTRALIAN POPULATION 
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2.1  Introduction 
The following published manuscript forms the basis of this results chapter.  It 
directly addresses research question R1 (see section 1.7):  what are the age-
standardised incidence rates of primary single and multiple BCCs according 
to age, sex and anatomic subsite of occurrence during 1997 to 2006? 
 
2.2  Contribution of the candidate 
I conceived and designed the investigation with advice from Prof Adèle 
Green and Dr Jolieke van der Pols.  I developed a set of new variables for 
the analyses required; they included variables capturing the number of times 
a person had been affected by BCC during the observation period and 
person time at risk variables.  The remaining variables were available in the 
existing datasets.  I requested pathology reports from the Queensland 
pathology laboratories for those lesions that did not have data available for 
the specific anatomic site.  I performed most of the data analyses and drafted 
the manuscript.  With input from the other co-authors, I was responsible for 
all subsequent editing and redrafting and submission of the final manuscript.  
I prepared the responses to reviewers’ comments with input from Prof Gail 
Williams, Dr Jolieke van der Pols and Prof Adèle Green. 
 
2.3  Acknowledgement of the contribution of others 
All the data included in the following manuscript were collected as part of the 
Nambour Skin Cancer Study.  The Nambour Skin Cancer Study was 
conceived and designed by the Nambour Skin Cancer Follow-up Study 
investigators, namely, Prof Adele Green and Prof Gail Williams.  Dr Rob 
Ware calculated the 95% confidence intervals.  Nirmala Pandeya and Prof 
Gail Williams gave advice for the statistical approach using SAS software.  Dr 
Rachel Neale assisted with the editing of the manuscript.  Dr Jolieke van der 
Pols and Prof Adèle Green contributed to the interpretation of the results and 
assisted with the editing and drafting of the manuscript. 
 
  37 
Principal Supervisor Confirmation  
 
The authors listed above have certified that: 
1. they meet the criteria for authorship in that they have participated in the 
conception, execution, or interpretation, of at least that part of the 
publication in their field of expertise; 
2. they take public responsibility for their part of the publication, except for 
the responsible author who accepts overall responsibility for the 
publication; 
3. there are no other authors of the publication according to these criteria;  
4. potential conflicts of interest have been disclosed to (a) granting bodies, 
(b) the editor or publisher of journals or other publications, and (c) the 
head of the responsible academic unit, and 
5. they agree to the use of the publication in the student’s thesis and its 
publication on the Australasian Digital Thesis database consistent with 
any limitations set by publisher requirements.  
 
 
I have sighted email correspondence from all Co-authors confirming their 
certifying authorship. 
 
Adèle C Green  
Name       Signature                        Date 
 
 
2.4  Manuscript: Incidence of Basal Cell Carcinoma 
Multiplicity and detailed Anatomic Distribution: 
Longitudinal Study of an Australian Population 
(Published in Journal of Investigative Dermatology February 2009) 
 

  44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3  
MELANOCYTIC NEVI AND BASAL CELL CARCINOMA:  
IS THERE AN ASSOCIATION? 
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3.1  Introduction 
This results chapter comprises a manuscript that will soon be submitted to an 
international peer-reviewed journal, and as such is presented here in a 
general format required for manuscript submission.  It directly addresses 
research question R2 (see section 1.7): what is the association between the 
propensity for melanocytic nevi on the arms and on the back, and the 
occurrence of single and multiple BCCs, and their anatomic site of 
occurrence among people affected more than once? 
 
3.2  Contribution of the candidate 
I conceived and designed the investigation with advice from Prof Adèle 
Green and Dr Jolieke van der Pols.  I developed new variables to capture the 
number of times a person had been affected by BCC during the observation 
period.  The remaining variables were available in the existing datasets.  I 
performed the data analyses and drafted the manuscript.  With input from the 
other co-authors, I was responsible for all subsequent editing and redrafting 
and submission of the final manuscript.  I prepared the responses to 
reviewers’ comments with input from both co-authors. 
 
3.3  Acknowledgement of the contribution of others 
All the data included in the following manuscript were collected as part of the 
Nambour Skin Cancer Study.  The Nambour Skin Cancer Study was 
originally conceived and designed by the Nambour Skin Cancer Study 
principal investigator, Prof Adèle Green.  Dr Jolieke van der Pols and Prof 
Adèle Green contributed to the interpretation of the results and assisted with 
the editing and drafting of the manuscript. 
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Abstract 
 
It is important to establish the existence and magnitude of the association 
between melanocytic nevi and basal cell carcinoma (BCC) to give possible 
insights into shared pathways of solar ultraviolet tumorigenesis.  We 
investigated this in a community-based Australian study with 21 years of 
follow-up.  Dermatologists counted nevi on the forearms (1986) and back 
(1992), and BCC frequency and sites were prospectively monitored to 2007. 
 
Of 1621 study participants at baseline (1992), 1339 (mean age 49-years; 
56% women) had complete follow-up.  Of those followed up, 401 (30%) had 
a total of 1202 histologically-confirmed BCCs.  After adjustment for age, sex, 
skin color, nevi on the back, and sun exposure, BCC risk increased 
significantly in those with forearm nevi (odds ratio (OR), 1.5; 95% confidence 
intervals (CI), 1.1-1.9).  For BCC on the back, risk was doubled in those with 
many (11 or more) forearm nevi compared with no forearm nevi (OR=2.4; 
95%CI 1.1-4.8).  Nevi on the back were not associated with subsequent 
BCC.  This suggests that high site-specific nevus prevalence, reflecting both 
a nevus propensity and high sun exposure early in life, influences future BCC 
development. 
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Introduction 
Although both basal cell carcinoma (BCC) and cutaneous melanoma are 
caused by exposure to solar ultraviolet radiation (International Agency for 
Research on Cancer, 1992), they are considered unusual because in general 
their relationship with sun exposure is not dose-dependent (Rosso et al., 
1998).  They have broadly similar body site distributions with a substantial 
proportion of both tumors occurring on the back as well as the face (Neale et 
al., 2005), and both have relatively young ages of onset (Richmond-Sinclair 
et al., 2009; Siskind et al., 2005).  Skin pigmentary factors indicating sun-
sensitivity determine risks of both BCC and melanoma (English et al., 1998; 
Green et al., 1996; Naldi et al., 2000; Siskind et al., 2005) and some 
molecular profiles are common to both (Greinert, 2009).  While it is known 
that the prevalence of melanocytic nevi is strongly predictive of melanoma 
occurrence (Chang et al., 2009), the association with BCC is uncertain based 
on the mixed evidence to date. Two recent Italian case-control studies have 
reported respectively no association (Zanetti et al., 2006) and a significantly 
increased risk for BCC on the trunk (Pelucchi et al., 2007), among people 
with nevi on the upper limbs.  A case-control study in Western Australia 
found that overall risk of BCC rose with increasing nevus counts on the back 
(Kricker et al., 1991), while the Health Professionals Follow-up Study in the 
USA showed that nevi on the forearms were modest but significant predictors 
of risk for BCC (van Dam et al., 1999).  We ourselves have previously 
reported some limited prospective data from the Nambour Skin Cancer Study 
suggesting that persons with nevi on the back were at a moderately 
increased risk of first BCC on the head and neck but not the trunk (Neale et 
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al., 2007).  In this report we have substantially lengthened the period of 
follow-up of the Nambour Study cohort to two decades and have now 
investigated the association between prevalence of melanocytic nevi on the 
forearms as well as nevi on the back and the occurrence of histologically 
confirmed BCC. 
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Results 
There were 1339 participants who had complete follow-up until either death 
(102, 8%) or end of observation on 31 December 2007 (1237, 92%).  At 
baseline in 1992 their mean age was 49 years, 56% were women and 18% 
had a past history of BCC.  During the 16-year observation period 401 
individuals (207 women, 194 men), had a total of 1202 primary histologically-
confirmed BCCs.  Of these, 169 (100 women, 69 men) developed a single 
primary BCC while the remaining 232 (58%) (107 women, 125 men) 
developed multiple primary BCCs.  Average age at diagnosis of a first BCC in 
the study period was 61 years (60 for women, 61 for men). 
 
Among all participants, 1162 people (87%) had nevi either on the forearms in 
1986 or the back in 1992.  Nevi on the forearms were present in 530 
participants of whom 56 (11%) had no nevi on the back (14 people did not 
have data available for nevi on the forearms).  Nevi on the back were present 
in 1092 participants of whom 618 (57%) had no nevi on the forearms.  25 
people had 11 or more nevi on the arm as well as the back.  Among those 
with any nevi on the forearms slightly more were female (358, 68%) 
compared to the proportion of females among those with nevi on the back 
(608,56%; (p=<0.001), but age distributions were similar (Table 1).  
Regardless of whether people had nevi on one or both sites, the proportion of 
people affected by BCC (including multiple BCCs) was the same for each 
group (Table 2).  
 
  53 
People with nevi present on the forearms in 1986 were more likely to be 
affected by BCC during the follow-up study period 1992-2007 compared to 
those without nevi on the forearms (OR=1.5, 95%CI 1.1-1.9), and the same 
was found for each nevus-count category (Table 2).  We separately analysed 
people with a single BCC and those with multiple BCCs and found that 
presence of forearm nevi was more strongly associated with multiplicity of 
BCC (OR=1.6, 95%CI 1.2-2.2) than with occurrence of a single BCC 
(OR=1.4, 95%CI 0.94-2.0) in the follow-up period (Table 2).  There was no 
consistent association between numbers of nevi on the back in 1992 and 
subsequent occurrence of BCC (Table 2). There was no association between 
BCC and the presence of any nevi on back or forearms versus no nevi 
(OR=1.1, 95%CI 0.80-1.6).   
 
We further assessed whether there was an association between the 
anatomic site of BCC and number of nevi on the forearms or on the back.  
The presence of nevi on the forearms was associated with BCC on the head 
and neck (OR=1.5, 95%CI 1.1-2.1) and BCC on the trunk (OR=1.7, 95%CI 
1.2-2.5), but not with BCC on the limbs (Table 3).  Neither combined-sites 
nevus counts (data not shown) nor nevi on the back were associated with 
BCC at any specific anatomic site (Table 3). 
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Discussion  
 
In this prospective study with 21
 
 years of follow-up, we have shown that the 
presence of nevi on the forearms is associated with an increased occurrence 
of BCC overall and also with multiple occurrences of primary BCC over time.  
With regard to sites of occurrence of BCC, people with many forearm nevi 
had a modestly raised risk of BCC on the typically sun-exposed head and 
neck and had an even higher (doubling) of risk for BCC on the trunk, 
compared with people who had no nevi on the forearms.  BCC on the limbs 
was not related to nevi on the forearms however.  In contrast to the 
observations for nevi on the arm, nevi on the back in general showed no 
association with BCC occurrence. 
The findings of this study are consistent with those of another prospective 
study that has investigated the association between nevi and BCC 
occurrence in the USA (van Dam et al., 1999).  That study reported a 
modestly raised risk of BCC in male health professionals who had any nevi 
on their forearms, with no effect of number of nevi.  Our results are also 
similar to those of a hospital-based case-control study of a Southern 
European population where people affected with BCC had an increased 
number of nevi on the forearms overall, again with no increased risk with 
increasing numbers of nevi (Naldi et al., 2000).  On the other hand, a 
Western Australian case-control study showed a non-significant increase in 
odds ratios for BCC overall with increasing counts of nevi on the back 
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(Kricker et al., 1991), and yet other case-control studies have found no 
association (Vlajinac et al., 2000; Zanetti et al., 2006). 
 
Nevi mostly develop during childhood and adolescence (Crane et al., 2009).  
They are influenced by habitual childhood (Green et al., 1988b) and 
adolescent sun exposure (Darlington et al., 2002).  Twin studies in restricted 
geographic locations reinforce the importance of genetic and environmental 
factors (Wachsmuth et al., 2001; Zhu et al., 1999).  Although the etiology of 
melanocytic nevi is incompletely understood we have previously suggested 
that there is site-dependent susceptibility to melanocytic changes: that 
melanocytes on the trunk require less cumulative sun exposure than 
melanocytes of the head and neck or the arms to undergo change (Green, 
1992).  The fact that nevi on the forearms but not nevi on the back predict the 
multiple occurrence of BCC over time leads us to speculate that there is 
more than simple nevus propensity playing a role, and that it is the amount of 
sun exposure early in life (Green et al., 1988b; MacLennan et al., 2003), 
namely the first two decades, that is influencing BCC risk.  Whilst nevi on the 
forearms appear to reflect high childhood sun exposure (Darlington et al., 
2002) clearly it is not sufficient for BCC development later in life.  This study 
did not investigate the association between solar lentigines, another type of 
benign pigmented lesion that occurs on sun-exposed areas of the skin and 
are associated with ageing (Chen et al., 2010; Yaar and Gilchrest, 2007).  
Unlike nevi, one would expect a priori a positive association between solar 
lentigines, as indicators of cumulative sun exposure with age, and BCC, and 
indeed this is what we have previously observed in this population (Neale et 
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al., 2007).  We conclude the combined effects of ultraviolet radiation received 
early in life and during adult life lead to BCC pathogenesis. 
 
The present findings and other longitudinal data may point to an intriguing 
commonality of genetic risk factors between nevi and BCC (e.g. frequency of 
UVB-induced genetic lesions (Wang et al., 2005) since it is highly unlikely 
that forearm nevi per se could directly influence BCC occurrence given the 
difference in target cell type and the lack of association of BCC with nevi on 
the trunk. 
 
A limitation to be considered in the interpretation of the comparisons between 
the associations of BCC with forearm nevi on one hand and back nevi on the 
other, is that the counts of nevi on forearms and on the back were made 
some 5 years apart (end of 1986 and start of 1992 respectively).  Because it 
is believed that nevi involute as adults grow older (Bataille et al., 2007; Green 
and Swerdlow, 1989), it is likely that the absolute nevus counts on the back 
would have been higher had they been recorded in 1986.  Indeed a small 
proportion of people with nevi present on the back in 1986 may have been 
classified as having no nevi on the back in 1992 due to the natural history of 
nevi.  While it seems unlikely that this bias could wholly explain the 
qualitatively different associations of forearm versus back nevi with BCC, it is 
possible that it influenced the relative magnitude of the associations reported 
here.  We also considered the possibility that there may be a differential 
biopsy rate of limb BCCs among individuals who had nevi on the forearms 
compared to those who did not.  The lack of association between nevi on the 
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forearms and BCC on the limbs (predominantly the arms) in our data does 
not support this.  Nor did we find that nevi on the back were associated with 
BCC on the back.   
 
In summary our results indicate that people with nevi on the forearms were 
significantly more likely to be affected by BCCs during the two decades of 
follow-up than people without nevi on the forearms.  People with nevi on the 
back were not at increased risk of subsequent BCC however.  This increase 
in risk of BCC was particularly strong for multiple primary BCCs over the two 
decades of follow-up, and was specific for BCCs on the head and especially 
the trunk.  
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Materials and methods 
 
At baseline in 1986, 2095 residents of the subtropical Queensland township 
of Nambour (latitude 26°S) were randomly selected from the electoral 
register of all adults in the township (Green et al., 1988a).  Between 1992 
and 1996, 1621 of these adults (77%) participated in a field trial to assess 
daily sunscreen application and beta-carotene supplementation in the 
prevention of skin cancer (Green et al., 1999).  After the trial, follow-up of 
skin cancer continued (van der Pols et al., 2006) till 2007.  Ethical approval 
was obtained from the ethics committee of the Queensland Institute of 
Medical Research. 
 
In 1986 dermatologists recorded the number of melanocytic nevi greater than 
2mm in diameter, raised or flat, on participants’ forearms and hands 
(hereafter referred to simply as forearms).  Nevi on participants’ backs were 
similarly recorded in 1992, and all participants completed a baseline standard 
questionnaire about pigmentary traits and sun exposure history. Regarding 
the latter, participants reported both their occupational and recreational sun 
exposure as mainly outdoors/mainly indoors/ or mixed indoors, outdoors. 
Detailed information about all skin cancers that occurred from 1992 to 1996 
was collected during 3 separate full-body skin examinations conducted by 
dermatologists (Green et al., 1996; Green et al., 1999).  Following the trial, 
participants consented to have pathology records of all further skin cancers 
made available to the investigators allowing virtually complete ascertainment 
of histologically-confirmed BCCs through regional pathology laboratories.  
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Because the same BCC may be histologically confirmed twice, at initial 
biopsy/excision and again if re-excised, all records of apparently multiple 
BCCs verified within a 6-month period in the same person on the same 
anatomical site were cross-checked to identify duplicate reports.  Recurrent 
BCCs diagnosed at the sites of earlier primary lesions were excluded. 
 
Data analysis 
 
Only people who experienced a new histologically-diagnosed BCC during the 
study period, 1992 to 2007, were considered cases.  We did not exclude 
those people who had a BCC prior to the observation period because the 
BCC records for that time were incomplete for some participants.  We can 
therefore only be certain about the BCC status of all participants for the 16-
year observation period.  For investigation of the number of BCCs that 
participants developed, analyses were person-based and affected 
participants were classified according to the number of BCCs they developed 
in the 16-year study period: none, one, or multiple primary BCCs 
(synchronously or over time).  Anatomic site analyses were lesion-based 
such that for analyses of associations with BCCs occurring on the head and 
neck, all people without a BCC constituted the reference group.  Thus while 
the sites of occurrence of individual BCCs were mutually exclusive, the sites 
of BCC occurrence within multiply-affected individuals were not, in the sense 
that they could contribute BCCs to several sites. 
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Nevus counts were recorded as categorical variables and used to estimate 
odds ratios (OR) with 95% confidence intervals (CI).  Multivariate logistic 
regression was used to assess the association of nevi on the forearms or on 
the back with the development of BCC.  Analyses of associations with nevi 
on the forearm (or back) were adjusted for age, sex, skin color as evaluated 
by a dermatologist, self-reported skin response to acute sun exposure, 
occupational sun exposure and recreational sun exposure (categorised as 
above), randomised sunscreen treatment group during the field trial, and 
presence of nevi on the back (or forearm).  Occupational and recreational 
sun exposure, the predominant determinants of the scale of adult sun 
exposure, were accounted for in all analyses relating to BCC development.  
Statistical analyses were conducted using SAS version 9.1 (SAS Institute 
Inc., Cary, North Carolina) and SUDAAN 10 (RTI Institute, Research Triangle 
Park, North Carolina). 
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Table 1:  Distribution of age and sex of participant according to melanocytic nevi on the back and forearms 
 
 Nevi on the forearms in 1986 Nevi on the back in 1992 Single 
BCC 
Multiple 
BCC 
Participant characteristics No Yes No Yes   
 
Age 
 
      
    Less than 40 years 166 (21%) 185 (35%) 41 (19%) 313 (29%) 28 (17%) 26 (11%) 
    40 to 59 years 374 (47%) 273 (51%) 94 (44%) 539 (49%) 92 (54%) 111 (48%) 
    60 years or older 253 (32%) 72 (14%) 79 (37%) 240 (22%) 49 (29%) 95 (41%) 
 
Sex 
 
    Female 382 (52%) 358 (68%) 129 (60%) 608 (56%) 100 (59%) 107 (46%) 
    Male 411 (48%) 172 (32%) 85 (40%) 484 (44%) 69 (41%) 125 (54%) 
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Table 2:  Odds ratios* for BCC 1992 to 2007 according to melanocytic nevi on the back and forearms in 1992 
 BCC count (%) At least one BCC Single BCC Multiple BCCs 
 
Participant characteristics 
No BCC  
(n=928) 
Single BCC        Multiple BCCs     
   (n=169)                (n=232) 
Odds 
ratio 
95% CI‡ Odds 
ratio 
95% CI Odds 
ratio 
95% CI 
 
Nevi on the forearms in 1986 
         
    No 555 (60%) 98 (59%) 140 (61%) 1.0 Ref 1.0 Ref 1.0 Ref 
        
       1-10 
 
318 (34%) 
 
 
54 (32%) 
 
 
74 (32%) 
 
 
1.4 
 
(1.1, 1.9) 
 
1.2 
 
(0.83, 1.8) 
 
1.6 
 
 
(1.1, 2.3) 
        11 or more  55 (6%) 
 
14 (8%) 
 
15 (7%) 
 
1.8 (1.0, 3.0) 1.8 (0.93, 3.6) 1.7 
 
(0.86, 3.3) 
  
 
Nevi on the back in 1992 
   
    No 148 (16%) 18 (11%) 48 (21%) 1.0 Ref 1.0 Ref 1.0 Ref 
        
       1-10 592 (64%) 129 (79%) 149 (66%) 
 
1.2 
 
(0.83, 1.7) 
 
1.9 
 
(1.1, 3.3) 0.87 (0.59, 1.3) 
       11 or more  178 (19%) 17 (10%) 27 (12%) 0.76 (0.47, 1.2) 1.0 (0.5, 2.1) 0.67 (0.38, 1.2) 
 
 
 Nevi on the forearms or back   
   
    No 
 
117 (13%) 
 
15 (9%) 
 
44 (19%) 1.0 Ref 1.0 Ref 1.0 
        
Ref 
 
       1-10 697 (74%) 132 (79%) 
 
163 (70%) 
 
1.2 
 
(0.82, 1.7) 
 
1.9 (1.1, 3.4) 0.91 (0.60, 1.4) 
        
      11 or more 
 
124 (13%) 
 
21 (12%) 
 
25 (11%) 1.0 (0.64, 1.6) 1.5 (0.74, 2.9) 0.84 
 
(0.50, 1.4) 
   
   
 
* Adjusted for age as a continuous variable, sex, randomised sunscreen treatment (daily sunscreen application or discretionary use 
during field trial), skin response to acute sun exposure (tan, burn then tan, burn) and occupational type and recreation type (both 
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variables are categorised as mainly indoors, indoors and outdoors, mainly outdoors) and naevi on the back or forearms as 
appropriate (no, 1-10, 11 or more); ‡ CI, confidence interval. 
Table 3:  Odds ratios* for site-specific‡ BCC 1992 to 2007 according to melanocytic nevi on the back and forearms in 1992 
  
 Distribution of cases (count (%))3 Head and neck Trunk Limbs 
Participant characteristics 
 
No BCC 
(n=928) 
Head and 
neck (n=271) 
Trunk 
(n=173) 
Limbs  
(n=135) 
Odds 
ratio 
95% CI♣ Odds 
ratio 
95% CI Odds 
ratio 
95% CI 
 
Nevi on the forearms in 1986 
      
   No 555 (60%) 389 (64%) 204 (62%) 164 (71%) 1.0 Ref 1.0 Ref 1.0 Ref 
       
      1-10 
 
318 (34%) 
 
 
182 (30%) 
 
 
100 (31%) 
 
 
57 (25%) 
 
 
1.5 
 
(1.0, 2.1) 
 
1.6 
 
(1.1, 2.3) 1.2 (0.73, 1.9) 
       11 or more  55 (6%) 
 
42(7%) 
 
24 (7%) 
 
9 (4%) 
 
1.7 (0.88, 3.3) 2.4 (1.2, 4.8) 0.79 (0.27, 2.3) 
 
Nevi on the back in 1992 
 
    
    No 148 (16%) 103 (17%) 75 (23%) 62 (26%) 1.0 Ref 1.0 Ref 1.0 Ref 
    Yes 
 
770 (84%) 
 
502 (83%) 
 
248 (77%) 
 
173 (74%) 
 
1.2 (0.78, 1.8) 0.75  (0.48, 1.2) 0.75 
 
 (0.44, 1.3) 
     
 
* Adjusted for age as a continuous variable, sex, randomised sunscreen treatment (daily sunscreen application or discretionary use 
during field trial), skin response to acute sun exposure (tan, burn then tan, burn) and occupational type and recreation type (both 
variables are categorised as mainly indoors, both indoors and outdoors, mainly outdoors) and naevi on the back or forearms as 
appropriate (no, 1-10, 11 or more); ‡The site-based sub-groups are not mutually exclusive; persons with BCC on the head and neck 
and trunk and limbs were analysed as ‘affected persons’ for each anatomic region; ♣CI, confidence interval. 
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CHAPTER 4  
CLINICAL SIGNS OF PHOTODAMAGE ARE 
ASSOCIATED WITH BASAL CELL CARCINOMA 
MULTIPLICITY AND SITE: A 16-YEAR LONGITUDINAL 
STUDY 
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4.1  Introduction 
This results chapter comprises a manuscript that has been accepted for 
publication by the International Journal of Cancer and as such is presented 
here in the accepted preprint format.  It directly addresses research 
questions R3 and R4 (see section 1.7): is the association between risk 
factors for BCC (age, sex, pigmentary traits, sun-exposure, sun dose) 
different among people who are affected by 2-3 or ≥ 4 BCCs compared to 
people singly affected?  And are anatomic sites with cutaneous sun damage 
more likely to develop BCCs than sites without cutaneous sun damage? 
 
4.2  Contribution of candidate 
I conceived and designed the investigation with advice from Prof Adèle 
Green.  I performed the data analyses and drafted the manuscript.  I 
constructed a set of new variables for the analyses; they included variables 
capturing the number of times a person had been affected by BCC during the 
observation period and time-dependent variables for sun exposure and sun 
damage that related to the persons and the lesion.  The remaining variables 
were available in the existing datasets.  I requested pathology reports from 
the Queensland pathology laboratories for those lesions that did not have 
data available for the specific anatomic site and assisted with the data entry 
for this information. 
 
4.3  Acknowledgement of the contribution of others 
All the data included in the following manuscript were collected as part of the 
Nambour Skin Cancer Study.  The Nambour Skin Cancer Study was 
conceived and designed by the Nambour Skin Cancer Follow-up Study 
investigators, namely, Prof Adèle Green and Prof Gail Williams.  Nirmala 
Pandeya and Prof Gail Williams gave advice for the statistical approach 
using SAS and SUDAAN software.  Dr Rachel Neale assisted with the editing 
of the manuscript.  Dr Jolieke van der Pols and Prof Adèle Green contributed 
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to the interpretation of the results and assisted with the editing and drafting of 
the manuscript. 
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Statement about novelty:   
 
Using evidence from a 20 year prospective Australian study we demonstrate that 
among those newly affected by BCC, chronic cutaneous sun damage predicts those 
who will be affected by more than one BCC, while chronic sun damage on the head 
and neck, trunk and limbs predicts BCC occurrence at each site respectively. 
 
Statement about novelty:   
 
These findings suggest that control of BCC multiplicity in the population at large is 
feasible through decreasing cumulative sun exposure, thereby helping to curb the 
substantial encumbrance that BCC places on health systems serving white 
populations.  Follow-up of BCC patients requires thorough whole body skin 
examinations, rather than being limited to typically sun-exposed sites or to sites 
previously affected by BCCs. 
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Abstract 
 
Although sun exposure is known to be associated with basal cell carcinoma (BCC), it 
is not known what determines multiple occurrences of BCCs among sporadically 
affected individuals or why BCCs develop on uncommonly sun-exposed body sites 
like the trunk.  In a prospective community-based skin cancer study in Queensland, 
Australia, we studied all participants who experienced a histologically-confirmed 
BCC from 1992 to 2007.  Sun exposure history was monitored and dermatologists 
documented phenotype at baseline and signs of photodamage over the study period.  
Anatomic sites of all incident BCCs were recorded.  Odds ratios (OR) and 95% 
confidence intervals (95% CI) were calculated using logistic regression.  Of 401 
participants who developed a new BCC during the 16-years of follow-up, 232 (58%) 
developed more than one.  Male sex (OR=2.5, 95%CI 1.5-5.3) and age 60 or over 
(OR=4.2, 95%CI 1.5-11.8) but not skin type were associated with highest BCC 
counts among those affected.  Participants with high numbers of solar keratoses 
were most likely to experience the highest BCC counts overall (OR=4.3, 95%CI 1.4-
13.5).  Moreover occurrences of BCC on the trunk (OR=3.3, 95%CI 1.4-7.6) and on 
the limbs (OR=3.7, 95%CI, 95%CI 2.0-7.0) were strongly associated with high 
numbers of solar keratoses on these sites respectively.  Among those newly affected 
by BCC, chronic cutaneous sun damage predicts those who will be affected by more 
than one BCC, while chronic sun damage on the trunk and limbs predicts BCC 
occurrence on the trunk and limbs respectively. 
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Introduction   
 
The commonest cancer, basal cell carcinoma (BCC), occurs more than once, 
in a high proportion of individuals sporadically affected.  In North American study 
populations with relatively low incidence of BCC 1 2, two prospective cohort studies 
reported that around 34% of affected people developed multiple BCCs within 5-years 
of follow-up 3, 4.  In a high incidence Australian population, nearly 50% of affected 
people developed multiple BCCs over 10-years 5.  Hence it is not only the number of 
people affected but also the multiple tumors they develop that underlies the 
substantial health expenditure attributed to BCC treatment in North America 6, 
Europe 7 and Australia 8. 
 
A limited number of previous studies in selected clinical populations have 
suggested that multiple BCC occurrence is associated with increasing age 9, male 
sex 10 and fair skin 11, 12, but little is known about the importance of other pigmentary 
and environmental factors including sun exposure history and photodamage. 
 
Another unanswered question about BCC is why a sizable proportion occur 
on sites that are often sun-protected like the trunk and limbs, given BCC’s strong 
association with sun exposure 13.  Some have suggested different mechanisms of 
BCC pathogenesis on different sites because head/neck BCCs appeared more 
strongly associated with a sun-sensitive phenotype than trunk BCCs 12, 14, 15.  Also 
people initially affected by trunk BCC were reported to be affected more often 
subsequently on the trunk than people with an initial head/neck BCC 16.  Overall, 
however, there is limited evidence about where on the body successive BCCs arise 
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among people affected more than once 9, 16, 17 and factors underlying BCC’s site 
distribution in general remain uncertain. 
 
In order to answer these questions we monitored the occurrence of all BCCs 
in a subtropical Australian community from 1992 to 2007.  We examined the 
anatomic sites of BCC occurrence and assessed in detail the associations between 
pigmentary traits and various measures of sun exposure with BCC multiplicity.  We 
hypothesised that people who develop multiple BCCs would have a more sun-
sensitive phenotype than people with a single BCC during the same period.  
. 
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Material and methods  
 
The Nambour Skin Cancer Study 
 
Study participants were originally randomly selected in 1986 from the electoral 
register of all adult residents of the subtropical township of Nambour in Queensland, 
Australia (latitude 26°S) for a baseline study of skin cancer 18.  2095 people (70%) 
took part and were shown to be a representative sample of the community with 
regard to risk factors for skin cancer 18.  Of these, 1621 (77%) participated in a field 
trial between 1992 and 1996 to assess sunscreen application and betacarotene 
supplementation in the prevention of skin cancer.  Detailed descriptions of the 
community sample, field trial and its long-term outcomes have been published 
previously 19, 20.  On conclusion of the trial in 1996, participants were invited to take 
part in a further follow-up study of skin cancer.  Continuing participants consented to 
have subsequently diagnosed skin cancers notified to the investigators by regional 
pathology laboratories in Queensland, allowing 100% ascertainment of all 
histologically confirmed BCCs.  No participants were immuno-compromised, and 
none had nevoid basal cell carcinoma syndrome.  Follow-up of skin cancers 
continued to the end of 2007.  Ethical approval was obtained from the ethics 
committee of the Queensland Institute of Medical Research. 
 
Data collection 
  
Pigmentary traits, sun exposure and photodamage 
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Participants’ head, neck, arms and hands were examined at baseline in 1986 
by dermatologists who documented standard signs of cumulative photodamage 
(telangiectasia of the face, elastosis of the neck, solar lentigines and solar keratoses) 
and number of melanocytic nevi on arms. All participants completed a baseline 
standard questionnaire about pigmentary traits (hair and eye color) and sun-
exposure habits (occupational and recreational, and sunscreen use when in the 
sun).  At the start of the trial in 1992 participants again completed a standard 
questionnaire including their skin response to acute sun exposure.  In 1992, 1994 
and 1996 information about sun exposure was updated by questionnaire and 
dermatologists carried out full skin examinations.  From 1997 to 2007, participants 
reported their sunscreen use each year and based on their responses were 
classified as regular or irregular sunscreen users 21.   
 
Basal cell carcinomas 
 
All BCCs were verified histologically.  Because the same BCC may be 
histologically confirmed twice, at initial biopsy/excision and again if re-excised, all 
records of apparently multiple BCCs verified within a 6-month period in the same 
person and on the same anatomic site were cross-checked to identify duplicate 
reports.  Recurrent BCCs diagnosed at the sites of earlier primary lesions were 
excluded.   
 
Data management 
 
Cases and tumors 
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Only people who experienced a new histologically-diagnosed BCC during the 
study period, 1992 to 2007, were included in the analyses.  For investigation of the 
number of BCCs that participants developed, analyses were person-based and 
affected participants were classified according to the number of BCCs they 
developed in the 16-year study period: one; 2-3; 4 or more (synchronously and/or 
over time).  Anatomic site analyses were lesion-based such that for analyses of 
associations with BCCs occurring on the head/neck, all BCCs that occurred on the 
trunk or limbs constituted the reference group.  Thus while the sites of occurrence of 
individual BCCs were mutually exclusive, the sites of BCC occurrence within 
multiply-affected individuals were not, in the sense that they could contribute BCCs 
to several sites. 
 
Time-dependent exposures 
 
For person-based analyses, only sun exposure and photodamage data prior 
to the date of diagnosis of an individual’s first BCC were used; for tumor-based 
analyses, all exposures predated diagnosis of each BCC when more than one BCC 
occurred.  For example, for a BCC diagnosed in 1995 the extent of photodamage 
was taken as the greatest recorded in either 1986, 1992 or 1994 (but not 1996).  The 
responses used for recreational and occupational sun exposure analyses always 
reflected the level of these exposures reported for the majority of time prior to BCC 
diagnosis. 
 
Statistical analysis 
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Multivariate polytomous and repeated-measures binomial logistic regression 
were used to assess the associations between factors of interest and BCC 
multiplicity and site of occurrence among those affected, respectively.  The repeated-
measures analyses accounted for the intra-person correlation of BCCs on different 
sites from the same person.  Each exposure variable was treated categorically to 
estimate the odds ratio (OR) with 95% confidence intervals.  All analyses were 
adjusted for age, sex and randomised sunscreen treatment during the trial.  Models 
also included pigmentary traits and sun exposure variables where appropriate.  
Statistical analyses were conducted using SAS version 9.1 (SAS Institute Inc., Cary, 
North Carolina) and SUDAAN 10 (RTI Institute, Research Triangle Park, North 
Carolina). 
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Results  
 
Study population 
 
During the 16-year observation period 401 participants (30%) of the overall 
Nambour study cohort, had at least one surgically-excised, histologically-confirmed 
BCC.  Of these 401, 66 had a history of BCC prior to 1992.  During the study period 
approximately equal proportions of women (207; 52%) and men (194; 48%) were 
diagnosed with an incident BCC, with an average age at diagnosis of the first BCC in 
the study period of 60-years for women and 61-years for men.  The average age at 
diagnosis of a first BCC was the same for those who developed one or more than 
one BCC (mean age 60-years).  As anticipated, a high proportion of cases had a 
sun-sensitive phenotype: 62% had fair skin color, 49% had blue/grey eyes and 60% 
had a light hair color (Table 1).  
 
Among those with a new BCC in the 16-year period, 169 people developed 
one BCC only (42%; 100 women and 69 men) and 232 people developed more than 
one BCC (107 women and 125 men), representing a cumulative incidence of 
multiple BCC of 58%.  Among those people who experienced more than one BCC, 
61 (26%) had 3 BCC tumors, 31 (13%) had 4 BCC tumors and 13 (6%) had 5 or 
more (up to 37) BCC tumors.  A total of 1202 new BCCs were excised from the 401 
affected individuals between 1992 and 2007. 
 
Associations with BCC multiplicity among those affected by BCC 
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People with multiple BCCs in the study period, synchronously and/or over 
time, were more likely to be older and male than those with a single BCC.  
Specifically, those aged 60-years or older at the start of observation were more likely 
to develop ≥4 BCCs (OR 4.2, 95% CI 1.5-11.8) compared to people younger than 
40-years.  Males were more likely than females to be affected by 2-3 BCCs (OR 1.8, 
95%CI 1.1-3.2) and ≥4 BCCs (OR 2.8, 95%CI 1.5-5.3) among all affected by BCC in 
the study period (Table 1). 
 
Compared with cases who tanned, cases who had skin that always burnt 
upon exposure to the summer sun were not more likely to develop multiple BCCs 
(Table 1).  Cases with light eye color were more likely to develop multiple BCCs 
compared to cases with dark eyes, though this was significant only for people with 
hazel/green eyes who developed 2-3 BCCs (OR 2.5, 95%CI 1.0-6.5).  Whilst 
presence of melanocytic nevi on the arms was not associated with multiple BCCs, 
cases with nevi on the back were significantly less likely to develop multiple BCCs 
(2-3 BCCs: OR 0.39, 95%CI 0.18-0.84, ≥4 BCCs OR 0.29, 95%CI 0.12-0.67, Table 
1).  No association was found between recreational or occupational sun exposure 
and BCC multiplicity (Table 1). 
 
Regarding measures of acute photodamage, number of lifetime sunburns 
reported prior to BCC diagnosis was not associated with multiplicity of BCC among 
cases (Table 1) and nor were facial telangiectasia and solar elastosis of the neck, as 
measures of chronic photodamage (Table 1).  Among all those affected by BCC, 
strong associations with increasing BCC multiplicity were evident for increasing total 
body SK counts such that for those with 5 or more SKs the odds for developing ≥4 
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BCCs over the observation period were 4 times greater (OR 4.3, 95%CI 1.4-13.5) 
compared to those with no SKs (Table 1). 
 
Pattern of anatomic sites affected by BCC 
 
Among the 169 study participants affected only once by BCC in the study 
period, nearly half were affected on the head/neck (47%) followed by the trunk or 
limbs (29% and 24% respectively; Figure 1).  Among the 232 participants with more 
than one BCC, 140 people (60%) were affected on more than one anatomic site.  Of 
the 139 who developed 2-3 BCCs, the most common site combination within an 
individual was both the head/neck and trunk affected.  However, among the 93 who 
developed ≥4 BCCs, the tumors usually occurred across all the three anatomic sites 
specified (Figure 1).  Among cases multiply affected, 192 (83%) people experienced 
at least one BCC on the head/neck region, 126 (54%) at least one BCC on the trunk 
and 75 (32%) at least one BCC on the limbs.  Overall the pattern of tumor 
occurrence across anatomic sites was similar, whether cases had a single BCC or 
multiple BCCs, with the head/neck by far the most commonly affected site (Figure 1). 
 
Associations with anatomic site of BCC 
 
Among all newly affected by BCC in the period, neither age nor sex was 
significantly associated with the anatomic site of BCC development (Supplementary 
Table 1). 
 
Page 12 of 26
John Wiley & Sons, Inc.
International Journal of Cancer
 13 
Cases with facial telangiectasia were more likely to develop BCCs on the 
head/neck (OR 2.1, 95%CI 1.0-4.1) compared to cases with no facial telangiectasia 
(Table 2).  The presence of many solar lentigines on the face was also associated 
with BCC on the head/neck (OR 1.8, 95%CI 1.0-3.2) but solar elastosis of the neck 
was not (Table 2).  Cases with 5 or more SKs on the face were more likely to have 
BCC on the head/neck (OR 2.0, 95%CI 1.1-3.7) compared to cases without SKs on 
the face.  Similarly, cases with increasing numbers of SKs on the trunk were 
increasingly likely to develop BCCs on the trunk so that the odds for developing a 
BCC on the trunk for those who had 5 or more SKs at this body site were 3 times 
greater (OR 3.3, 95%CI 1.4-7.6) than those without SKs on the trunk.  The presence 
of any solar lentigines on the back was significantly associated with BCCs on the 
trunk and the association was strongest among those cases who had many solar 
lentigines (OR 2.5, 95%CI 1.3-4.9, Table 2) but neither freckles on the trunk nor 
melanocytic nevi on the back were associated with BCCs on the trunk.  Similarly, 
while melanocytic nevi on the arms were not associated with limb BCCs, 5 or more 
SKs on the limbs were strongly associated (OR 3.7, 95%CI 2.0-7.0, Table 2).  
Supplementary Table 1 shows associations between each measure of photodamage 
and BCCs at each anatomic site. 
 
We repeated analyses after exclusion of the 66 participants who had a past 
history of BCC, most of whom (79%) went on to develop multiple BCCs in the study 
period.  When analyses were based only on those participants (n=335) who 
experienced their first BCC during the observation period, there was no material 
difference in results. 
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Discussion 
 
In this prospective study of 401 people affected by incident BCC in a 16-year 
period we found that those who developed high numbers of incident BCCs were 
significantly more likely than those who developed a single BCC to have been 
diagnosed previously with SKs.  There were no significant differences in pigmentary 
traits or self-reported sun exposure histories among BCC cases who developed 
multiple compared with a single BCC however, in contrast to our study hypothesis.  
BCCs were more likely to occur on sites that had clinical evidence of photodamage 
than on sites without.  We also showed that people with multiple BCCs are usually 
affected at more than one site, almost always including the head/neck. 
 
Previous studies have described the predilection for sun-sensitive pigmentary 
traits seen among people affected by BCC compared to those without BCC 22-24.  
Our study extends this work to describe the differences between cases who 
developed intermediate or high numbers of BCCs compared to those who developed 
a single BCC in over a decade and a half of follow-up.  Complexion type was not 
associated with the numbers of BCCs people developed, in agreement with a 
hospital-based British study of 266 BCC cases 12 who found no significant 
association between the skin’s ability to tan and rate of development of subsequent 
BCCs. 
 
We next assessed if sun exposure history was able to distinguish between 
people with single versus multiple BCCs but after prolonged follow-up we found no 
association with recreational or occupational sun exposure.  Nor did we find any 
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evidence that the number of sunburns, a measure of acute sun damage, was 
associated with multiple BCCs.  Our results again agree with those of the British 
study, which found no association between individuals’ hours of sun exposure per 
year prior to their first BCC or number of childhood sunburns and the number of 
subsequent BCCs 12.  While ultraviolet radiation (UVR)  is the main environmental 
factor in the development of BCCs 13, current available evidence cannot reliably 
identify the specific aspects of UVR exposure concerned with the occurrence of 
BCCs (whether initial or subsequent).  This can be attributed partly to the recall error 
that is inherent in all self-reported estimates of past sun exposure and partly to the 
self-selection of susceptible people to an indoor lifestyle 22. 
 
In contrast, an association between objective clinical markers of photodamage and 
general BCC occurrence was noted and this has been described previously by other 
investigators 24, 25.  We have now precisely quantified the relationship, in particular 
the strong associations between total body SK counts and intermediate and high 
numbers of BCCs, overall and site-specifically.  The objective presence of SKs flags 
a history of chronic sun exposure 26 26  and removes the error when recall is used to 
assess the past sun exposure of an individual.  Moreover their site-specific 
prevalence can be regarded as evidence for and personal dosimeters of chronic sun 
damage to the site affected by SKs, making them useful for quantifying site-specific 
associations between UVR and BCC.  Thus our data indicate that those who develop 
multiple BCCs have received a greater dose of UVR than people with a single BCC, 
in general as well as on specific sites, even including the trunk and limbs. 
 
Page 15 of 26
John Wiley & Sons, Inc.
International Journal of Cancer
 16 
The theory that different causal mechanisms are responsible for the 
pathogenesis of BCC on different anatomic site was largely based on cross-sectional 
findings showing that sun-sensitivity and cutaneous sun damage were risk factors for 
a first BCC on the head/neck, whereas a less sun-sensitive phenotype and a history 
of sunburns were associated with a first BCC on the trunk 12, 14, 15.  It is important to 
note that these studies did not take into account any subsequent BCCs (and their 
site) that the participants developed.  Meanwhile another study described in broad 
terms how people with multiple BCCs tended to develop their BCCs on a single site 
16
, presented no evidence about the proportion of people who developed BCC on a 
single or more than one site.  On the other hand a hospital-based Dutch study with a 
median follow-up time of 3.1-years revealed that 33% of people affected by multiple 
BCCs were affected across different sites 9.  In a US study 45% of people affected 
by multiple BCCs developed BCCs on different sites during 7-years of follow-up 17.  
In the present study, with 16-years of follow-up, 60% of people with multiple 
occurrences of BCC developed BCCs on more than one anatomic region suggesting 
a common pathogenic mechanism is shared by BCCs across sites. 
 
Regarding limitations of this study, although our findings did not suggest that 
sunburns contributed to BCC multiplicity we could not exclude this possibility 
because of the known poor reproducibility of sunburn history 27.  Consequently we 
have not been able to assess if the acute intense pattern of UVR is associated with 
BCC multiplicity and site.  Whilst some participants had a BCC prior to the 
observation period, the BCC records for that time were incomplete for some 
participants. We can therefore only be certain about the BCC status of all 
participants for the 16-year observation period.  On repeating our analyses only in 
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those who did not have previous BCC however, similar results were obtained and 
thus we believe this has not influenced our findings to any material extent. 
 
In conclusion, we have shown that among people affected by BCC, those who 
develop intermediate or high numbers of BCCs show evidence of severe sun 
damage both overall and for BCCs at different sites.  How might our findings be 
useful as evidence for effective BCC prevention and healthcare?  These findings 
suggest that control of BCC multiplicity in the population at large is feasible through 
decreasing cumulative sun exposure, thereby helping to curb the substantial 
encumbrance that BCC places on health systems serving white populations.  Follow-
up of BCC patients requires thorough whole body skin examinations, rather than 
being limited to typically sun-exposed sites or to sites previously affected by BCCs. 
Page 17 of 26
John Wiley & Sons, Inc.
International Journal of Cancer
 18 
Acknowledgements 
 
We thank the Nambour Skin Cancer Study participants and their doctors who 
assisted in long-term monitoring of skin cancer.  Many volunteer helpers from the 
Nambour community have given their invaluable support to these studies.  Our 
thanks are extended to Queensland Medical Laboratory and Sullivan Nicolaides 
Pathology for providing pathology reports for all study tumors.  
This work was supported by a grant from the National Health and Medical 
Research Council [grant number 442976].  Naomi Richmond-Sinclair was supported 
by a Smart State PhD Scholarship, an ANZ Trustees Medical Research in 
Queensland PhD Scholarship and Queensland Institute of Medical Research PhD 
Top-Up Scholarship.  Rachel Neale is supported by a NHMRC (Aust) Career 
Development Award. 
 
 
 
 
 
 
 
 
 
 
 
 
Page 18 of 26
John Wiley & Sons, Inc.
International Journal of Cancer
 19 
References 
 1. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin 
cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol 2001;45:528-36. 
 2. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in 
incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. 
New Hampshire Skin Cancer Study Group. Int J Cancer 1999;81:555-9. 
 3. Karagas MR, Stukel TA, Greenberg ER, Baron JA, Mott LA, Stern RS. Risk of 
subsequent basal cell carcinoma and squamous cell carcinoma of the skin among 
patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 
1992;267:3305-10. 
 4. Robinson J. Risk of developing another basal cell carcinoma: a 5-year prospective 
study. Cancer 1987;60:118-20. 
 5. Richmond-Sinclair NM, Pandeya N, Ware RS, Neale RE, Williams GM, van der 
Pols JC, Green AC. Incidence of basal cell carcinoma multiplicity and detailed 
anatomic distribution: longitudinal study of an Australian population. J Invest 
Dermatol 2009;129:323-8. 
 6. Chen JG, Fleischer AB, Jr., Smith ED, Kancler C, Goldman ND, Williford PM, 
Feldman SR. Cost of nonmelanoma skin cancer treatment in the United States. 
Dermatol Surg 2001;27:1035-8. 
 7. Morris S, Cox B, Bosanquet N, Cost of skin cancer in England. Tanaka Business 
School, Imperial College of London, 2005. 
 8. AIHW, Health system expenditures on cancer and other neoplasms in Australia, 
2000-01. AIHW cat. no. HWE 29. Australian Institute of Health and Welfare, 2005. 
 9. van Iersel CA, van de Velden HV, Kusters CD, Spauwen PH, Blokx WA, 
Kiemeney LA, Gerritsen MJ. Prognostic factors for a subsequent basal cell 
carcinoma: implications for follow-up. Br J Dermatol 2005;153:1078-80. 
 10. Tangrea J, Edwards B, Taylor P, Hartman A, Peck G, Salasche S, Menon P, 
Benson P, Mellette J, Guill M, Robinson J, Guin J, et al. Long-Term Therapy With 
Low-Dose Isotretinoin for Prevention of Basal Cell Carcinoma: A Multicenter 
Clinical Trial. Journal of the National Cancer Institute 1992;84:328-32. 
 11. Ramachandran S, Lear JT, Ramsay H, Smith AG, Bowers B, Hutchinson PE, 
Jones PW, Fryer AA, Strange RC. Presentation with multiple cutaneous basal cell 
carcinomas: association of glutathione S-transferase and cytochrome P450 
genotypes with clinical phenotype. Cancer Epidemiol Biomarkers Prev 1999;8:61-7. 
 12. Lovatt TJ, Lear JT, Bastrilles J, Wong C, Griffiths CE, Samarasinghe V, 
Roebuck J, Ramachandran S, Smith AG, Jones PW, Fryer AA, Strange RC. 
Associations between ultraviolet radiation, basal cell carcinoma site and histology, 
host characteristics, and rate of development of further tumors. J Am Acad Dermatol 
2005;52:468-73. 
 13. Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, Benbrahim-
Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. WHO International Agency 
for Research on Cancer Monograph Working Group.  A review of human 
carcinogens--part D:  radiation. Lancet Oncol 2009:751-2. 
 14. Lovatt TJ, Lear JT, Bastrilles J, Wong C, Griffiths CE, Ramachandran S, Smith 
AG, Salim A, Fryer AA, Jones PW, Strange RC. Associations between UVR 
exposure and basal cell carcinoma site and histology. Cancer Lett 2004;216:191-7. 
 15. Neale RE, Davis M, Pandeya N, Whiteman DC, Green AC. Basal cell carcinoma 
on the trunk is associated with excessive sun exposure. J Am Acad Dermatol 
2007;56:380-6. 
Page 19 of 26
John Wiley & Sons, Inc.
International Journal of Cancer
 20 
 16. Ramachandran S, Fryer AA, Smith A, Lear J, Bowers B, Jones PW, Strange RC. 
Cutaneous basal cell carcinomas: distinct host factors are associated with the 
development of tumors on the trunk and on the head and neck. Cancer 2001;92:354-
8. 
 17. Marghoob A, Kopf AW, Bart RS, Sanfilippo L, Silverman MK, Lee P, Levy E, 
Vossaert KA, Yadav S, Abadir M. Risk of another basal cell carcinoma developing 
after treatment of a basal cell carcinoma. J Am Acad Dermatol 1993;28:22-8. 
 18. Green A, Beardmore G, Hart V, Leslie D, Marks R, Staines D. Skin cancer in a 
Queensland population. J Am Acad Dermatol 1988;19:1045-52. 
 19. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks GC, Gaffney 
P, Battistutta D, Frost C, Lang C, Russell A. Daily sunscreen application and 
betacarotene supplementation in prevention of basal-cell and squamous-cell 
carcinomas of the skin: a randomised controlled trial. Lancet 1999;354:723-9. 
 20. van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged 
prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer 
Epidemiol Biomarkers Prev 2006;15:2546-8. 
 21. Van der Pols JC, Williams GM, Neale RE, Clavarino A, Green AC. Long-term 
increase in sunscreen use in an Australian community after a skin cancer prevention 
trial. Preventive Medicine 2006;42:171-6. 
 22. Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a 
subtropical Australian population: incidence and lack of association with occupation. 
The Nambour Study Group. Am J Epidemiol 1996;144:1034-40. 
 23. Kricker A, Armstrong BK, English DR, Heenan PJ. Pigmentary and cutaneous 
risk factors for non-melanocytic skin cancer--a case-control study. Int J Cancer 
1991;48:650-62. 
 24. Naldi L, DiLandro A, D'Avanzo B, Parazzini F. Host-related and environmental 
risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control 
study. J Am Acad Dermatol 2000;42:446-52. 
 25. Marks R. Solar keratoses. Br J Dermatol 1990;122 Suppl 35:49-54. 
 26. Rossi R, Mori M, Lotti T. Actinic keratosis. Int J Dermatol 2007;46:895-904. 
 27. Shoveller J, Lovato C. Measuring self-reported sunburn: challenges and 
recommendations. Chronic Diseases in Canada 2001;22:75-87. 
 
 
Page 20 of 26
John Wiley & Sons, Inc.
International Journal of Cancer
  21 
Figures  
 
Figure 1:  Anatomic sites of basal cell carcinoma (BCC) among people with 
single and multiple occurrences of BCC in 1992 to 2007, Queensland, Australia 
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Table 1:  Odds ratios for multiple basal cell carcinomas (BCC) compared to people with a 
single BCC in 1992 to 2007, according to age, sex, pigmentary traits, sun exposure and 
cutaneous signs of sun damage in Queensland, Australia 
 
  
Distribution of cases (count (%)) 
 
Persons with 2 to 3 
BCCs 
 
Persons with ≥4 
BCCs 
Participant 
characteristics 
 
All 
(n=401) 
 
Single BCC 
(reference, 
n=169) 
 
2 to 3 BCCs 
(n=139) 
 
≥4 BCCs 
(n=93) 
 
Odds 
ratio 
 
95% CI1 
 
Odds 
ratio 
 
95% CI 
 
Age2 
        
    Less than 40 years 54 (13%) 28 (17%) 18 (13%) 8 (9%) 1.0 Ref 1.0 Ref 
    40 to 59 years 203 (51%) 92 (54%) 69 (50%) 42 (45%) 1.2 (0.57, 2.4) 2.0 (0.79, 4.9) 
    60 years or older 144 (36%) 49 (29%) 52 (37%) 43 (46%) 1.4 (0.60, 3.2) 4.2 (1.5, 11.8) 
 
Sex2 
        
    Female 207 (52%) 100(59%) 70 (50%) 37 (40%) 1.0 Ref 1.0 Ref 
    Male 194 (48%) 69 (41%) 69 (50%) 56 (60%) 1.8 (1.1, 3.2) 2.8 (1.5, 5.3) 
 
Pigmentation traits 
 
Skin color2 
 
 
       
    Olive / medium 152 (38%) 66 (39%) 56 (40%) 30 (32%) 1.0 Ref 1.0 Ref 
    Fair 249 (62%) 103 (61%) 83 (60%) 63 (68%) 0.87 (0.52, 1.4) 1.3 (0.73, 2.4) 
 
Skin response to sun exposure2 
   
    
    Tan / burn then tan 295 (74%) 125 (74%) 109 (78%) 61 (66%) 1.0 Ref 1.0 Ref 
    Always burn 106 (26%) 44 (26%) 30 (22%) 32 (34%) 0.63 (0.35, 1.1) 1.4 (0.76, 2.6) 
 
Eye color3 
        
    Dark / light brown 38 (10%) 21 (12%) 10 (7%) 7 (8%) 1.0 Ref 1.0 Ref 
    Hazel / green 165 (41%) 70 (42%) 61 (44%) 34 (37%) 2.5 (1.0, 6.5) 2.4 (0.73, 8.1) 
    Blue/grey 195 (49%) 77 (46%) 67 (49%) 51 (55%) 2.1 (0.82, 5.4) 2.1 (0.61, 6.9) 
 
Hair color2 
        
    Black / Dark brown 158 (40%) 69 (41%) 57 (41%) 32 (35%) 1.0 Ref 1.0 Ref 
    Light brown / blonde 203 (51%) 88 (52%) 64 (47%) 51 (55%) 0.96 (0.58, 1.6) 1.3 (0.71, 2.3) 
    Red / ginger / auburn 37 (9%) 11 (7%) 17 (12%) 9 (10%) 2.2 (0.88, 5.4) 2.2 (0.75, 6.2) 
 
Melanocytic nevi on back4 
     
  
    No 52 (15%) 13 (8%) 22 (16%) 17 (19%) 1.0 Ref 1.0 Ref 
    Yes 346 (85%) 155 (92%) 117 (84%) 74 (81%) 0.39 (0.18, 0.84) 0.29 (0.12, 0.67) 
 
Melanocytic nevi on arms4 
     
  
    No 238 (60%) 98 (59%) 87 (63%) 53 (59%) 1.0 Ref 1.0 Ref 
    Yes 157 (40%) 68 (41%) 52 (37%) 37 (41%) 1.0 (0.61, 1.6) 1.6 (0.87, 2.8) 
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Sun exposure 
 
Recreation type3 
      
  
    Mainly indoors 67 (17%) 27 (16%) 24 (17%) 16 (17%) 1.0 Ref 1.0 Ref 
    Indoors and outdoors 115 (28%) 52 (31%) 39 (28%) 24 (26%) 0.68 (0.31, 1.5) 0.54 (0.22, 1.4) 
    Mainly outdoors 219 (55%) 90 (53%) 76 (55%) 53 (57%) 0.63 (0.30, 1.3) 0.54 (0.22, 1.3) 
 
Occupation type2 
      
  
    Mainly indoors 153 (38%) 65 (39%) 56 (40%) 32 (34%) 1.0 Ref 1.0 Ref 
    Indoors and outdoors 146 (37%) 62 (37%) 50 (36%) 34 (37%) 0.84 (0.49, 1.5) 1.0 (0.55, 2.0) 
    Mainly outdoors 100 (25%) 40 (24%) 33 (24%) 27 (29%) 0.59 (0.30, 1.2) 0.80 (0.38, 1.7) 
 
Cutaneous signs of sun damage 
 
                 Acute 
 
     
  
Number of painful 
sunburns2 
      
  
    Never 47 (12%) 20 (12%) 18 (13%) 9 (10%) 1.0 Ref 1.0 Ref 
    1 to 5 200 (50%) 86 (51%) 70 (50%) 44 (47%) 1.0 (0.47, 2.2) 1.7 (0.67, 4.4) 
    6 or more 154 (38%) 63 (37%) 51 (37%) 40 (43%) 1.0 (0.43, 2.3) 1.8 (0.66, 4.8) 
 
            Chronic     
 
Telangiectasia of the face3 
     
  
    None / mild 217 (54%) 97 (57%) 68 (49%) 52 (56%) 1.0 Ref 1.0 Ref 
    Moderate / severe 184 (46%) 72 (43%) 71 (51%) 41 (44%) 1.3 (0.76, 2.3) 0.72 (0.37, 1.4) 
 
Solar elastosis of the neck2 
    
 
  
    None / mild 194 (48%) 91 (54%) 58 (42%) 45 (48%) 1.0 Ref 1.0 Ref 
    Moderate / severe 207 (52%) 78 (46%) 81 (58%) 48 (52%) 1.5 (0.90, 2.6) 0.86 (0.47, 1.6) 
 
Solar Keratoses4 
        
    None 58 (15%) 37 (22%) 17 (12%) 4 (4%) 1.0 Ref 1.0 Ref 
    1 to 4 105 (26%) 47 (28%) 34 (25%) 24 (26%) 1.4 (0.69, 3.0) 3.9 (1.2, 12.5) 
    5 or more 238 (59%) 85 (50%) 88 (63%) 65 (70%) 1.9 (0.92, 3.8) 4.3 (1.4, 13.5) 
 
1
 CI, confidence interval; 
 
2 Estimates were derived from a model that contained age, sex, randomised 
sunscreen treatment, self-reported skin response to acute sun exposure, sunscreen 
use since the trial and skin response to sun exposure, eye color, occupation type and 
number of lifetime sunburns; 
 
3
 The model was the same as in 2 but also contained hair color, recreation type, 
telangiectasia of the face and elastosis of the neck; 
 
4
 The model included age, sex, randomised sunscreen treatment, self-reported skin 
response to acute sun exposure and total number of solar keratoses or nevi where 
appropriate. 
 
 
 
Table 2:  Odds ratios1 for anatomic site of basal cell carcinoma (BCC) according to  
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cutaneous signs of sun damage of skin at the same site among people affected 1992 to 2007, in 
Queensland, Australia 
   
 
Cutaneous signs 
of sun damage 
 
Distribution of BCCs (count (%)) 
 
Odds ratios 
 
95% CI2 
 
Head/neck 
 
 
Trunk or limbs 
(n=345) 3 
 
Head/neck 
(n=856) 4 
 
 
Head/neck 
 
Telangiectasia of face 
 
    
    None 25 (7%) 22 (3%) 1.0 Ref  
    Mild / moderate / severe 320 (93%) 834 (97%) 2.1 (1.0, 4.1) 
 
Solar lentigines on face 
.    
    None  79 (23%) 161 (19%) 1.0 Ref  
    Some  213 (62%) 527 (61%) 1.2 (0.78, 1.8) 
    Many 53 (15%) 168 (20%) 1.8 (1.0, 3.2) 
 
Solar elastosis of neck 
    
    None 16 (5%) 13 (2%) 1.0 Ref  
    Mild / moderate / severe 329 (95%) 843 (98%) 1.7 (0.76, 3.8) 
 
Solar Keratoses on face 
    
    None 54 (16%) 64 (8%) 1.0 Ref  
    1 to 4 118 (34%) 238 (28%) 1.4 (0.85, 2.5) 
    5 or more 173 (50%) 554 (64%) 2.0 (1.1, 3.7) 
 
Trunk 
 
Freckles on trunk 
 
Head/neck or 
limbs 
(n=574) 5 
 
Trunk 
(n=627) 6 
Trunk 
 
 
    None 89 (16%) 79 (13%) 1.0 Ref 
    Some  184 (32%) 247 (39%) 1.6 (0.90, 3.0) 
    Many 300 (52%) 297 (48%) 1.5 (0.82, 2.7) 
 
Solar lentigines on back 
    
    None 182 (32%) 119 (19%) 1.0 Ref  
    Some 258 (45.%) 309 (50%) 1.7 (1.0, 2.8) 
    Many 132 (23%) 193 (31%) 2.5 (1.3, 4.9) 
 
Melanocytic nevi on back 
    
    None 78 (14%) 111(18%) 1.0 Ref  
    Some 417 (73%) 411 (66%) 0.87 (0.52, 1.4) 
    Many 77 (13%) 101 (16%) 1.4 (0.63, 3.3) 
 
Solar keratoses on trunk 
  
  
    None 413 (72%) 317 (51%) 1.0 Ref  
    1 to 4 135 (24%) 206 (33%) 1.6 (1.0, 2.5) 
    5 or more 26 (4%) 104 (16%) 3.3 (1.4, 7.6) 
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Limbs 
 
Nevi on arms 
 
Head/neck or 
trunk 
(n=721) 7 
 
Limbs 
(n=480) 8 
Limbs 
 
 
    No  409 (58%) 350 (75%) 1.0 Ref 
    Yes 301 (42%) 114 (25%) 0.74 (0.47, 1.2) 
 
Solar Keratoses on limbs 
  
  
    None 217 (30%) 58 (12%) 1.0 Ref 
    1 to 4 200 (28%) 55 (12%) 1.4 (0.72, 2.5) 
    5 or more 304 (42%) 367 (76%) 3.7 (2.0, 7.0) 
 
1 Adjusted for age, sex, skin color and randomised sunscreen treatment; 
 
2 CI, confidence interval;   
3
 Reference group: BCCs that developed on either the trunk or limbs;   
4
 BCCs that developed on the head/neck only;   
5
 Reference group: BCCs that developed on either the head/neck or limbs; 
6
 BCCs that developed on the trunk;   
7
 Reference group: BCCs that developed on either the head/neck or trunk; 
8
 BCCs that developed on the limbs. 
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CHAPTER 5  
OCCURRENCE AND DETERMINANTS OF BASAL CELL 
CARCINOMA BY HISTOLOGICAL SUBTYPE IN AN 
AUSTRALIAN COMMUNITY COHORT 
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5.1  Introduction 
This results chapter comprises a manuscript that will soon be submitted to an 
international peer-reviewed journal, and as such is presented here in a 
general format required for manuscript submission.  It directly addresses 
research questions R5 and R6 (see section 1.7):  what are the common 
histological growth patterns of basal cell carcinoma in a high risk Australian 
population? and do nodular and superficial BCCs have the same association 
to risk factors (age, sex, pigmentary traits, sun exposure, sun dose) when 
compared to people unaffected by BCC? 
 
5.2  Contribution of candidate 
I conceived and designed the investigation with advice from Prof Adèle 
Green and Dr Jolieke van der Pols.  I developed new variables to capture the 
number of times a person had been affected by BCC during the observation 
period and all of the time-dependent variables that captured each person’s 
sun exposure history and degree of photodamage.   The remaining variables 
were available in the existing datasets.  I requested pathology reports from 
the Queensland pathology laboratories for those lesions that did not have 
data available for the specific histologic growth patterns and assisted with the 
data entry for this information.  I performed the data analyses and drafted the 
manuscript. 
 
5.3  Acknowledgement of the contribution of others 
All the data included in the following manuscript were collected as part of the 
Nambour Skin Cancer Study.  The Nambour Skin Cancer Follow-up Study 
was conceived and designed by the chief investigators, namely, Prof Adèle 
Green and Prof. Gail Williams.  Prof H.Konrad Muller assisted with the 
classification of the BCC growth patterns and the editing of the manuscript.  
Dr Jolieke van der Pols and Prof Adèle Green contributed to the 
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interpretation of the results and assisted with the editing and drafting of the 
manuscript. 
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Abstract 
 
Background The pleomorphism of basal cell carcinoma (BCC) is well-known 
but the relative frequencies and causes of different growth patterns are not. 
 
Objective Describe frequencies of growth patterns and quantify the 
associations between pigmentary traits and sun exposure and nodular and 
superficial BCCs. 
 
Method In a community-based cohort in Queensland, Australia, we 
prospectively recorded growth patterns and sites of all confirmed BCCs 
(1992 to 2007).  Risks of nodular and superficial BCCs in relation to baseline 
phenotype and sun exposure were estimated using logistic regression. 
 
Results In 16-years, 401 of the cohort of 1339 (average age 49 at baseline) 
developed 1202 BCCs.  792 (77%) had a single growth pattern and 235 
(23%) were mixed.  Among all BCCs the nodular followed by the superficial 
growth patterns were commonest.  In general, compared to people 
unaffected, risks of nodular and superficial BCCs were significantly raised 
among those older than 50, males, those with light eye color or multiple past 
sunburns.  Risk of nodular and superficial BCCs on the head was raised if 5 
or more solar keratoses were present on the face (ORs 1.8 and 4.5 
respectively) and similarly on the trunk in the presence of multiple solar 
keratoses on the trunk (ORs 4.2 and 2.2 respectively).   
 
Limitations The predominant growth pattern was not available for BCCs with 
mixed composition. 
 
Conclusion We conclude that nodular and superficial BCCs have similar 
associations with severely sun damaged skin whatever the site, suggesting 
that actual BCC growth patterns are determined by local tissue factors rather 
than degree of sun exposure. 
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Capsule summary 
 
• Among people affected by BCCs nearly 40% develop BCCs with 
mixed histologic composition. 
• BCCs of nodular and superficial growth patterns have similar 
etiologies with regard to the affected persons’ sun exposure histories 
and their clinical signs of severe sun damage. 
• The observed growth patterns of BCCs are probably determined by 
local tissue factors rather than external exposure factors. 
 
Abbreviations     
 
BCC, basal cell carcinoma 
OR, odds ratio 
CI, confidence interval 
SK, solar keratosis 
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Introduction 
 
Basal cell carcinomas (BCC) are distinct skin cancers occurring with high 
frequency and highly varied histologic presentations 1.  At least 20 BCC 
subtypes have been defined 2 and mixed composition is not unusual 3.   
 
The well-described histological morphologies include the nodular, superficial 
and morpheic/infiltrative subtypes 4.  The nodular growth pattern is the most 
common (accounting for up to 81% of BCCs) 5 and BCCs of this type tend to 
occur on the head and neck  5-7.  This is the anatomic site with the highest 
opportunity for sun exposure and also the site most frequently treated for 
BCC overall 8-10.  Superficial BCCs are the second most common 9 and occur 
predominantly on the trunk 5-7, the site second most commonly treated for 
BCC 8, 10, 11.  These collective findings have led to the hypothesis that BCC 
histological subtypes have different etiologies 6, 7, 12.  The majority of studies 
that have supported this hypothesis however have been based on assorted 
large series of retrospectively collected pathology reports.  Furthermore the 
only study that assessed risk factors for nodular and superficial BCCs 
separately did not account for anatomic site of occurrence 13. Hence it 
remains unclear if risk factors for BCCs of certain subtypes are determined 
by their anatomic sites of occurrence, the sun exposure histories of the host, 
or some other factors.  The epidemiology of BCCs of mixed histologic 
composition remains unknown. 
 
We monitored the occurrence of BCC according to growth patterns among 
participants in a community-based skin cancer study in subtropical 
Queensland, Australia during the period 1992 to 2007. We further conducted 
a detailed assessment of personal and environmental factors associated with 
the development of the main histological growth patterns of BCC.  We 
hypothesised that BCCs of different histological subtypes have similar rather 
than different etiologies with regard to sun exposure histories of affected 
persons. 
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Materials and methods 
 
The Nambour Skin Cancer Study 
 
Study participants were originally randomly selected in 1986 from the 
electoral register of all adult residents of the subtropical township of Nambour 
in Queensland, Australia (latitude 26°S)  for a baseline study of skin cancer 
14.  2095 people (70%) took part and were shown to be a representative 
sample of the community with regard to risk factors for skin cancer 14.  Of 
these, 1621 (77%) participated in a field trial between 1992 and 1996 to 
assess sunscreen application and betacarotene supplementation in the 
prevention of skin cancer and full details have been published previously 15, 
16.  In 1996, participants were invited to take part in a further follow-up study 
of skin cancer and provided consent to have subsequently diagnosed skin 
cancers notified to the investigators by regional pathology laboratories in 
Queensland, allowing 100% ascertainment of all histologically confirmed 
BCCs.  No participants were immuno-compromised, and none had nevoid 
basal cell carcinoma syndrome.  Follow-up for skin cancers continued to the 
end of 2007.  Ethical approval was obtained from the ethics committee of the 
Queensland Institute of Medical Research. 
 
Basal cell carcinomas 
 
People who experienced a new histologically-confirmed BCC during the 
study period, 1992 to 2007, were considered cases.  Investigators abstracted 
details of histologic subtype from pathology reports.  If more than one growth 
pattern was described all were recorded.  The BCC histological 
subclassification system proposed by the World Health Organisation was 
applied for those tumors with a single growth pattern 17, 18.  Because the 
same BCC may be histologically confirmed twice, at initial biopsy/excision 
and again if re-excised, all records of apparently multiple BCCs verified within 
a 6-month period in the same person and on the same anatomic site were 
 108 
 
cross-checked to identify duplicate reports.  Recurrent BCCs diagnosed at 
the sites of earlier primary lesions were excluded. 
Pigmentary traits, sun exposure and photodamage 
 
Participants’ head, neck, and trunk were examined in 1986, 1992, 1994 and 
1996 by dermatologists who documented the number and sites of solar 
keratoses.  All participants completed a baseline standard questionnaire 
about pigmentary traits (skin and eye color) and sun-exposure habits 
(occupation and number of lifetime painful sunburns), which was updated 
during the trial and additional information obtained about participants’ skin 
responses to acute sun exposure.  From 1997, participants reported their 
sunscreen use each year and based on their responses were classified as 
regular or irregular sunscreen users 19. 
 
Statistical analysis 
 
Repeated-measures binomial logistic regression was used to assess the 
associations between personal factors and BCCs of nodular and of 
superficial histological subtypes (there were insufficient numbers of the less 
common subtypes), taking participants unaffected by BCC during the study 
period as the reference group.  The repeated-measures analyses accounted 
for the intra-person correlation when people had multiple BCCs.  Differences 
between nodular and superficial BCCs were formally tested by a case-case 
comparison of nodular and superficial BCC cases.  Each exposure variable 
was treated categorically to estimate the odds ratio (OR) with 95% 
confidence intervals.  Analyses were stratified by anatomic site to account for 
differences in the proportion of BCCs of the nodular or superficial growth 
pattern that occurred by site and all analyses were adjusted for age, sex, and 
randomised sunscreen treatment during the trial.  Only a person’s sun 
exposure and photodamage recorded prior to the date of diagnosis of BCC 
were considered.  Statistical analyses were conducted using SAS version 9.1 
(SAS Institute Inc., Cary, North Carolina) and SUDAAN 10 (RTI Institute, 
Research Triangle Park, North Carolina). 
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Results 
 
Study population 
 
1339 participants had complete follow-up until the end of 2007.  At the start 
of follow-up in 1992 their mean age was 49 years, and 56% were female.  Of 
these, 401 (207 women) were diagnosed with a combined total of 1202 
histologically-confirmed BCCs.  169 people developed one BCC only (42%, 
including 100 women) and 232 people developed more than one BCC (58%, 
including 107 women).    
 
Prevalence of single and mixed histological composition 
 
Histological growth patterns were available for 1027 (85%) of the BCCs.  
Pathology reports were unavailable for 5 BCCs and growth patterns were not 
reported for 170 BCCs.  BCCs with unknown growth patterns were similar to 
BCCs with known growth patterns in terms of age at diagnosis, sex, site of 
occurrence and skin color, however, they were more likely to have been 
diagnosed in earlier study years (prior to 1997, 63% and 34% respectively 
(p=<0.001)).  Among the BCCs with known growth patterns, 792 (77%) BCCs 
from 329 (82%) people had a single growth pattern, while 235 (23%) BCCs 
from 153 (38%) people had mixed composition, with up to three different 
growth patterns in a single BCC.  212 (21%) had two different growth 
patterns and 23 (2%) had three different growth patterns.  In this series of 
BCCs 19 different growth patterns were described.  There was little 
difference in sex and age of persons with single or mixed composition 
tumours. 
 
Among the 792 BCCs with a single growth pattern the nodular type was the 
most common (403, 51%) followed by superficial (284, 36%), morpheic (48, 
6%) and then micronodular (18, 27%) BCCs (Figure 1).  Among 235 BCCs 
with mixed histological composition, the nodular pattern was present in 200 
(85%) BCCs of which 104 (44%) also showed morpheic growth patterns, 
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while 56 (24%) also showed a superficial growth pattern component (Figure 
1). 
 
One versus multiple basal cell carcinomas 
 
Among the 146 people affected once by BCC, 111 (76%) had a BCC of a 
single growth pattern.  Among the 226 people affected by multiple BCCs, 218 
(96%) had at least one BCC of a single growth pattern (total 681 BCCs with a 
single pattern) and 117 (52%) were diagnosed with at least one BCC of two 
or more growth patterns (total 200 with mixed pattern).  The proportions of 
BCCs with single and mixed histological composition were similar among 
people affected by one or multiple BCCs (p=0.7, Figure 1). 
 
Anatomic distribution 
 
Of the 533 BCCs on the head and neck of known growth pattern, 375 (71%) 
had a single growth pattern, lower than for BCCs on the trunk (237, 86%) and 
limbs (177, 83%, Figure 2).  As a corollary more BCCs on the head and neck 
were of mixed composition (p=<0.001).  The most common growth pattern in 
head and neck BCCs was nodular and it was exclusively present in almost 
half (243, 46%).  In contrast BCCs on trunk (119, 43%) and limbs (99, 47%) 
the superficial growth pattern predominated (Figure 2).  Among BCCs with 
mixed histological composition, nodular remained the dominant pattern on all 
three anatomic sites. 
 
With regard to anatomic subsites on the head and neck (forehead, temples, 
ears, eyes, nose, cheek, perioral, chin, jaw, scalp, and neck) the proportion 
of BCCs with a single growth pattern was similar across subsites (around 
30%).  Further, among head and neck BCCs with a single growth pattern the 
highest proportion of nodular BCCs occurred in the periocular region (83%), 
whereas the cheek and perioral, and neck subsites had the greatest 
proportions of superficial BCC (24% and 32% respectively).  Varying 
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proportions of BCCs of the nodular, superficial and morpheic growth patterns 
occurred at each subsite (p=0.06). 
 
Determinants of the nodular and superficial growth patterns 
 
Head and neck 
 
People aged 50 years or older were more likely to have a nodular or 
superficial BCC on the head and neck than those aged under 50. 
 
The age association was strongest for nodular BCCs:  the odds of having a 
nodular BCC among those aged 50 years or older at the start of observation 
were 4 times higher (OR=4.4, 95%CI 3.0-6.4, Table 1) compared to those 
who were younger.  Nodular BCCs were more likely to occur among males 
than females (OR=2.2, 95%CI 1.6-3.3).  Compared to people with darker 
pigmentation traits, those with lighter, sun-sensitive phenotypes were 
generally at increased risk of both nodular and superficial BCCs although the 
magnitude and significance of individual associations varied (Table 1).  A 
history of 5 or more painful sunburns was strongly associated with nodular 
BCC (OR=3.2, 95%CI 1.8-5.7, (Table 1) but not significantly with superficial 
BCC. 
 
Although we found no association between reported occupational sun 
exposure and the diagnosis of BCCs of either growth pattern, strong 
associations with high numbers of facial solar keratoses were evident for 
BCCs of the nodular (OR=1.8, 95%CI 1.2-2.7) and superficial (OR=4.5, 
95%CI 2.1-9.7, Table 1) growth patterns compared to those with no solar 
keratoses. 
 
Trunk 
 
Overall, the associations between each of the risk factors and nodular and 
superficial BCCs on the trunk were similar to those for BCC on the head and 
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neck apart from a lack of association between sun-sensitive skin type and 
BCCs on the trunk of either subtype.  Strong associations with increasing 
truncal solar keratoses counts were particularly evident for both BCC 
subtypes on the trunk (Table 1). 
 
Differences between nodular and superficial BCCs 
 
Among BCCs on the head and neck the only significant difference between 
nodular and superficial BCCs was that people aged 50 years or older and 
males were more likely to develop a nodular BCC (data not shown).  This 
was not true for truncal BCCs.  With regard to the associations with 
pigmentary traits, sun exposure and solar keratoses there were no significant 
differences between the two growth patterns at either site. 
 
Discussion 
 
In this prospective community-based study with 401 people affected by one 
or more BCCs, we found that while most BCCs had a single histological 
growth pattern, mixed histological composition was seen in around a quarter 
of all new BCCs in the 16-year follow-up period.  When compared to people 
unaffected by BCC, there were no consistent and significant differences 
between risk factors for nodular and superficial BCCs with regard to 
pigmentary traits, self-reported sun exposure history or evidence of severe 
sun damage. 
 
It has been suggested that superficial and nodular BCCs vary in their causal 
relationship to sunlight  6, 7, 13.  Whilst previous studies have found superficial 
BCCs to be diagnosed at an earlier age and more often on the trunk when 
compared to nodular BCCs, these studies tended to be cross-sectional data 
or based on persons’ first BCCs only 6, 7.  The only previous study to assess 
the association between patient characteristics and BCC histology did not 
account for anatomic sites of occurrence, and hence it was unclear if the risk 
factors they identified for BCCs, namely solar keratoses and past sun burns, 
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were determined by the anatomic site rather than the sun exposure history 
per se.  To overcome this problem we stratified by anatomic site in order to 
account for the large difference in opportunity for sun exposure on the head 
and neck and the trunk.  It was then clear in our large community series of 
BCCs that there was no material difference between BCCs of the nodular 
and superficial growth patterns with regard to complexion, personal sun 
exposure history or clinical evidence of photoaging.  This was in line with our 
study hypothesis.  That is, BCCs of different histological growth patterns 
appeared to have similar etiologies which suggests that the growth patterns 
of BCCs are determined by their micro-environment (the skin at the anatomic 
site) influencing a multipotent cell of origin 20, 21 rather than the external 
environment (sun exposure history). 
 
Few previous studies have reported the details of occurrence of mixed 
histological composition among BCCs 3, 6, 7; some have reported the 
predominant growth pattern only 22.  In 1039 consecutive BCCs collected 
from American Hospital archives, up to 38% had evidence of mixed histology 
23, however, in another American case series 76% of 175 BCCs exhibited 
mixed histology (though the selection method for BCCs was not clear) 24.  
We have confirmed that mixed histological composition among BCCs is not 
uncommon.  It seems likely that this diversity in growth patterns reflects the 
BCC’s origin in a multipotent epithelial stem cell 20, 25. 
 
Our findings also showed that the nodular growth pattern is the most 
common among BCCs (including among those of mixed composition), 
followed by the superficial growth pattern 7, 9.  This is consistent with the 
findings of a previous study that reported the nodular pattern was 
predominant in nearly 50% of BCC with mixed composition 24 and with those 
of another that documented only mixed compositions that demonstrated the 
nodular pattern 7.  On the other hand our finding that histological growth 
patterns (and single and mixed compositions) occur in similar proportions 
among people who develop one or multiple BCCs does not accord with that 
of a previous study which found that people affected by multiple BCCs tend 
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to have had superficial rather than nodular tumours 26.  This may be because 
the present study is based on longitudinal data supported by a virtually 
complete skin cancer history for each participant rather than a highly selected 
cross-sectional sample of the previous series 26.   
 
Regarding limitations of the present study, we considered that the rate of 
reporting of mixed composition BCCs may have changed with time (for 
example, more mixed BCCs may have been diagnosed in recent study years 
compared to earlier study years) but this was not true in our dataset.  Also we 
were not able to classify our BCCs with mixed histology according to the 
World Health Organisation’s classification system because the predominant 
growth pattern for those BCCs was not available. 
 
In conclusion, we have shown that BCCs of nodular and superficial growth 
patterns have similar etiologies with regard to affected persons’ sun exposure 
histories and their clinical signs of severe sun damage.  These findings 
suggest that the observed growth patterns of BCCs are determined by local 
tissue factors rather than external exposure factors. 
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Figure 1  Histological growth patterns of all basal cell carcinomas (BCC)  
               according to people having a single BCC or multiple BCCs in            
               Queensland, Australia 1992-2007. 
 
*’Other’ includes microdudular for BCCs with a single histological growth 
pattern 
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Figure 2  Histological growth patterns of all basal cell carcinomas (BCC)  
               according to anatomic site of development in Queensland,  
               Australia 1992-2007. 
 
*’Other’ includes microdudular for BCCs with a single histological growth 
pattern 
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Table 1:  Odds ratios for persons affected by nodular and superficial growth patterns of basal cell carcinoma (BCC) compared to  
                people unaffected by BCC (1992-2007), Queensland, Australia. 
 
 
 
Participant 
Characteristics 
 
Distribution of participants (count (%)) 
 
Head and neck 
 
Trunk 
   
Head and neck 
 
Trunk 
 
Nodular 
 
Superficial  
 
Nodular  
 
Superficial  
  
Unaffected 
(n=938) 
 
Nodular 
(n=243) 2 
 
Superficial 
(n=65) 3 
 
Nodular 
(n=93) 2 
 
Superficial 
(n=119) 3 
 
Odds 
ratios 
 
95% CI1 
 
Odds 
ratios 
 
95% CI 
 
Odds 
ratio 
 
95% CI 
 
Odds 
ratio 
 
95%CI 
 
Age4 
            
   Less than 50 years 575 (61%) 58 (24%) 25 (38%) 31 (33%) 41 (34%) 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref 
   50 years or older 363 (39%) 185 (76%) 40 (62%) 62 (67%) 78 (66%) 4.4 (3.0, 6.4) 2.1 (1.2, 3.8) 2.3 (1.4, 3.8) 2.6 (1.6, 4.3) 
 
Sex4 
             
   Female 542 (58%) 88 36(%) 32 (49%) 37 (40%) 45 (38%) 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref 
   Male 396 (42%) 155 (64%) 33 (51%) 56 (60%) 74 (62%) 2.2 (1.6, 3.3) 1.2 (0.65, 2.2) 1.9 (1.1, 3.2) 2.0 (1.2, 3.2) 
 
Pigmentation traits 
 
Skin color5 
             
   Olive / medium 447 (48%) 83 (34%) 14 (22%) 38 (41%) 40 (34%) 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref 
   Fair 491 (52%) 160 (66%) 51 (78%) 55 (59%) 79 (66%) 1.4 (0.9, 2.1) 2.7 (1.2, 6.0) 0.98 (0.56, 1.7) 1.2 (0.69, 2.1) 
 
Skin response to sun5 
 
             
   Tan / burn then tan 769 (82%) 162 (67%) 43 (66%) 67 (72%) 80 (67%) 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref 
   Always burn 169 (18%) 81 (33%) 22 (34%) 26 (28%) 39 (33%) 1.8 (1.2, 2.8) 1.8 (0.88, 3.9) 1.6 (0.81, 3.0) 1.7 (0.90, 3.1) 
 
Eye color5 
             
   Dark / light brown 199 (21%) 16 (7%) 4 (6%) 7 (8%) 7 (6%) 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref 
   Hazel / green 345 (37%) 88 (36%) 22 (35%) 30 (32%) 55 (46%) 3.1 (1.6, 6.1) 3.1 (0.90, 10.9) 2.0 (0.79, 5.1) 3.8 (1.4, 9.7) 
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   Blue/grey 386 (42%) 137 (57%) 38 (59%) 56 (60%) 57 (48%) 3.5 (1.8, 6.7) 3.9 (1.1, 7.4) 3.1 (1.3, 7.4) 3.1 (1.2, 8.0) 
 
Sun exposure 
Occupation type4 
             
   Mainly indoors 412 (44%) 81 (33%) 26 (40%) 37 (40%) 42 (35%) 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref 
   Indoors and 
 
327 (35%) 79 (33%) 20 (31%) 33 (35%) 47 (40%) 1.1 (0.71, 1.8) 0.95 (0.44, 2.0) 0.90 (0.49, 1.7) 0.90 (0.51, 1.6) 
   Mainly outdoors 199 (21%) 82 (34%) 19 (29%) 23 (25%) 30 (25%) 1.4 (0.82, 2.2) 1.2 (0.51, 2.8) 0.95 (0.45, 1.9) 0.67 (0.34, 1.3) 
 
Number of painful sunburns4 
            
   None 139 (16%) 31 (13%) 13 (20%) 6 (6%) 13 (11%) 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref 
   1 to 5 506 (54%) 111 (46%) 28 (43%) 38 (41%) 60 (50%) 1.4 (0.84, 2.4) 1.0 (0.45, 2.3) 2.4 (0.95, 6.2) 2.0 (0.85, 4.6) 
   6 or more 292 (31%) 101 (41%) 24 (37%) 49 (53%) 46(39%) 3.2 (1.8, 5.7) 1.9 (0.74, 4.9) 6.0 (2.3, 15.8) 3.4 (1.4, 8.5) 
 
Skin changes  
Solar Keratoses on face4 6 
            
   None/1 to 4 716 (76%) 90 (37%) 25 (39%)   1.0 Ref 1.0 Ref     
   5 or more 222 (34%) 153 (63%) 40 (61%) n/a 1.8 (1.2, 2.7) 4.5 (2.1, 9.7) n/a 
 
Solar Keratoses on trunk4 
     
      
   None 837 (89%)   50 (54%) 69 (58%)     1.0 Ref 1.0 Ref 
   1 to 4 83 (9%) n/a 27 (29%) 38 (32%) n/a 2.7 (1.4, 5.5) 2.1 (1.1, 4.0) 
   5 or more 18 (2%)   16 (17%) 12 (10%)     4.2 (1.5, 11.9) 2.2 (1.1, 4.4) 
              
             1 CI, confidence interval; 
         2 BCCs of the nodular growth pattern only, occurring on the head and neck or the trunk as indicated; 
         3 BCCs of the superficial growth pattern only, occurring on the head and neck or the trunk as indicated; 
4 Estimates were derived from a multivariable model that contained age, sex, randomised sunscreen treatment and self-reported   
   skin response to acute sun exposure in addition to the variable of interest; 
5 The model used was the same as 4 but also included a term for occupation; 
6 This variable was collapsed into two categories because very few people with facial superficial BCCs had no solar keratoses on 
the face. 
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CHAPTER 6  
BASAL CELL CARCINOMA AND CUMULATIVE SUN 
EXPOSURE: AN AUSTRALIAN LONGITUDINAL COMMUNITY-
BASED STUDY 
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6.1  Introduction 
This results chapter comprises a manuscript that has been submitted for publication 
to the Archives of Dermatology and as such is presented here in the format required 
for manuscript submission.  This manuscript was first submitted on December 21 
2009 and has subsequently been resubmitted with revisions and is awaiting editorial 
decision.  It directly addresses research question R7 (see section 1.7):  To what 
extent do BCCs develop on people who have histological evidence of chronic 
cutaneous sun damage or other clinical signs of actinic skin damage? 
 
6.2  Contribution of the candidate 
I conceived and designed the investigation with advice from Prof Adèle Green and 
Dr Jolieke van der Pols.  I developed new variables to capture the number of times a 
person had been affected by BCC during the observation period and variables 
concerning the histology growth patterns of the BCCs.  I derived all time-dependent 
variables that captured each person’s sun exposure history.  The remaining 
variables were available in the existing datasets.  I assisted with the physical 
selection of individual tissue slides that were to be stained and oversaw the handling 
of the slides.  I performed the data analyses and drafted the manuscript. 
 
6.3  Acknowledgement of the contribution of others 
All the data included in the following manuscript were collected as part of the 
Nambour Skin Cancer Study.  The Nambour Skin Cancer Study was originally 
conceived and designed by the Nambour Skin Cancer Study investigators, namely, 
Prof Adèle Green and Prof Gail Williams.  Prof H.Konrad Muller performed the 
grading of each tissue section for the degree of solar elastosis (see Appendix 4) and 
the editing of the manuscript.  Dr Jolieke van der Pols and Prof Adèle Green 
contributed to the interpretation of the results and assisted with the editing and 
drafting of the manuscript. 
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Abstract 
 
Objective 
To investigate the relationship between incident basal cell carcinoma (BCC) and 
objective markers of cumulative sun damage to the skin.  
 
Design, setting and participants 
A randomly-selected sample of 97 incident BCCs that occurred during follow-up of 
participants in an Australian community-based study between 1992 and 2007 and for 
which diagnostic tissue was available for histologic assessment.  
 
Main Outcomes Measures 
Histologic dermal elastosis adjacent to the tumor and other markers of cumulative 
sun damage assessed by dermatologists prior to BCC occurrence, namely neck 
elastosis, telangiectasia, solar lentigines and solar keratoses, and the associations of 
these markers with BCC. 
 
Results  
Dermal elastosis was more likely to be seen adjacent to head and neck BCCs than 
trunk BCCs (p=0.01).  Severity of dermal elastosis increased on each site with 
increasing clinical signs of cutaneous sun damage on that site.  Among subsites of 
the head /neck itself, BCCs on neck (75%) and forehead (37%) most often showed 
adjacent severe elastosis while BCCs round the eyes showed the least (0%).  All 55 
people who developed head and neck BCCs had at least 3 different pre-existing 
signs of solar damage (including dermal elastosis) to skin of the face and neck, and 
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41 of the 42 people with trunk BCCs showed at least one pre-existing sign of solar 
damage to the skin of the trunk.  
 
Conclusions 
Histologic elastosis adjacent to BCCs generally reflects prevalent solar damage to 
skin in the same region.  All BCCs on the head, and all but one on the trunk, 
developed in people who had objective signs of cumulative cutaneous sun damage 
in the corresponding anatomic region prior to BCC occurrence. 
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Introduction 
Sun exposure is considered the major environmental factor associated with basal 
cell carcinoma (BCC) 1, supported by evidence such as the strong inverse latitude 
gradient in incidence rates 2 and an anatomic distribution that is consistent with 
general levels of sun exposure across body sites 3, 4. 
 
It has been debated however whether it is acute or cumulative sun damage that is 
necessary for BCC pathogenesis due to mixed results in relation to self-reported sun 
exposure 5-10.  For exploration of causal sun exposure, more reliable and objective 
measures than recalled sun exposure are needed and these include objective 
clinical signs or histologic evidence of photodamage.  A small number of studies 
(three case-control 6, 7, 11, one cohort 10) have shown, for example, that solar 
keratoses caused by long-term sun exposure, are significant risk factors for BCC.  At 
the tissue level, two previous studies have measured the degree of histologic dermal 
elastosis in or adjacent to BCC tumors 12, 13, 14.  The first 12, a Lebanese hospital-
based study of 262 BCCs (95% from the head and neck), reported that 93% of BCCs 
were associated with some degree of solar elastosis.  Facial subsites with the 
greatest proportion of BCCs that showed adjacent moderate/marked dermal 
elastosis were the nose, cheeks and forehead 12.  They also reported that 33% of 
BCCs had no or mild dermal elastosis, and paradoxically about half of these BCCs 
were from the head and neck.  In a study of 175 BCCs (58% from the head and 
neck) diagnosed at assorted primary care and specialist clinics in the northern USA, 
25% were observed to be associated with adjacent dermal elastosis 14. 
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In the present study we have documented in a representative sample of BCCs from 
the head and neck and the trunk, the presence of adjacent dermal elastosis, along 
with other measures of long-term cutaneous sun damage to the skin of the head and 
trunk among affected participants.  We also studied the relation of recalled number 
of sunburns as an objective sign of acute sun damage, to signs of chronic sun 
damage, in order to address the comparative roles of cumulative versus intense 
acute sun exposure in BCC development. 
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Materials and Methods 
 
The Nambour Skin Cancer Study 
 
Study participants were originally randomly selected in 1986 from the electoral 
register of all adult residents of the subtropical township of Nambour in Queensland, 
Australia (latitude 26°S), for a baseline study of skin cancer 15.  All participants 
completed a standard questionnaire at baseline about pigmentary traits including 
skin colour.  During 1992 to 1996, participants took part in a field trial to assess 
sunscreen application and betacarotene supplementation in skin cancer prevention.  
Detailed descriptions of the community sample, field trial and its long-term outcomes 
have been published previously 15-17.  In 1996, participants were invited to take part 
in a long-term follow-up study of skin cancer.  Continuing participants provided 
written consent to have skin cancers notified to the investigators by regional 
pathology laboratories in Queensland, allowing 100% ascertainment of histologically 
confirmed BCCs, 1992 to end of follow-up in 2007.  No participants were immuno-
compromised, and none had nevoid basal cell carcinoma syndrome.  Ethical 
approval was obtained from the ethics committee of the Queensland Institute of 
Medical Research. 
 
Cumulative photodamage and sunburn history 
 
Participants were examined at baseline by dermatologists who documented standard 
signs of photodamage (photodamage of the neck, telangiectasia, solar lentigines, 
solar keratoses).  In 1992, 1994 and 1996 information about sunburn history was 
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updated by questionnaire and dermatologists carried out full skin examinations.  All 
clinical signs in a person predated diagnosis of their BCC.  (For example, for a BCC 
diagnosed in 1995 the extent of photodamage was taken as the most severe 
recorded in either 1986, 1992 or 1994, but not 1996.)   
 
Basal cell carcinomas 
 
All BCCs were verified histologically.  Investigators abstracted details of anatomic 
site from pathology reports and requested the tumor tissue for all BCCs from the 
relevant pathology laboratories.  Among a total of 1202 BCCs, 489 had tumor tissue 
available upon request, 403 of which occurred on the head (typically sun-exposed) 
or trunk (not typically sun-exposed).  From these 403, 97 tumors were randomly 
selected as a manageable number for histologic assessment.  
 
Elastotic stain and grading 
 
Degree of dermal elastosis was assessed in the normal skin immediately adjacent to 
the BCC tumor tissue using whole transverse cross-sections (5 mm) cut from 
formalin-fixed, paraffin-embedded tumor blocks.  Sections were deparaffinized and 
rehydrated in 10mM citrate buffer (pH 6.0), stained with freshly prepared Verhoeff`s 
haematoxylin staining solution for 30 minutes, and following a water rinse, were 
dipped in 2% ferric chloride.  The differentiation process was controlled by dipping 
the slide in containers of either ferric chloride or water, and continued until black 
elastic fibres were distinguishable.  Slides were then rinsed in water for 2 minutes, 
treated with 95% alcohol for 2 minutes and again rinsed in water for 2 minutes.  
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Sections were counterstained with Van Gieson’s solution 18 for 3 minutes, 
dehydrated directly into absolute alcohol, mounted and dried.  For all BCCs a 
separate whole transverse cross-section stained with hematoxylin and eosin was 
available for histological reference. 
 
Dermal elastosis was graded on an ascending scale from 0 to 3.  Grade 0 referred to 
normal skin with no evidence of thickened elastic fibres.  Increasing scores 
represented increasing numbers of fibres from a few scattered, to large aggregations 
of strongly stained elastic fibres, up to a distinct band of elastotic material (grade 3). 
 
Statistical analysis 
 
Fisher’s exact test was used to assess statistical differences and a p value less than 
0.05 was considered statistically significant.  All variables were treated as categorical 
variables.  For the purposes of assigning a value to the degree of sun damage 
among those BCCs from people with similar evidence of sun damage, the modal 
category was chosen and where equal numbers of BCCs were associated with two 
categories the lower was chosen as the conservative estimate.  Statistical analyses 
were conducted using SAS version 9.1 (SAS Institute Inc., Cary, North Carolina).  
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Results 
 
Study population 
 
The 97 BCCs included in this study had been diagnosed in 73 study participants, 35 
males and 38 females, at an average age of 64 years.  Among these 73 people, 13 
had more than one BCC included in the study sample, of whom only one person had 
two BCCs diagnosed on the same date at the same anatomic site (the back).  All 
BCCs were from either the head and neck (55 BCCs, 57%) or trunk (42 BCCs, 43%).  
Among the 73 people, 48 (66%) had fair skin and 25 (34%) had medium skin colour. 
 
Perilesional dermal elastosis 
 
Amongst the 97 BCCs, 70 (72%) had histological evidence of dermal elastosis of any 
grade (Figure 1).  The majority of BCCs were associated with mild or moderate 
levels of dermal elastosis, 28% and 24% respectively.  Twenty (21%) BCCs were 
associated with severe dermal elastosis. 
 
The proportion of BCCs with associated dermal elastosis was similar among males 
and females (72% for males, 73% for females, p=0.16) and the degree of dermal 
elastosis increased with age at diagnosis (83% in those aged 60 years or older vs. 
56%% in those aged less than 60 years, p=0.02).  There was no difference in the 
degree of dermal elastosis when BCCs from people with a single BCC were 
compared to those from people with multiple BCCs (67% vs. 74% respectively, 
p=0.655).  This was also true when stratified by anatomic site and skin color. 
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Head and neck BCC 
 
Among the 55 BCCs from the head and neck, 42 (76%) had histological evidence of 
perilesional dermal elastosis.  With regard to clinical markers of cumulative actinic 
damage on the skin of the head and neck, every BCC in the study sample was 
associated with one or more of the following: neck photodamage (Figure 2), 
telangiectasia, solar lentigines or solar keratoses.  25 (45%) BCCs came from 20 
people all of whom had evidence of all five markers of cumulative cutaneous sun 
damage. 
 
Trunk BCC 
 
Among the 42 BCCs from the trunk, 26 (62%) had histological evidence of 
perilesional dermal elastosis.  With regard to clinical markers of skin damage due to 
cumulative sun exposure to the trunk, all BCCs except for one were associated with 
solar lentigines and or solar keratoses.  Of all BCCs on the trunk, 7 (17%) BCCs 
were from 6 people all of whom had evidence of all three markers of cumulative sun 
damage. 
 
Anatomic subsite and perilesional dermal elastosis 
 
Among all BCCs, those from the head and neck were significantly more likely to be 
associated with dermal elastosis than BCCs from the trunk, 76% and 67% 
respectively (p=0.012, supplementary table).  Specifically, 16 (29%) BCCs from the 
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head and neck were associated with a severe degree of dermal elastosis compared 
with 4 (10%) BCCs from the trunk. 
 
With regard to anatomic subsites on the head and neck and trunk, Table 1 describes 
the presence and degree of dermal elastosis associated with BCCs.  Whilst 58% of 
all head and neck BCCs had moderate to severe dermal elastosis, a higher 
proportion of the BCCs on the neck, and cheek and perioral subsites had moderate 
to severe dermal elastosis, 88% and 67% respectively.  Conversely, 75% of the 
BCCs from the eye area had no dermal elastosis.  Most BCCs from the back had 
nil/mild dermal elastosis (70%) and all chest BCCs had nil/mild dermal elastosis 
(Table 1). 
 
Recalled acute photodamage 
 
44 (80%) of head and neck BCCs and 39 (93%) of BCCs on the trunk occurred on 
37 and 35 participants, respectively, who had reported a history of sunburns 
(Supplementary table).  The single person who developed a trunk BCC without 
perilesional dermal elastosis or any other signs of cumulative sun damage reported 
experiencing at least 6 painful sunburns.    
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Discussion  
 
In a random sample of 97 BCCs developed by participants in an Australian 
community-based cohort study, we found that every tumor except one occurred in 
conjunction with perilesional dermal elastosis and/or other cutaneous signs of 
cumulative sun damage in the associated anatomic region.  Most BCCs occurred in 
people who had multiple signs of chronic photodamage.  Furthermore our data 
showed that the great majority of people affected by the 97 study BCCs reported 
suffering acute photodamage as well (usually multiple times). 
 
Numerous studies have assessed the effects of sun exposure on BCC risk.  
Previous studies, however, have been limited to a single BCC from affected people 
only 19, 20 and have sometimes excluded people with a previous skin cancer 20.  The 
findings from studies like these and larger descriptive studies of BCC’s anatomic 
distribution 22, 23 have led to the hypothesis that BCCs occurring on the head and 
neck have a different sun-related etiology to BCCs on the trunk.  In contrast, this 
study has studied representative samples of all BCCs from a community-based 
cohort with diagnostic tissue available and shown that almost all have developed in 
those who have pre-existing signs of long-term photodamage, on the anatomic site 
of BCC occurrence.  Further, virtually every BCC (with the exception of one on the 
trunk) was unique according to date and/or site including from the same person, and 
therefore could contribute independently to the study. 
  
Given the strong evidence for sun exposure in BCC pathogenesis we expected that 
all of the BCCs in this series would have some degree of perilesional dermal 
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elastosis but our findings showed some 28% of BCCs had no histological evidence 
of perilesional elastosis, including 24% of head and neck BCCs.  The proportion of 
BCCs in this study without perilesional dermal elastosis is somewhat higher than the 
7% reported by Zaynoun et al. 12 to be without dermal elastosis.  Another study from 
the temperate northern USA with roughly equal numbers of BCCs from the head and 
neck, and from the trunk, reported a lower prevalence of perilesional dermal 
elastosis at 25% which is most likely due to the lower ambient UV environment from 
which these BCCs arose 14.   
 
One previous study has also investigated the anatomic subsites of BCC in relation to 
the degree of perilesional dermal elastosis 12.  Similar to our findings they reported 
that the anatomic subsites with the greatest proportion of BCCs with no or mild 
dermal elastosis were the eyes and the ears.  There were some differences in our 
findings however.  Unlike our findings, the study by Zaynoun and colleagues 12 
showed that some BCCs from the eye area did have perilesional dermal elastosis 
where we had no BCCs from the eyes with this histological skin change.  This 
suggests that dermal elastosis can develop across all facial subsites.  Although a 
third of the BCCs had no evidence of associated dermal elastosis virtually all were 
associated with cumulative photodamage.  This suggests that cumulative sun 
exposure is necessary for the pathogenesis of the majority of BCCs.  Usually (in 
86% of cases) the pre-existing chronic signs were accompanied by a history of acute 
photodamage (sunburns), in agreement with a body of evidence to date also 
showing that self-reported histories of sunburns are strongly associated with general 
BCC risk 5-7, 10.  There is a literature surrounding the questionable reliability of 
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sunburn recall among adults 24, 25 making it a less robust measure of photodamage 
than the other more objective measurements used in this study. 
 
With regard to study limitations, only a restricted number of BCCs could be included 
in this study, even though they were chosen at random.  This placed a constraint on 
the statistical power of the study.  With regard to sunburns, beyond the poor 
reliability of past sunburns, nor could we be sure exactly which anatomic site/s were 
affected by the sunburn, and thus we were unable to assess the effects of acute sun 
damage on specific body sites in relation to site of BCC development. 
 
We conclude that BCC carcinogenesis is inextricably associated with cumulative 
photodamage to the particular site of BCC occurrence.  It appears that the most 
important aspect of previous sun exposure is the total UV dosage received by the 
epidermis (at the target cell level) rather than the pattern (cumulative or acute) 
whereby it was received. 
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Figures 
 
Figure 1  Photomicrographs of perilesional elastotic changes adjacent to basal 
cell carcinomas nil (A), mild (B), moderate (C) and severe (D).
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Figure 2  Examples of skin of the neck with (A) no-mild photodamage, (B) 
moderate photodamage or (C) severe photodamage. 
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Tables 
 
Table 1  Degree of solar elastosis associated with basal cell carcinomas   
according to anatomic subsite in Queensland, Australia 
 
 
 
  
 
Anatomic subsite 
 
Degree of solar elastosis 
 
 
 Nil 
 
Mild 
 
Moderate 
 
Severe 
 Head & Neck     
    Overall 13 (24%) 10 (18%) 16 (29%) 16 (29%) 
        Forehead & temple 3 (27%) 2 (18%) 2 (18%) 4 (37%) 
        Ears 1 (17%) 2 (33%) 3 (50%) 0 (0%) 
        Eyes  3 (75%) 1 (25%) 0 (0%) 0 (0%) 
        Nose 5 (36%) 1 (7%) 5 (36%) 3 (21%) 
        Cheek & perioral 1 (8%) 3 (25%) 5 (42%) 3 (25%) 
        Neck 0 (0%) 1 (12.5%) 1 (12.5%) 6 (75%) 
 
Trunk  
    
    Overall 14 (33%) 17 (40%) 7 (17%) 4 (10%) 
        Back  11 (30%) 15 (40%) 7 (19%) 4 (11%) 
        Chest 3 (60%) 2 (40%) 0 (0%) 0 (0%) 
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Supplementary data  
 
Supplementary Table 1  Markers of acute and long term skin damage associated with basal cell carcinomas (BCC) in Queensland,   
                                       Australia  
 
  
Histological 
perilesional 
skin damage 
 
Clinical cumulative skin damage 
 
Recalled 
acute skin 
damage 
  
Number of 
BCCs 
  
Head and neck 
 
Trunk 
 
  
Elastosis  
 
photodamage  
 
Telangiectasia  
 
Solar 
keratoses 
 
 
Solar 
lentigines 
 
Solar 
keratoses 
 
Solar 
lentigines 
 
History of 
sunburns 
 25 (45%)  Severe Severe Severe ≥5 1 to 10   1 to 5 
 7 (13%) Nil Moderate Severe ≥5 1 to 10   ≥6 
 7 (13%) Moderate Severe Moderate ≥5 1 to 10 Nil 
 5 (9%) Moderate Moderate Moderate ≥5 Nil 1 to 5 
 2 (3.6%) Severe Moderate Nil 1 to 4 1 to 10   1 to 5 
 1 (1.8%) Moderate Nil-mild Moderate Nil 1 to 10  
 
 
n/a 
≥6 
 2 (3.6%) Nil Moderate Moderate Nil Nil 1 to 5 
 2 (3.6%) Nil  Moderate Moderate 1 to 4 1 to 10 Nil 
 1 (1.8%) Severe Moderate Moderate ≥5 Nil Nil 
 1 (1.8%) Mild Moderate Nil  Nil 1 to 10 ≥6 
 1 (1.8%) Nil Moderate Moderate Nil 1 to 10 Nil 
 1 (1.8%) Nil  Moderate Moderate Nil 1 to 10  1 to 5 1 to 5 
         
 10 (24%) Moderate     Nil 1 to 10 1 to 5 
 7 (17%) Mild     1 to 4 1 to 10 1 to 5 
 5 (12%) Nil     1 to 4 1 to 10 ≥6 
 3 (7%) Nil    
n/a 
 Nil  Nil  ≥6 
 5 (12%) Nil   Nil  ≥11 1 to 5 
 3 (7%) Moderate   1 to 4 Nil  1 to 5 
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 5 (12%) Moderate   Nil  Nil  ≥6 
 1 (2%) Nil      1 to 4 Nil  ≥6 
 1 (2%) Moderate     1 to 4 Nil  Nil 
 2 (5%) Mild     Nil  1 to 10  Nil 
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CHAPTER 7  
DISCUSSION 
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Broadly, this collection of specific, connected studies sought to better 
understand the epidemiology of BCC.  In particular it aimed to address key 
knowledge gaps in the field: to document the incidence of BCCs with a focus 
on the occurrence of multiple BCCs and their body distribution, and also to 
document how constitutional and environmental factors contribute to the 
occurrence of multiple BCCs within individuals, the anatomic distribution and 
histologic subtypes of BCC.  Furthermore, this research project addressed 
these gaps in knowledge through a unique epidemiological platform: a 
community-based prospective study.   
 
As illustrated in Figure 7.1, new outcomes can be added on two levels to 
refine the epidemiological understanding of BCC in the context of recently 
published studies.  Study limitations have been discussed below, alongside 
the strengths.  This is followed by an exploration of recommended future 
work in this area. 
 
Inclusive approach to research methodology for BCC  
 
In consideration of the vast BCC literature, few studies have actually 
researched the phenomenon of multiple BCCs per person (key articles 
include: (Marghoob et al., 1993; Raasch and Buettner, 2002; Ramachandran 
et al., 2009; van Iersel et al., 2005) (All references in Chapter 7 can be found 
in the final List of References).  This is a consequence of the fact that most 
previous BCC investigations stem from studies of the case-control or cross-
sectional design (key articles include: (Gallagher et al., 1995; Naldi et al., 
2000; Pelucchi et al., 2007; Rosso et al., 1996), so the data required to 
support explicit research into BCC multiplicity were often not available.  
Further, previous BCC studies that were founded on the prospective study 
design often restricted their investigations to the first BCC for each person 
(Neale et al., 2007) or did not acknowledge multiple BCCs (Han et al., 2006; 
van Dam et al., 1999).  Whilst these previous studies were insightful and 
contributed to an increase in BCC information, it is possible they did not 
sufficiently assess BCC because for those people who had had more than 
one BCC they  
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Figure 7.1  Diagrammatic overview of thesis outcomes 
 
 
 
analysed only part of their disease occurrence.  Multiplicity of BCC should be 
an important consideration for future research projects: findings of BCC 
investigations that account for the full disease complement for each person 
will more accurately reflect BCC biology.   
 
Another important consideration is that the association between BCC and its 
major environmental risk factor, sun exposure, becomes stronger with time.  
This is reflected most clearly in the increase of BCC incidence with older age, 
suggesting the association is time- and/or dose-dependent.  In the case of 
Overarching research aim 
To better understand the epidemiology of BCC in order to
reduce the burden of this skin cancer
New approach to research methodology for BCC
Papers
1 and 3
Outcome 1
Identification of magnitude 
of the burden of multiple BCCs
Papers 
2, 3, 4 and 5
Outcome 2
Cumulative sun exopsure causing 
photodamage is associated with 
BCC multiplicity,  site of 
occurrence and histology
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multiple BCCs, people may develop them over time, at different ages.  It is 
therefore necessary to account for the timing of the exposure in relation to 
each BCC’s development.  This approach was taken in this research project, 
such that if a person, for example, experienced a BCC in 1993 the exposure 
data predated 1993.  In the Nambour Study exposure data were collected in 
1986 and 1992 so data from these years could be analysed in relation to the 
BCC diagnosed in 1993.  If the person were then to develop another BCC, 
four years later, in 1997, the exposure data used still predated the date of 
diagnosis for this lesion.  After 1992, exposure data were updated in 1994 
and 1996, hence data from these years could also be analysed in relation to 
the BCC diagnosed in 1997 or any BCC that occurred newly after these data 
collections.  This approach was critical for analysing data about cutaneous 
markers of photodamage, including solar keratoses and elastosis that 
change with time. 
 
As above, it is by virtue of the prospective and community-based design of 
the Nambour Skin Cancer Study that this research project was afforded the 
opportunity to consider the multiplicity of BCC in all investigations.  In each 
aspect of this research project all people affected by BCC and all known 
BCCs developed by those people have been included.  In some cases this 
required an analytical approach that accounted for the intra-person 
correlation when more than one BCC came from the same person (repeated 
measures analysis).  This approach is rarely used in the research of BCC 
(Karagas et al., 1992; Pandeya et al., 2005).  By having taken this all-
inclusive approach this research project can substantially advance the 
understanding of BCC. 
 
Identification of the magnitude of the burden of multiple BCCs and 
associations with multiple BCCs (Papers 1 and 3) 
 
It is widely acknowledged that BCC is the most common malignancy among 
fair-skinned populations.  However, true incidence estimates are sparse 
because BCCs are not routinely registered.  Incidence estimates have largely 
come from ad hoc studies.  In North America and Europe (Bath-Hextall et al., 
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2007a; Karagas et al., 1999) incidence estimates are typically an order of 
magnitude lower than corresponding estimates for Australia.  A survey in 
2002 of over 57,000 Australians estimated an age-standardised incidence 
rate of 884 BCCs per 100,000 persons (Staples et al., 2006).  No previous 
estimates however have accounted for the occurrence of multiple BCCs per 
person and it is likely therefore that these previous studies underestimated 
the true BCC incidence.  Using up-to-date data from the Nambour Skin 
Cancer Study this research project has generated the most recent incidence 
estimates for BCC in the Australian population: the overall age-standardised 
incidence of BCC was 1541 people per 100,000 pyar, 1813 per 100,000 pyar 
among men and 1269 per 100,000 pyar among women.  These are the 
highest cancer incidence estimates ever published. 
 
Incidence overall was broken down into incidence of persons affected by a 
single BCC: 935 per 100,000 pyar and by multiple BCCs: 705 per 100,000 
pyar.  Similar to previous reports (Bath-Hextall et al., 2007a; Karagas et al., 
1999; Staples et al., 2006), for both males and females, all incidence 
estimates increased steadily with age and incidence was low before the age 
of 40 years.  More males than females were affected by BCC.  The overall 
findings reinforce the high rate at which BCCs occur and reveal for the first 
time the rate of occurrence of multiple BCCs among people who reside in a 
high UVR environment. 
 
Most previous studies of BCC that have made mention of multiple BCCs 
have limited this to a brief adjunct statement about the proportion of people 
affected by multiple BCCs.  In New Hampshire, USA, multiple BCCs occurred 
in 16% of affected patients in a 2-year period (Karagas et al., 1999), while in 
a tropical Australian community, 26% of BCC patients were treated for 
multiple BCCs in a 3-year period (Raasch and Buettner, 2002).  A follow-up 
hospital-based study in the Netherlands reported the five-year risk for a 
subsequent BCC was 30% (van Iersel et al., 2005) and in a meta-analysis of 
seven American-based studies with up to seven years follow-up, this figure 
was 53% (Marghoob et al., 1993).  It was generally unclear previously 
whether the multiple BCCs were diagnosed at the same time or different 
  152 
times.  In comparison this research project showed that over a 10 year period 
in a high incidence population, 46% of those sporadically affected by BCC 
experienced multiple BCCs and when observation was extended by 6 years, 
to a period of 16 years, this figure climbed to nearly 60%.  Among our study 
participants affected by multiple BCCs, 29% were diagnosed with two or 
more BCCs on the same date.  These estimates of the proportion of people 
affected by more than one BCC are broadly consistent with the previous 
estimates from other studies of sporadic BCCs given the longer period of 
follow-up in this research study.  They also indicate that those affected by 
multiple BCCs tend to be affected over time. 
 
We also documented in detail the anatomic distribution of BCCs among 
persons affected sporadically by more than one BCC.  A previous study with 
a mean follow-up time of two and a half years and limited only to those 
patients with a first BCC on the head and neck or the trunk, described in 
broad terms how people with multiple BCCs tended to develop them on a 
single site, in particular patients with a first BCC on the trunk (Ramachandran 
et al., 2001).  The investigators did not, however, present any indication of 
the proportion of people who developed BCC on a single or more than one 
anatomic site.  Further, the follow-up time in their study was limited to a small 
snap-shot of the true amount of time a person remains at risk of developing 
subsequent BCCs.  On the other hand a hospital-based study in the 
Netherlands with a median follow-up time of 3.1-years showed that 33% of 
people affected by multiple BCCs were affected across different sites (van 
Iersel et al., 2005), and in an American study, 45% of people affected by 
multiple BCCs developed BCCs on different anatomic sites during 7-years of 
follow-up (Marghoob et al., 1993).  In the present research study, with 16-
years of follow-up, 60% of those with multiple occurrences of BCC developed 
them on more than one anatomic region.  Further, among those who 
developed two to three BCCs, the most common site combination was to 
have both the head and neck, and trunk affected.  And among those with four 
or more BCCs, the tumors usually occurred on the head and neck, limbs and 
trunk.  Overall the pattern of tumor occurrence across anatomic sites was 
similar, whether people had a single BCC or multiple BCCs, with the head 
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and neck by far the most commonly affected site.  The site-specific incidence 
estimates were consistent with the level of sun exposure reaching each site, 
in agreement with other studies (Bastiaens et al., 1998; Buettner and 
Raasch, 1998; Franceschi et al., 1996).  In general, people affected by 
multiple BCCs tend to develop them across more than one anatomic site. 
 
These multiple incidence figures in conjunction with the latest overall 
incidence estimates are striking and make it apparent that the actual BCC 
tumour burden is greater in a population than is evident simply from 
incidence rates of general BCC occurrence per person.  They give some 
indication as to why treatment of BCC consumes a substantial proportion of 
annual health spending in Australia (AIHW, 2005), North America (Chen et 
al., 2001) and Europe (Morris et al., 2005).  The commonness of multiple 
BCCs, and the fact that those who have multiple BCCs tend to be affected 
across more than one anatomic site, have a two-fold public health relevance.  
Firstly for people affected by BCC there is a clear need for regular skin 
checks and these follow-up checks should be inclusive of the whole body, 
even sites that are not typically sun exposed.  This will increase the 
opportunity for early detection and treatment of subsequent BCC among 
people previously affected.  Secondly, the knowledge about anatomic sites of 
BCC predilection can be translated directly into specific evidence-based 
health messages about sun-protection.  The prevention of basal cell 
carcinoma can be achieved by the avoidance of excessive UV exposure 
especially to the head and neck, and in particular, the nose.  In terms of 
scientific value, the frequency of people with multiple BCCs being affected on 
more than one anatomic site suggests a common pathogenic mechanism is 
shared by BCCs across sites (see below).  This research project provides 
insight into the potential magnitude of the BCC tumour burden in Caucasian 
populations, especially those living in places of intense sun exposure or 
frequently holidaying in such places. 
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BCCs have strong associations with clinical signs of early life sun 
exposure and cumulative photodamage 
 
Sun exposure is considered the major environmental factor for general BCC 
pathogenesis (Rubin et al., 2005).  Previous studies have shown that the 
nodular growth pattern is the most common (Boi et al., 2003) and nodular 
BCCs tend to occur on the head and neck  (Bastiaens et al., 1998; Boi et al., 
2003).  This is the site most commonly treated for BCC (Raasch et al., 2006) 
and has a greater opportunity for sun exposure than the trunk where 
superficial BCCs, the second most common subtype mostly occur (Bastiaens 
et al., 1998; Raasch et al., 2006).  These previous observations led to the 
hypothesis that BCCs of different histological subtypes or different sites of 
occurrence have different sun-related etiologies (Pelucchi et al., 2007; 
Scrivener et al., 2002).  The majority of studies that have supported this 
hypothesis however have been based on assorted large series of 
retrospectively collected pathology reports.  In the current study we were in a 
strong position to be able to assess BCCs on different anatomic sites for their 
relationship to sun exposure, because markers of chronic sun damage at 
each site of occurrence could be used to test for site-specific associations.  
Among people with facial telangiectasia, solar lentigines and solar keratoses 
the odds for developing a BCC on the head and neck was 2-fold higher than 
people without these signs of photodamage.  Similarly for people with solar 
lentigines or solar keratoses on the trunk the odds for developing a BCC at 
this site were about 3-fold higher than the odds for people without these skin 
changes.  This site-specific association was also seen for BCC on the limbs: 
among people with solar keratoses on the limbs the odds for developing a 
BCC were nearly 4 times higher than for people without solar keratoses on 
the limbs.  These findings suggest that BCCs regardless of anatomic site of 
occurrence are strongly associated with previous high solar ultraviolet 
radiation exposure. 
 
With regard to the above-mentioned hypothesis that BCCs of different 
histological subtypes have different sun-related aetiologies, it was not clear, 
based on the evidence available, if the risk was mainly determined by the 
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anatomic site, the sun exposure histories of the host, or some other factors.  
This is because the only study to have assessed risk factors for nodular and 
superficial BCCs separately did not account for anatomic site of occurrence 
(Pelucchi et al., 2007).  In this thesis the importance of clinical markers of sun 
damage was also assessed in relation to BCC’s two major histological growth 
patterns, nodular and superficial.  Present analyses were stratified by 
anatomic site to ensure that the associations were not due to the different 
opportunity for sun exposure on the head and neck, and the trunk.  For BCCs 
on the head and neck and those on the trunk a history of five or more painful 
sunburns was strongly associated with nodular and superficial BCCs.  Strong 
associations with increasing solar keratoses counts were evident for both 
BCC subtypes on each site when compared to people with no solar 
keratoses.  These results suggest that BCCs of different histological growth 
patterns appear to have similar aetiologies which suggests that the growth 
patterns of BCCs are determined by their micro-environment (the skin at the 
anatomic site) perhaps influencing the target cell rather than the external 
environment (sun exposure history). 
 
With regard to multiple BCCs within a person, a limited number of previous 
studies in selected clinical populations have suggested that multiple BCC 
occurrence is associated with increasing age (van Iersel et al., 2005) and fair 
skin (Lovatt et al., 2005; Ramachandran et al., 1999), but little was known 
about the importance of sun exposure history and photodamage over time, in 
the development of sporadic multiple BCCs.  Skin complexion was not 
associated with multiple BCCs among all people affected by BCC.  We next 
assessed if sun exposure history was able to distinguish between people with 
single versus multiple BCCs but after prolonged follow-up found no 
association between reported recreational or occupational sun exposure and 
the occurrence of intermediate or high numbers of BCCs versus single BCC.  
Nor did we find any evidence that the number of sunburns, a measure of 
acute sun damage, was associated with multiple BCCs.  We did however; 
find that melanocytic nevi on the forearm but not the back are associated with 
multiple BCCs later in life.  Given the difference in melanocyte biology across 
sites (those on the trunk require less cumulative sun exposure than 
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melanocytes on other site to undergo changes) suggests that there is more 
than simple nevus propensity playing a role and that it likely reflects the 
importance of childhood sun exposure influencing risk.  The most striking 
observed difference between the patient groups was that the odds for 
developing many BCCs were over 4-fold higher among participants who had 
high numbers of solar keratoses.  Other measures of photodamage, facial 
telangiectasia and solar elastosis, were not associated with multiplicity of 
BCC among cases. 
 
Given the apparent importance of photodamage to BCCs, it was 
hypothesised as part of this research project that all BCCs would have 
evidence of perilesional solar elastosis, a histological marker of cumulative 
photodamage.  This was not observed to be true however.  Among the 
unselected 55 head and neck BCCs sampled, 25 BCCs (45%) were from 20 
people who had facial elastosis, telangiectasia, solar keratoses, solar 
lentigines and perilesional solar elastosis.  Among the 42 truncal BCCs 
sampled, 28 BCCs (67%) were from 25 people who had a history of at least 
two clinical signs of photodamage (truncal solar keratoses, solar lentigines, 
perilesional solar elastosis) and 17% had evidence of all three of these skin 
changes.  Overall, most BCCs occurred in people who had multiple signs of 
chronic photodamage and every tumour except one occurred in conjunction 
with perilesional elastosis and/or other cutaneous signs of cumulative sun 
damage in the associated anatomic region.  BCCs from the head and neck 
were significantly more likely to be associated with perilesional elastosis than 
BCCs from the trunk and severity of dermal elastosis increased on each site 
with increasing clinical signs of cutaneous sun damage on that site.  BCC 
carcinogenesis appeared to be inextricably associated with cumulative 
photodamage to the particular site of BCC occurrence. 
 
The results generated from this research project challenge the view that 
BCCs on different body sites or of the nodular or superficial growth patterns 
are different in their association past sun exposure.  The analyses presented 
in this thesis differ somewhat to those of previous studies because 
participants’ subsequent BCCs were taken into account for analyses where 
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the site of occurrence was the outcome and when histological subtype was 
the outcome, the site of occurrence was accounted for. This approach meant 
there was less opportunity for confounding in our analyses.  Our findings 
suggest that all BCCs have similar aetiologies in the sense that they are 
strongly associated with experience of high sun exposure.  This was 
observed consistently when considering BCC site of occurrence, nodular and 
superficial growth patterns, and multiple BCC occurrences.  Further the site-
specific prevalence of photodamage, especially solar keratoses, can be 
regarded as evidence for, and personal dosimeters of, chronic sun damage 
to the site affected.  Thus our data indicate that persons who develop 
multiple BCCs have received a greater dose of solar UVR than people with a 
single BCC in general.  A history of sunburns, however, was associated with 
BCC histology but not site or multiplicity.  This is likely to be because these 
analyses included only people affected by BCC, whereas the former included 
a reference group of people who were unaffected by BCC.  For this reason it 
is possible that sunburn is associated with BCC multiplicity and site when 
comparisons are made to people unaffected by BCC.  Given the observation 
that not all BCCs have histologic evidence of perilesional photodamage but 
are associated with photodamage at the general site of occurrence, even for 
BCCs across different sites, suggests a common pathogenic mechanism is 
shared by BCCs.  This study’s finding that the association between forearm 
nevi and increased odds for BCC on the head and neck and trunk is stronger 
when the individual has reported a high lifetime sun exposure history further 
supports this theory.  In terms of scientific value it is apparent from our 
findings that BCCs can and do arise in specific anatomic sites that do not 
have histological evidence of severe sun damage, suggesting that BCC 
carcinogenesis occurs prior to severe and long term photodamage.  The 
public health relevance of this is that BCCs, regardless of site, histology, 
order of occurrence can be prevented through limiting the cumulative amount 
of sun exposure.  These findings suggest that control of BCC multiplicity in 
the population at large is feasible through decreasing cumulative sun 
exposure, thereby helping to curb the substantial encumbrance that BCC 
places on health systems serving white populations. 
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Limitations 
 
As above, the strengths of this study were the longitudinal data collection and 
the community-based sample who were representative of their community at 
large (Green et al., 1994), with complete ascertainment of all histologically-
confirmed BCCs in a 16-year period.  Despite its strengths, this research 
project it is not without limitations.  Whilst some participants had a BCC prior 
to the observation period, the BCC records for that time were incomplete for 
some participants.  Therefore certainty about the BCC status of all 
participants was only possible for the 16-year observation period.  Due to the 
substantial length of follow-up time the data upon which this thesis is based 
represent the typical BCC-experience of a community during a window of 16 
years.  The analyses were, however, repeated in the sub-group of 
participants who reported that they did not have previous BCC (n=335) and 
similar results were obtained, thus we believe this has not influenced our 
findings to any material extent. 
 
A second epidemiological limitation inherent in the data collected as part of 
the Nambour Skin Cancer Study is that a retrospective evaluation of some 
exposure information was required.  In particular information about sun 
exposure, including: sunburns, recreational and occupational histories.  Due 
to the longitudinal nature some of the information was collected on repeated 
occasions.  It is possible therefore that some participants provided some 
information following the diagnosis of a skin cancer and thus the diagnosis 
may have affected their accuracy of recall.  The lack of association between 
recreational and occupational sun exposure history and BCC (multiplicity, site 
of occurrence and histology) may be explained by the phenomenon where 
people especially at low latitudes, self-select occupations to which they are 
suited (more olive skinned people working in outdoor occupations (Green et 
al., 1996)).  Regarding sunburn history, there is mixed literature surrounding 
the reliability of sunburn recall among adults (Berwick and Chen, 1995; 
Shoveller and Lovato, 2001; van der Mei et al., 2006).  This may be attributed 
to the acute nature of sunburns, making it a subjective measure of sun 
damage than other more objective measurements.  Also the disparate 
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prevalence of sunburn between countries and studies (going from extremely 
common in Australian to rare in some European populations) may give 
invalid recall.  Consequently this study’s estimates of the acute intense 
pattern of sun exposure in a high prevalence setting may not reflect the true 
association.  Further it is uncertain exactly which anatomic site/s were 
affected by sunburn, which limited the assessment of the site-specific effects 
of acute sun damage.  This uncertainty, however, was offset somewhat by 
the use of objectively measured clinical markers of cumulative sun damage.  
Markers of chronic photodamage such as solar keratoses flag a history of 
long-term sun exposure (Rossi et al., 2007) and thereby remove the error 
when recall is used to assess the amount of past sun exposure a person has 
experienced.  Interpretation of findings in relation to photodamage and BCC 
in general are strongly indicative of the role of overexposure to UVR but not 
the specific aspects of that overexposure, for example the pattern and exact 
dose received.   Interpretations of the perilesional elastosis data were limited 
due to the restricted number of BCCs assessed; there was not sufficient 
statistical power to test for differences between various subgroups.  Thus this 
research study has not been able to specifically identify which aspects of 
long-term/intense UV exposure cause BCC pathogenesis. 
 
This thesis presented odds ratios as an estimate of the level of risk 
associated with the exposures.  Although all data for this research study were 
taken from a cohort study and relative risk estimates would normally be 
expected from such data, due to the nature of BCC occurring multiple times 
in some people and the polytomous outcome variables used in these 
analyses, a multinomial log regression, where repeated measures can be 
accounted for, would have been the most appropriate approach.  This was 
not possible for this student to perform at the time of analysing these data 
and thus multinomial logistic regression with repeated measures was used.  
Relative risk estimates were generated, however, using binomial logistic 
regression, and the magnitude of the estimates was similar (data not shown).  
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Future directions 
 
Although this research project has made a substantial advancement in our 
understanding of BCC, a significant amount of further work is still needed to 
fully explore the implications of the findings.  Future work is required on two 
levels: the medical research and public health platforms. 
 
Medical research 
 
A critical step in furthering our understanding of BCC and ultimately reducing 
the burden of this skin cancer lies in understanding the role that molecular 
factors play in BCC pathogenesis.  A key goal of future studies should be to 
relate the patient phenotype and clinical cancer profile to a list of defining 
genomic, proteomic and immunologic principles.  For this to happen it will be 
critical to pursue an integrated approach, through the combination of 
epidemiologic and laboratory-based disciplines. 
 
Whilst much information is known about genetic aberrations associated with 
sporadic BCC development, (including in Patched-1, smoothened, and p53), 
the role of detoxifying proteins (like GST) and immunological factors, future 
studies need to understand what this information means in light of other 
relevant data in order to turn this information into useful knowledge about the 
cancer.  Future studies should focus on whether these factors vary according 
to fundamental aspects of the skin cancer and its host, including site of 
occurrence, histology, the multiplicity of BCC, past history of skin cancer and 
host phenotype information.  Further, the pooling of resources between 
studies (for example, using tissue samples from the Nambour Skin Cancer 
Study and other prospective population-based datasets) to boost sample size 
and the generalisability of results will make the most of the opportunities that 
interdisciplinary research can provide.  The ultimate goal of these studies 
should be to understand how elements at the sub-human level influence 
responses to exposures at the environmental level and vice versa. 
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Public health 
 
In contrast to many other cancers, skin cancers, including BCC are largely 
preventable.  Prevention efforts for BCC often occur in conjunction with other 
skin cancers because they each share the same major environmental 
exposure – ultraviolet radiation.  In order to advance prevention efforts, 
changes to primary and secondary prevention approaches are necessary.   
 
Primary prevention efforts should be centred on the effective communication 
of skin cancer information and evidence-based prevention messages.  This 
information should be disseminated widely, including to people of all ages 
and residing in all locations within Australia.  It should be made readily 
available through a variety of sources including, the internet, newspapers, 
pamphlets, TV and radio.  Further, specific prevention messages should be 
created for key populations that have been identified as being at risk of high 
levels of sun exposure or being especially susceptible to skin cancer (for 
example, solid organ transplant patients).  Just as these prevention 
strategies should encourage the individual to be sun-aware, they must also 
target the relevant bodies responsible for providing infrastructure to the 
community, such that they provide improved shade design, including tree 
planting for outdoor areas.  All in all primary prevention efforts should 
continue to focus on the reduction of intense acute and cumulative sun 
exposure throughout a person’s life, such as through midday sun avoidance 
and the targeted use of protective clothing and sunscreen on those sites that 
sustain the greatest amount of sun exposure. 
 
With regard to primary prevention I suggest two actions for the continued and 
better prevention of skin cancer: 
 
1. The Australian government (www.skincancer.gov.au) endorses an 
awareness campaign that encourages people not rely on a single 
means of sun protection.  This could be encouraged at the many 
Australian schools.  For example, the current “No hat.  No play” policy 
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could be extended by to include sunscreen:  “No hat or sunscreen. No 
Play”. 
 
2. Theoretically, if a person adheres to skin cancer prevention guidelines 
their risk for skin cancer should be minimised.  Realistically though 
there are a number of barriers that discourage some people from 
taking these actions and one of them is the purchase of sun-protective 
clothing and sunscreens.  I suggest therefore that the government 
provide subsidy for the cost of these items thus making them more 
readily available to the community at large. 
 
In terms of secondary prevention, it will be important for all individuals 
affected by BCC, especially those with photodamage, to be monitored by 
health care professionals for the development of subsequent BCCs.  
Furthermore patient education should focus on the key warning signs of 
BCC: clinical markers of photodamage. 
 
Finally, efforts should also be directed toward monitoring and evaluating the 
existing prevention programs and revitalising them, in light of new evidence-
based research information, when needed. 
 
These actions will ultimately lead to a better understanding of what causes 
BCC and how best to control the onset of this disease. 
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Appendix 1 
 
Publication of work partly performed during the PhD but unrelated to the main 
thesis topics: 
 
Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and 
p16 immunostaining in cutaneous melanomas 
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Appendix 2 
 
Key publications from the Nambour Skin Cancer study 
 
The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: 
Design and Baseline characteristics of Participants 
 
Daily sunscreen application and betacarotene supplementation in 
prevention of basal-cell and squamous-cell carcinomas of the skin: a 
randomised controlled trial 
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Appendix 3 
 
Studies presenting the association between selected pigmentary 
characteristics, sunburn and sun exposure measures1 and basal cell 
carcinoma 
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Reference, 
location, 
study name 
 
 
Study 
description 
 
Exposure 
assessment 
 
Exposure categories 
 
Risk estimates 
 
Naldi et al 
2000, Italy, 
Italian Group 
for 
Epidemiologi
cal research 
in 
Dermatology 
 
Case-control: 528 
cases with 
incident 
histologically 
confirmed BCC 
diagnosed in 
hospotial study 
centres, 512 non-
dermatology 
patients of same 
hospitals, 1995-
1996 
 
Dermatologically 
assessed 
 
Skin colour 
  Dark, olive 
  Medium 
  Fair/pale  
 
1.0 
1.1 (0.7-1.6) 
1.1 (0.7-1.6) 
 Hair colour 
  Black, dark brown 
  Light brown 
  Blonde 
  Red 
 
1.0 
1.0 (0.7-1.4) 
1.0 (0.6-1.8) 
9.1 (1.1-73.4) 
  Eye colour 
  Black, brown 
  Green, hazel 
  Blue, grey 
 
1.0  
1.9 (1.4-2.7) 
1.8 (1.3-2.5) 
  Melanocytic nevi 
  None 
  1-5 
  ≥6 
 
1.0  
1.7 (1.2-2.3) 
1.6 (1.1-2.4) 
  Self 
administered 
questionnaire 
Skin reaction to sun exposure 
  Never burn 
  Burn occasionally 
  Burn frequently/always 
 
1.0 
1.1 (0.8-1.4) 
2.4 (1.7-3.8) 
   Number of severe sunburn 
episodes before age 15 
  None 
  1 
  2+ 
 
 
1.0  
2.8 (1.9-4.1) 
3.9 (1.6-9.2) 
   Actinic keratoses 
  No  
  Yes  
 
1.0 
2.8 (2.0-4.0) 
Vlajinac et a;, 
2000, 
Belgrade and 
Zrenjanin, 
Yugoslavia, 
1996-1997 
Case-control: 200 
consecutive 
cases at skin 
departments, 
100% 
histologically 
confirmed, 399 
non-cancer 
dermatology 
patients from 
same skin 
departments 
Interviewer-
administered 
standard 
questionnaire 
Eye colour: brown 0.09 (0.02-0.37) 
Skin reaction to sun exposure: 
usually burns with no or little 
tan  
 
4.34 (2.27-8.31) 
  
Kricker et al, 
1991, 
Geraldton, 
Australia, 
Case-control: 201 
cases with 
incident BCC 
from population 
survey, 100% 
histologically 
confirmed, 700 
controls who 
were disease free 
at population 
survey/year prior 
Personal 
calendar and 
interviewer-
administered 
standard 
questionnair 
Number of painful sunburns to 
the BCC affected site 
  None 
  1 to 2  
  3 to 10 
  11+ 
 
 
1.0 
1.1 (0.7-1.8 
1.8 (1.0-2.9) 
1.5 (1.0-2.3) 
Zanetti et al, 
2006, 14 
Case-control: 215 
male cases with 
Interviewer 
administered 
Hair colour 
  Dark 
 
1.0 
  208 
centres in 
Italy, spain, 
france, 
Portugal, 
Denmark, 
Germany, 
Argentina, 
2001-2002 
incident BCC 
diagnosed in 
hospitals, 100% 
histologically 
confirmed.  349 
non-dermatology 
male patients of 
same hospitals 
as controls 
standard 
questionnaire 
  Brown 
  Blonde 
  Light blonde/red 
1.6 (1.07-2.52) 
2.3 (1.32-3.94) 
2.6 (1.39-5.02) 
 Eye colour 
  Dark 
  Green 
 
1.0 
2.6 (1.63-4.13) 
 Tendency to tan 
  Tan 
  No tan 
 
1.0 
1.5 (1.01-2.12) 
  Number of nevi 
  None 
  Some 
  Several 
 
1.0 
1.2 (0.82-1.91) 
1.5 (0.68-3.38) 
   Sunburns during lifetime 
  Never 
  Sometimes 
  Often  
 
1.0 
1.4 (1.01-2.42) 
1.7 (1.01-2.82) 
Kricker et al, 
1991, 
Geraldton, 
Australia, 
1987 
Case-control: 226 
cases with 
histologically 
confirmed BCC, 
1015 controls 
with no skin 
cancers 
Dermatologically 
assessed 
Hair colour 
  Dark brown 
  Light brown 
  Blonde, fair 
  Red  
 
1.0 
1.15 (0.82-1.61) 
1.47 (0.88-2.47) 
1.80 (1.18-6.66) 
  Eye colour 
  Dark brown/hazel 
  Blue  
  Green  
 
1.0 
1.00 (0.71-1.39) 
1.14 (0.75-1.75) 
   Propensity to burn 
  Brown/no burn 
  Burn/ then tan 
  Pain/ peeling 
  Burn/ blisters 
 
1.0 
1.38 (0.81-2.34) 
1.69 (0.98-2.91) 
1.53 (0.79-2.99) 
   Ability to tan 
  Very brown 
  Moderate tan 
  Mild tan 
  Freckle/no tan 
 
1.0 
1.66 (1.10-2.51) 
2.23 (1.37-3.63) 
2.13 (0.99-4.59) 
   Number of nevi on back 
  None to 3 
  4+ 
 
1.0 
1.80 (1.22-2.65) 
   Solar keratoses 
  None 
  1 to 5 
  6 to 14 
  15 to 39 
  40+ 
 
1.0 
2.07 (1.28-3.36) 
2.75 (1.64-4.61) 
5.31 (3.26-8.63) 
10.44 (5.81-18.78) 
Han et al, 
2006, USA, 
Nurse’s 
Health Study 
Nested case-
control study, 283 
cases, 804 
controls 
Retrospective 
self-
administered 
questionnaire 
Severe sunburns in lifetime 
  None 
  1 to 4 
  5 to 9 
  ≥10 
 
1.0 
1.38 (0.90-2.11) 
1.55 (0.95-2.55) 
1.37 (0.81-2.21) 
Green et al, 
1996, 
Nambour, 
Australia, 
Nambour 
Skin Cancer 
Study 
1675 randomly 
selected adults 
from community 
register, skin 
cancer diagnoses 
followed up 1985-
1992, 250 BCC  
cases 
Self-
administered 
questionnaire, 
Skin colour 
  Olive 
  Medium 
  Fair  
 
1.0 
0.98 (0.54-1.75) 
2.0 (1.18-3.39) 
 Hair colour 
  Dark brown/black 
  Blonde/light brown 
  Red/auburn 
 
1.0 
1.36 (1.03-1.81) 
1.81 (1.12-2.82) 
  209 
Number of melanocytic nevi 
on arms and hands 
  None 
  1 to 10 
  11 to 20 
  ≥21 
 
 
1.0 
0.91 (0.66-1.25) 
1.60 (0.94-2.74) 
1.72 (0.55-5.42) 
 Dermatologically 
assessed 
Number of painful sunburns 
  None 
  1 
  2 to 5 
  6+ 
 
1.0 
0.91 (0.55-1.50) 
1.10 (0.73-1.67) 
1.68 (1.10-2.57) 
   Solar keratoses in 1986 
  None 
  1 to 10 
  ≥11 
 
1.0 
2.48 (1.78-3.43) 
3.78 (2.59-5.53) 
Van Dam et 
al, 1999, 
USA, Health 
Professionals
’ Follow-up 
Study 
44 951 male 
health 
professionals, 
including 3273 
BCC cases, 
1986-1994 
Self-
administered 
questionnaire 
Hair colour 
  Black 
  Dark brown 
  Light brown 
  Blonde 
  Red  
 
1.0 
1.08 (0.93-1.25) 
1.15 (0.99-1.34) 
1.13 (0.94-1.35) 
1.46 (1.15-1.86) 
   Eye colour 
  Brown 
  Hazel/green 
  Blue  
 
1.0 
1.19 (1.07-1.32) 
1.10 (0.98-1.22) 
   Skin reaction to sun exposure 
as an adolescent 
  Tan, not burn 
  Burn, then tan 
  Painfully burn, then peel 
 
1.0 
1.51 (1.37-1.67) 
2.13 (1.90-2.38) 
   Melanocytic nevi on arms 
  None 
  1 to 2 
  3 to 5 
  ≥6 
 
1.0 
1.27 (1.14-1.41) 
1.29 (1.11-1.50 
1.20 (1.00-1.45) 
   Sunburns during lifetime 
  None  
  1 to 2 
  3 to 3 
  6 to 9 
  10+ 
 
1.0   
1.14 (1.00-1.30) 
1.20 (1.05-1.38) 
1.33 (1.14-1.54) 
1.49 (1.30-1.71) 
Gallagher et 
al, 1995, 
Alberta, 
Canada, 
1983-1984 
Case-control: 226 
male cases with 
incident BCC 
identified from 
cancer registry, 
100% 
histologically 
confirmed, 406 
male controls 
selected from 
population based 
health register 
Interviewer 
administered 
standard 
questionnaire 
Skin colour 
  Dark 
  Medium 
  Light  
 
1.0 
4.8 (1.7-13.6) 
4.0 (1.4-11.3) 
Hair colour 
  Black  
  Brown  
  Blonde  
  Red  
 
1.0  
0.6 (0.3-1.4) 
0.6 (0.3-1.4) 
2.1 (0.7-2.2) 
  Eye colour 
  Black 
  Hazel 
  Green, grey 
  Blue  
 
1.0 
1.7 (0.9-3.1) 
1.1 (0.6-2.3) 
1.4 (0.8-2.4) 
  Severe sunburn during lifetime 
  No 
  Yes  
 
1.0 
0.9 (0.6-1.3) 
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Walther et al, 
2004, Ulm 
and Dresden,  
Germany, 
1985-1997 
Case-control: 213 
cases with 
histologically 
confirmed BCC 
identified through 
dermatology 
departments, 411 
dermatology and 
non-cancer 
patients from 
same 
departments 
Interviewers 
administered 
standard 
questionnaire 
Immediate skin reaction to 
short period of UV exposure 
  No redness  
  Redness  
 
 
1.0 
2.2 (1.4-3.3) 
Skin colour 
  III or IV 
  I or II 
 
1.0 
3.5 (2.5-5.0) 
 Hair colour 
  Brown or black 
  Red or fair 
 
1.0 
3.7 (2.6-5.2) 
  Eye colour 
  Brown 
  Grey or green 
  Blue  
 
1.0 
1.8 (1.1-2.9) 
2.7 (1.8-4.1) 
  Sunburn 
  No  
  Yes 
 
1.0 
3.2 (2.2-4.6) 
   Actinic keratoses 
  No 
  Yes  
 
1.0 
7.2 (4.8-10.8) 
Rosso et al, 
1996, 8 
centres on 
France, Italy 
and Spain, 
1989-1993, 
HELIOS 
study 
Case-control: 
1549 cases with 
histologically 
confirmed BCC 
cases diagnosed 
in 5 cancer 
registries and 2 
hospitals, 1795 
controls from 5 
population 
registers and 
non-cancer, non-
dermatology 
patients of 3 
hospitals 
Interviewer 
administered 
standard 
questionnaire 
Hair colour 
  Black 
  Brown 
  Light brown 
  Blonde 
  Light blonde 
  Red  
 
1.0 
1.16 (0.87-1.54) 
1.21 (0.90-1.62) 
1.24 (0.89-1.71) 
1.70 (1.14-2.54) 
1.34 (0.57-3.12) 
 Eye colour 
  Black/dark brown 
  Blue/hazel/grey/green 
 
1.0 
1.39 (1.17-1.65) 
  Skin reaction to sun exposure 
  Tan, no burn 
  Burn then tan 
  Burn, never tan 
 
1.0 
1.48 (1.24-1.76) 
2.81 (2.18-3.62) 
  Sunburns during lifetime  
  Less than 3 
  ≥3 
 
1.0 
1.05 (0.86-1.42) 
Rosso et al, 
1998, 
Europe, 
1984-1993 
Case-control: 420 
cases with 
histologically 
confirmed BCC 
selected from 
HELIOS study, 
835 controls 
selected from 
HELIOS study 
and population 
Interviewers 
administered 
standard 
questionnaire 
Hair colour 
  Black/brown 
  Light brown 
  Blond/red  
 
1.0 
1.3 (1.0-1.7) 
1.8 (1.2-2.6) 
  Eye colour 
  Dark 
  Blue/green/hazel 
 
1.0 
1.1 (0.8-1.5) 
  Skin reaction to sun exposure 
  Tan, no burn 
  Burn then tan 
  Burn, never tan 
 
1.0 
1.3 (0.9-1.6) 
2.4 (1.4-4.0) 
Corona et al, 
2001, Rome, 
Italy, 1995-
1997 
Case-control: 166 
cases with 
incident BCC 
histologically 
confirmed 
diagnosed at 
referral hospital, 
158 dermatology 
patients from 
same hospital 
Interviewer 
administered 
standard 
questionnaire 
Actinic keratoses 
  No 
  Yes  
 
1.0  
3.2 (1.1-9.4) 
  
1 Sunburn and sun exposure measure are italicised 
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Appendix 4 
 
 
Solar elastosis scoring sheet 
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Nambour Skin Cancer Study Solar Elastosis Scoring Sheet 
Scored by............                Date…......... 
 
 
Study ID / 
Lesion 
Number 
 
Amount of elastotic 
material adjacent to 
malignant tissue 
 
0 = nil 
+ = minimal/mild 
++ = moderate 
+++ = severe 
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